UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-K
(Mark
One)
☒
ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the fiscal year ended December 31 , 2025
OR
☐
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO
Commission
File Number 001-42909
FUSEMACHINES
INC.
(Exact
name of Registrant as specified in its Charter)
Delaware
98-1602789
(State
or other jurisdiction of
incorporation
or organization)
(I.R.S.
Employer
Identification
No.)
251
West 30th Street , 5th Floor
New
York . New York
10001
(Address
of principal executive offices)
(Zip
Code)
Registrant’s
telephone number, including area code: (347) 212-5075
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading
Symbol(s)
Name
of each exchange on which registered
Common
stock, $0.0001 par value per share
FUSE
The
Nasdaq Stock Market LLC
Warrants,
each exercisable for one share of Common Stock
FUSEW
The
Nasdaq Stock Market LLC
Securities
registered pursuant to Section 12(g) of the Act: None
Indicate
by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
Indicate
by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒
Indicate
by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer
☐
Accelerated
filer
☐
Non-accelerated
filer
☒
Smaller
reporting company
☒
Emerging
growth company
☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. ☐
If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The registrant was no t a public company as of June 30, 2025, the last business day of its most recently completed
second fiscal quarter, and therefore, cannot calculate the aggregate market value of its voting and non-voting common equity held by non-affiliates
as of such date. The registrant’s common stock began trading on the Nasdaq Global Market on October 23, 2025.
The
number of shares of the registrant’s common stock outstanding as of March 26, 2026 was 28,938,266 .
Auditor
Firm Id:
2983
Auditor
Name:
KNAV
CPA LLP
Auditor
Location:
Atlanta, Georgia
Table
of Contents
Page
PART I
1
Item
1.
Business
1
Item
1A.
Risk Factors
3
Item
1B.
Unresolved Staff Comments
30
Item
1C.
Cybersecurity
30
Item
2.
Properties
31
Item
3.
Legal Proceedings
31
Item
4.
Mine Safety Disclosures
31
PART II
32
Item
5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
32
Item
6.
[Reserved]
32
Item
7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
33
Item
7A.
Quantitative and Qualitative Disclosures about Market Risk
58
Item
8.
Financial Statements and Supplementary Data
58
Item
9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
58
Item
9A.
Controls and Procedures
59
Item
9B.
Other Information
60
Item
9C.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
60
PART III
61
Item
10.
Directors, Executive Officers and Corporate Governance
61
Item
11.
Executive Compensation
61
Item
12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
61
Item
13.
Certain Relationships and Related Transactions, and Director Independence
61
Item
14.
Principal Accounting Fees and Services
61
PART IV
61
Item
15.
Exhibits, Financial Statement Schedules
61
Item
16.
Form 10-K Summary
61
i
Special
Note Regarding Forward-Looking Statements
This
Annual Report on Form 10-K (“Annual Report”) contains forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”). These forward-looking statements are based on our management’s current beliefs and assumptions
and on information currently available to our management, and are contained principally in the sections entitled “Business,”
“Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Forward-looking statements include all statements that are not historical facts and can be identified by terms such as “anticipates,”
“believes,” “best in class,” “could,” “seeks,” “estimates,” “expects,”
“first-in-class,” “focused,” “goal,” “intends,” “may,” “objective,”
“opportunity,” “pipeline,” “plans,” “potential,” “predicts,” “projects,”
“pursuing,” “should,” “target,” “treatment option,” “will,” “would,”
“might,” “can,” “continue” or similar expressions and the negatives of those terms.
These
forward-looking statements include, among other things, statements about:
●
our
ability to effectively operate our business segments;
●
our
ability to manage our research, development, expansion, growth and operating expenses;
●
our
ability to evaluate and measure our business, prospects and performance metrics;
●
our
ability to compete, directly and indirectly, and succeed in a highly competitive and evolving industry;
●
our
ability to respond and adapt to changes in technology and customer behavior;
●
our
ability to protect our intellectual property and to develop, maintain and enhance a strong brand; and
●
other
factors (including the risks contained in the section of this Annual Report on Form 10-K entitled “ Risk Factors ”)
relating to our industry, our operations and results of operations.
Should
one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ
significantly from those anticipated, believed, estimated, expected, intended or planned.
Factors
or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of
them. We cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including
the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements
to actual results.
ii
References
to Fusemachines Inc.
In
this Annual Report on Form 10-K, unless otherwise stated or the context otherwise indicates, references to the “Company,”
“FUSE,” “Fusemachines,” “we,” “our” and “us” mean Fusemachines Inc., a Delaware
corporation, and its consolidated subsidiaries.
Trademarks
and Tradenames
The
Fusemachines logo and other trademarks of the Company appearing in this Annual Report on Form 10-K are the property of the Company. All
other trademarks, service marks and trade names in this Annual Report on Form 10-K are the property of their respective owners. Solely
for convenience, trademarks and trade names referred to in this report may appear without the ® or ™ symbols.
Market
Data, Forecasts, and Other Information
Unless
otherwise indicated, information in this Annual Report on Form 10-K concerning economic conditions, our industry, and our markets, including
our general expectations and competitive position, market opportunity and market size, is based on a variety of sources, including information
from independent industry analysts and publications, as well as our own estimates and research. In addition, certain information included
references to third-party publications regarding our business, results of operations, products, and product candidates.
Our
estimates are derived from industry and general publications, studies and surveys conducted by third-parties, as well as data from our
own internal research. These publications, studies and surveys generally indicate that their information has been obtained from sources
believed to be reliable, although they do not guarantee the accuracy or completeness of such information, and we have not independently
verified industry data from such third-party sources. While we believe our internal research is reliable and that our internal estimates
are reasonable, such research has not been verified by any independent source and our internal estimates are based on our good faith
beliefs as of the respective dates of such estimates.
iii
PART
I
Item
1. Business.
Fusemachines
is a leading provider of enterprise AI solutions, offering AI products including AI Studio, AI Engines, and AI Agents, along with supporting
services to organizations across a wide range of industries. With more than a decade of experience, we help enterprises integrate AI
into their operations to improve efficiency, reduce costs, and drive innovation. Our products and services are uniquely supported by
a global talent pool largely sourced from underserved communities, enabling us to deliver high quality AI solutions at scale while advancing
our mission of democratizing access to AI.
Our
diverse client base spans industries including consumer brands, healthcare, media, technology, government, and others. These clients
use our AI solutions to address critical business challenges such as improving sales forecasting accuracy, eliminating manual data entry
errors, automating recruitment processes, and detecting fraud in real time. Our focus on delivering measurable business outcomes has
enabled us to build long-term relationships with our clients and position Fusemachines as a partner in their AI driven transformation
efforts.
In
addition to our enterprise AI solutions, we are committed to education and talent development. Our AI training programs, including our
AI Fellowship Program, are designed to upskill students and professionals by providing hands-on experience with real world AI applications.
To date, we have certified hundreds of AI Fellows across the United States, Nepal, and the Dominican Republic. These programs help expand
the global AI talent pool and address the growing shortage of skilled AI professionals.
AI
Solutions
At
Fusemachines, we develop industry focused and problem specific AI solutions that combine software products with implementation services
to address complex business challenges. Our core platform, AI Studio, enables experimentation, model training, deployment, and lifecycle
management of AI systems. Built on top of AI Studio, AI Engines provide specialized AI capabilities for targeted use cases such as fraud
detection in food and beverage transactions or information extraction from loan documents. We also offer AI Agents that can assist with
or automate operational tasks such as interviewing candidates during the hiring process.
Our
services complement these products and include activities such as customizing and fine tuning models, integrating AI systems into existing
enterprise workflows, and developing bespoke solutions tailored to specific client needs. Clients can choose to engage with Fusemachines
through software, services, or a combination of both depending on their requirements.
Products
Our
product suite consists of our platform AI Studio, outcome-specific AI Engines, and advanced interactive AI Agents, designed to help organizations
build, deploy, and operationalize AI solutions at scale.
AI
Studio
AI
Studio is the foundational platform that powers Fusemachines’ AI solutions, enabling organizations to build, deploy, and manage
AI applications at scale. By providing a unified environment for data scientists, engineers, and business teams, AI Studio simplifies
the process of developing and operationalizing AI solutions.
AI
Studio is structured into four integrated layers that enable organizations to operationalize AI solutions efficiently. The Business Layer
sits at the top and contains the business applications, workflows, and AI-powered use cases that organizations deploy to support decision-making
and operations. Beneath it, the AI Hub provides the environment for developing, integrating, and managing AI models, engines, and agents
that power these applications. The Data Layer connects and organizes enterprise data from various sources, enabling AI systems to access
and process both structured and unstructured data. Supporting all layers is the Governance Layer, which ensures secure deployment, monitoring,
compliance, and lifecycle management of AI systems across the platform.
AI
Engines
AI
Engines are specialized AI software solutions built on top of AI Studio that are designed to deliver industry- and pain point–specific
outcomes. Each engine focuses on solving targeted business challenges within particular domains by leveraging advanced AI technologies
such as large language models (LLMs), computer vision, machine learning, and deep learning. By addressing clearly defined operational
problems, AI Engines enable organizations to automate processes, improve efficiency, and generate actionable insights that directly support
business objectives. For example, AI Engines can be used to extract information from complex documents, generate accurate answers and
summaries from large datasets, or detect suspicious activities and patterns in financial transactions at retail outlets. By combining
technologies such as document understanding, Retrieval Augmented Generation (RAG), and predictive analytics, these engines enable organizations
to automate workflows, improve operational efficiency, and gain deeper insights from their data.
AI
Engines are designed to be highly customizable and adaptable to the needs of different industries such as finance, legal, healthcare,
and enterprise operations. They can operate within a customer’s existing infrastructure while maintaining strong data security,
governance, and access control.
AI
Agents
AI
Agents are intelligent systems built on top of AI Engines and AI Studio that automate complex workflows and interact with users or systems
to accomplish specific tasks. These agents combine capabilities such as reasoning, retrieval, API execution, data processing, and decision
support, enabling organizations to deploy AI systems that actively assist employees and customers in real-time operations.
For
instance, an AI Agent designed for recruitment can act as an interview assistant, assisting recruiters by asking role-specific questions
and evaluating responses. The agent can analyze candidate answers, generate summaries of strengths and areas for improvement, and produce
standardized evaluation reports for hiring teams. By automating parts of the interview and evaluation process, such agents help organizations
streamline hiring workflows, improve consistency in candidate assessments, and reduce manual effort for recruiters and hiring managers.
Services
Our
services are delivered by Forward Deployed Engineers (FDEs) who work closely with customer teams to design, implement, and operationalize
AI solutions built on top of AI Studio. These services provide hands-on support for organizations that require deeper technical collaboration
to successfully deploy AI within their environments. Leveraging the capabilities of AI Studio, our teams help customers customize and
deploy AI Engines, integrate AI into existing systems, and develop bespoke solutions that address complex challenges across AI, data,
and software systems.
1
Customization,
Model Tuning, and Deployment:
We
assist clients in customizing our AI Engines or AI Agents to meet their specific needs. This includes fine-tuning models, configuring
workflows, and deploying solutions through AI Studio. Our teams also support the integration of these engines and agents into the client’s
existing business workflows, data pipelines, and enterprise systems to ensure seamless operation and alignment with business objectives.
Bespoke
AI Solutions:
For
organizations with specific requirements where existing AI Engines may not fully address their needs, we develop custom AI Engines and
AI Agents tailored to their specific business challenges. This may involve designing new models, building specialized AI capabilities,
and integrating them with enterprise data systems and workflows to deliver solutions that align closely with the client’s operational
requirements.
To
manage these engagements at scale, we developed Squadery, an internal platform that supports multiple teams within Fusemachines. Squadery
centralizes operational data from various sources including our CRM and HR systems to streamline project management, resource allocation,
and delivery coordination across service engagements.
Intellectual
Property
Intellectual
property (IP) is a critical asset for Fusemachines, and we take significant measures to protect our innovations. Our IP portfolio includes
patents, trademarks, copyrights, and trade secrets, all of which are designed to safeguard our technology and maintain our competitive
edge.
● Patent
Portfolio : As of December 31, 2025, Fusemachines holds 8 patent applications. These
patents cover a range of technologies that are central to our AI solutions, and we continue
to pursue additional IP protection as we develop new products and solutions.
● IP
Strategy : We rely on a combination of IP protection strategies, including license
agreements, intellectual property assignment agreements, confidentiality agreements, and
non-disclosure agreements. These measures help us secure our intellectual property rights
and ensure that they are respected globally.
For
more information, please see “Risk Factors – Risks Related to Business, Industry, and Operations”.
Competition
and Market Opportunity
Competition
The
AI and digital transformation landscape is highly competitive, with a wide range of players offering various solutions. Fusemachines
faces competition from several sources, including:
●
Corporate
IT organizations that develop internal AI solutions.
●
Commercial
enterprise and point solution software providers that offer specialized AI tools.
●
Open-source
software platforms with data management, machine learning, and analytics capabilities.
●
Public
cloud providers offering discrete tools and microsolutions for AI and analytics.
●
System
integrators that provide custom software solutions tailored to specific business needs.
Market
Opportunity
The
global AI market is set for substantial growth, with the global AI market itself is expected to reach nearly $1.4 trillion by 2029, and
the AI software segment is anticipated to generate around $791.5 billion in revenue by 2025. However, this expansion is challenged by
a global shortage of AI talent, with 63% of businesses citing AI and machine learning as their biggest skills gap.
We
believe we are well-positioned to capitalize on this market opportunity. With over a decade of experience in developing AI solutions,
we have gained valuable insights into addressing customer challenges. Our solutions, including AI Studio and AI Engines, along with our
comprehensive AI services, allow us to provide highly specialized and problem-specific solutions that deliver substantial ROI. Moreover,
our AI talent development programs, such as the AI Fellowship program, support our ability to cultivate skilled talent as needed, fueling
our growth and helping us capture a significant share of the market in the years ahead.
Our
Corporate History
We
were originally organized as CSLM Acquisition Corp. (“CSLM”), a Cayman Islands exempted company. CSLM was formed as a special
purpose acquisition company for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses. CSLM closed its IPO (the “CSLM IPO”) in January 2022, generating
gross proceeds of $189,750,000.
2
On
January 22, 2024, CSLM, entered into a business combination agreement, as amended on August 27, 2024, by and among CSLM, CSLM Merger Sub, Inc., a Delaware
corporation and a direct, wholly-owned subsidiary of CSLM (“Merger Sub”), Fusemachines Inc., a Delaware company (“Legacy
Fusemachines”), and CSLM Holdings, Inc. (“CSLM Holdings”) (as amended, the “Business Combination Agreement”).
On
October 22, 2025, (a) CSLM merged with and into CSLM Holdings, at which time the separate existence of CSLM ceased and CSLM Holdings
became the surviving corporation (the “Company” or “Fusemachines”) (such transactions, the “Business
Combination”). In connection with the Business Combination, the Company was renamed “Fusemachines Inc.”
and Legacy Fusemachines was renamed “Fusemachines USA, Inc.”
Available
Information
Our principal offices are located at 251 West 30th Street, 5th Floor, New
York, New York 10001. We also maintain a website at www.fusemachines.com and https://ir.fusemachines.com/, where additional information
about our company and solutions can be found. Information contained on or that can be accessed through our website is neither a part of,
nor incorporated by reference into, this Annual Report on Form 10-K, and you should not consider information on our website to be part
of this Annual Report on Form 10-K.
Human
Capital
As of December 31, 2025, we had more
than 270 full-time employees. As of December 31, 2025, none of our employees were represented by
labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good. We
emphasize several measures and objectives in managing our human capital assets, including, among others, (i) employee safety and
wellness, (ii) talent acquisition and retention, (iii) employee engagement, development, and training, (iv) diversity and inclusion
and (v) compensation. These targeted ideals may include annual bonuses, stock-based compensation awards, a 401(k) plan., healthcare,
and insurance benefits, health savings and flexible spending accounts, paid time off, family leave, family care resources, and/or
employee assistance programs. We also provide our employees with access to various innovative, flexible, and convenient health and
wellness programs. We designed these programs to support employees’ physical and mental health by providing tools and
resources to improve or maintain their health status and encourage engagement in healthy behaviors.
Item
1A. Risk Factors.
Investing
in our securities involves a high degree of risk. Before you make a decision to buy our securities, in addition to the risks and uncertainties
discussed above under “Special Note Regarding Forward-Looking Statements,” you should carefully consider the risks and uncertainties
described below together with all of the other information contained in this Annual Report, including our financial statements and related
notes included at the end of this Annual Report and in the section titled “Management’s Discussion and Analysis of Financial
Condition and Results of Operations.” If any of the events or developments described below were to occur, our business, prospects,
operating results and financial condition could suffer materially, the trading price of our securities could decline, and you could lose
all or part of your investment. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties
not presently known to us or that we currently believe to be immaterial may also adversely affect our business.
3
Risk
Factors Summary
Below
is a summary of material factors that make an investment in our securities speculative or risky. Importantly, this summary does not address
all of the risks and uncertainties that we face. You should carefully consider the full risk factor disclosure outlined in this Annual
Report, in addition to the other information herein, including the section of this report titled “Management’s Discussion
and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes.
●
The
market for our enterprise AI services and products is relatively new, and may decline or experience limited growth, and our business
is dependent on our clients’ continuing adoption and use of its services and products.
●
We
have experienced moderate growth in the past several years, and if we fail to effectively manage our growth, then our business, results
of operations and financial condition could be adversely affected.
●
Our
sales efforts involve considerable time and expense and our sales cycle is often long and unpredictable. These fluctuations may negatively
impact our results of operations and financial condition.
●
Our
results of operations depend on sales to commercial enterprise organizations, which make product purchasing decisions based in part
or entirely on factors, or perceived factors, not directly related to the features of the platforms.
●
A
limited number of customers account for a substantial portion of our revenue. If existing customers do not make subsequent purchases
from us or renew their contracts with us, or if our relationships with its largest customers are impaired or terminated, our revenue
could decline, and its results of operations would be adversely impacted.
●
If
we do not successfully develop and deploy new technologies to address the needs of its customers, its business and results of operations
could suffer.
●
Our
ability to sell its products and satisfy its customers is dependent on the quality of our services, and our failure to offer high
quality services could have a material adverse effect on its sales and results of operations.
●
If
we are not able to maintain and enhance its brand and reputation, our relationships with its customers, partners, and employees may
be harmed, and its business and results of operations may be adversely affected.
●
If
the market for our platforms and services develops more slowly than we expect, our growth may slow or stall, and our business, financial
condition, and results of operations could be harmed.
●
Issues
raised by the use of AI (including machine learning) in our platforms may result in reputational harm or liability.
●
Real
or perceived errors, failures, defects, or bugs in our products, or platforms could adversely affect our results of operations and
growth prospects.
●
We
have not been profitable in the past and may not achieve or maintain profitability in the future.
●
We
require substantial additional funding, which may not be available to us on acceptable terms, or at all, and, if not so available,
may require us to delay, limit, reduce or cease its operations.
●
Our
independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about
its ability to continue as a “going concern.”
●
Our
indebtedness could adversely affect our business and growth prospects.
●
We
face intense competition within our industry and are subject to the effects of technological change.
●
Our
proprietary products and services and service delivery may not operate properly, which could damage its reputation, give rise to
claims against us, or divert application of its resources from other purposes, any of which could harm its business and operating
results.
●
If
critical components used in our products become scarce or unavailable, we may incur delays in delivering our products and providing
services, which could damage its business.
●
If
our security measures are breached or fail and unauthorized access is obtained to a customer’s data, our service may be perceived
as insecure, the attractiveness of our services to current or potential customers may be reduced, and we may incur significant liabilities.
●
We
depend on key information systems and third party service providers.
●
Cyber-attacks
and security vulnerabilities could lead to reduced revenue, increased costs, liability claims, or harm to our competitive position.
●
We
may not be able to adequately protect or enforce our intellectual property rights or prevent unauthorized parties from copying or
reverse engineering our solutions.
●
We
rely on unpatented proprietary information, trade secrets, processes and know-how, as well as open source software in certain instances.
Our failure to protect our confidential information, trade secrets, processes and know-how, and our reliance on open source solutions,
could negatively impact our business and results of operations.
●
Algorithms
embedded in AI solutions, and AI datasets, often suffer from lack of transparency, bias, and risks of inadvertent disclosure of information,
which could subject us to adverse consequences.
●
Use
of open source software creates inherent risk and could subject us to adverse consequences.
●
Claims
by others that we infringe upon their intellectual property could force us to incur significant costs or revise the way we conduct
our business.
●
We
depend on our management team and other key employees, and the loss of one or more of these employees or an inability to attract
and retain highly skilled employees could adversely affect its business.
●
We
are subject to evolving laws and regulations that could impose substantial costs, legal prohibitions or unfavorable changes upon
our operations or products, and may be a party to material legal proceedings in the future.
●
Our
management team has limited experience managing a public company and regulatory compliance may divert their attention from the day-to-day
management of our business.
4
●
Material
adverse developments in domestic and global economic conditions, or the occurrence of other world events, could materially adversely
affect our revenue and results of operations.
●
Our
business is heavily dependent upon our international operations, particularly in Nepal, and any disruption to those operations would
adversely affect us.
●
We
have significant fixed costs related to lease facilities.
●
Our
sites operate on leasehold property, and our inability to renew our leases on commercially acceptable terms or at all may adversely
affect our results of operations.
●
Catastrophic
events, including those which impact third parties on which we materially rely, could materially adversely affect our business, results
of operations and/or financial condition.
●
We
have identified material weaknesses and significant deficiencies related in our internal control over financial reporting. If we
fail to remediate these material weaknesses, maintain effective internal control over financial reporting or identify additional
material weakness or significant deficiency in its internal control over financial reporting, our ability to report our financial
condition and results of operations in a timely and accurate manner could be adversely affected, investor confidence in our company
could diminish, and the value of our stock may decline.
●
We
filed a Quarterly Report on Form 10-Q for the period ended September 30, 2025 later than required, and any failure to timely file
our periodic reports in the future could adversely affect our compliance with securities laws and exchange listing standards, impair
our access to capital, increase regulatory scrutiny and litigation risk, and negatively impact our business and the market price
of our securities.
●
Changes
in accounting principles or their application to us could result in unfavorable accounting charges or effects, which could adversely
affect our results of operations and growth prospects.
●
If
our judgments or estimates relating to its critical accounting policies are based on assumptions that change or prove to be incorrect,
our results of operations could fall below expectations of securities analysts and investors, resulting in a decline in its stock
price.
●
Our
results of operations could be affected by currency fluctuations.
●
We
have limited insurance which may not cover claims by third parties against us or its officers and directors.
●
We
could be subject to additional tax liabilities.
●
Ongoing
and escalating political volatility in Nepal may adversely affect our business, financial condition, and results of operations.
●
The
price of our Common Stock may be volatile.
●
Our
executive officers and directors exercise significant control over the company, which may limit your ability to influence corporate
matters and could delay or prevent a change in corporate control.
●
The
requirements of being a public company may strain the Company’s resources and distract management and we will incur substantial
costs as a result of being a public company.
●
Sales
of a substantial amount of Common Stock in the public market, particularly sales by our executive officers, directors and significant
stockholders, or the perception that these sales could occur, could cause the market price of the Common Stock to decline.
●
A
decline in the price of the Common Stock could affect the company’s ability to raise working capital and adversely impact the
company’s ability to continue operations.
●
We
do not intend to pay any cash dividends in the foreseeable future and, therefore, any return on your investment in the company’s
capital stock must come from increases in the fair market value and trading price of the capital stock.
●
If
the price of the Common Stock fluctuates, you could lose a significant part of your investment.
●
The
public stockholders will experience immediate dilution as a consequence of future issuances of Common Stock pursuant to the Fusemachines
Equity Incentive Plan.
●
The
future exercise of registration rights may adversely affect the market price of the Common Stock.
●
The
Company may redeem your unexpired Public Warrants prior to their exercise at a time that is disadvantageous to you, thereby making
your Public Warrants worthless.
●
Public
Warrant holders will only be able to exercise their Public Warrants on a “cashless basis” under certain circumstances,
and if they do so, they will receive fewer shares of Common Stock from such exercise than if such warrants were exercised for cash.
●
The
Warrant Agreement will designate the courts of the State of New York or the United States District Court for the Southern District
of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of the
warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes.
●
We
are a “smaller reporting company” and “emerging growth company” under the U.S. federal securities laws, and
the reduced reporting requirements applicable to smaller reporting companies and emerging growth companies could make our common
stock less attractive to investors.
●
We
are currently an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and to the extent
we have taken advantage of certain exemptions from disclosure requirements available to emerging growth companies or smaller reporting
companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance
with other public companies.
●
We
may be subject to the Excise Tax included in the Inflation Reduction Act of 2022 in connection with redemptions of Public Shares
after December 31, 2022.
5
●
Delaware
law and the Company’s Organizational Documents contain certain provisions, including anti-takeover provisions that limit the
ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.
●
The
provisions of the Certificate of Incorporation requiring exclusive forum in the Court of Chancery of the State of Delaware and the
federal district courts of the United States for certain types of lawsuits may have the effect of discouraging lawsuits against our
directors and officers.
●
We
will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies,
which could adversely affect our business, financial condition, and results of operations.
●
We
are an “emerging growth company,” and our election to comply with the reduced disclosure requirements as a public company
may make our common stock less attractive to investors.
●
We
may lose our emerging growth company status and become subject to the SEC’s internal control over financial reporting management
and auditor attestation requirements.
●
If
we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce
timely and accurate financial statements or comply with applicable regulations could be impaired.
●
Our
business, financial condition, and results of operations may fluctuate on a quarterly and annual basis, which may result in a decline
in our stock price if such fluctuations result in a failure to meet the expectations of securities analysts or investors.
●
Changes
in accounting principles may cause previously unanticipated fluctuations in our financial results, and the implementation of such
changes may impact our ability to meet our financial reporting obligations.
●
If
our estimates or judgments relating to our critical accounting policies prove to be incorrect, our business, financial condition,
and results of operations could be adversely affected.
●
There
may not be an active trading market for our securities, which may make it difficult to sell shares of our common stock or warrants.
●
The
market price of our securities may be volatile, which could cause the value of your investment to decline.
●
There
can be no assurance that we will be able to comply with the continued listing standards of Nasdaq.
●
Because
we have no current plans to pay cash dividends on our common stock for the foreseeable future, you may not receive any return on
investment unless you sell your common stock for a price greater than that which you paid for it.
●
Sales
of a substantial number of shares of our Common Stock in the public market could cause our stock price to fall.
●
Future
sales and issuances of our Common Stock or rights to purchase Common Stock, including pursuant to our equity plans, could result
in additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall.
●
Our
management has limited experience in operating a public company.
Risks
Related to Business, Industry, and Operations
The
market for our enterprise AI services and products is relatively new, and may decline or experience limited growth, and our business
is dependent on our clients’ continuing adoption and use of its services and products.
The
use of enterprise AI is still relatively new, and customers may not recognize the need for or benefits of our services and products.
If customers do not recognize the need for and benefits of our services and products, then they may decide to adopt alternative services
to satisfy their business needs. In order to grow our business and extend our market position, Fusemachines intends to focus on educating
potential customers about the benefits of our services and products, expanding the range of our services and bringing new technologies
to market to increase market acceptance and use of our platform. Our ability to expand the market that our services and products address
depends upon a number of factors, including the cost, performance and perceived value associated with our services and products. The
market for our services and products could fail to grow significantly or there could be a reduction in demand for our services and/or
products as a result of a lack of acceptance, technological challenges, competing services, a decrease in spending by current and prospective
customers, weakening economic conditions and other causes. If the market for enterprise AI does not experience continued significant
growth, or demand for its services and/or products decreases, then our business, financial condition and results of operations could
be adversely affected.
We
have experienced moderate growth in the past several years, and if we fail to effectively manage our growth, then our business, results
of operations and financial condition could be adversely affected.
We
have experienced moderate growth in our business since our founding in 2012. This growth has placed, and may continue to place, significant
demands on our corporate culture, operational infrastructure and management. Any failure to manage our anticipated growth and organizational
changes in a manner that preserves the key aspects of its culture and services could adversely affect our overall chance for future success,
including its ability to recruit and retain personnel, and effectively focus on and pursue its corporate objectives. This, in turn, could
adversely affect its business, financial condition and results of operations.
6
In
addition, our ability to manage its operations and future growth will require us to continue to improve its operational, financial and
management controls, compliance programs with multiple and changing international laws and regulations and reporting systems. We may
not be able to implement improvements in an efficient or timely manner and may discover deficiencies in existing controls, programs,
systems and procedures, which could have an adverse effect on its business, reputation, results of operations and financial condition.
Our
sales efforts involve considerable time and expense and our sales cycle is often long and unpredictable. These fluctuations may negatively
impact our results of operations and financial condition.
Our
results of operations may fluctuate, in part, because of the intensive nature of our sales efforts and the length and unpredictability
of our sales cycle. The length of our sales cycle, from initial evaluation to payment often lasts six to eight months, but can extend
to a year or more for some customers. As part of our sales efforts, we invest considerable time and expense evaluating the specific organizational
needs of our potential customers and educating these potential customers about the technical capabilities and value of our products and
services.
Our
sales strategy is comprised of two main constituents: our direct sales team and our channel partners. Our direct sales team is tasked
with both acquiring clients in established verticals and acquiring new channel partners in expansionary markets. We leverage our channel
partners to generate leads in new verticals and geographies which we then scale through our direct sales force. Our sales team is supported
by engineers with deep technical expertise and responsibility for pre-sales technical support, solutions for engineering for our customers
and technical training for our channel partners. We generate customer leads, accelerate sales opportunities and build brand awareness
through our marketing programs and through our channel partner relationships. Our marketing programs target business units within companies
rather than purchasing, human resources or administrative departments to drive sales by demonstrating the impact of our product capabilities
on results. Our principal marketing programs include webinars, roadshows, sponsored exhibitions and events, cooperative marketing efforts
with channel partners, and use of our website.
Our
results of operations depend on sales to commercial enterprise organizations, which make product purchasing decisions based in part or
entirely on factors, or perceived factors, not directly related to the features of the platforms, including, among others, that customer’s
projections of business growth, uncertainty about macroeconomic conditions (including the occurrence of natural disasters, pandemics,
geopolitical tensions (particularly those relating to the People’s Republic of China), military conflicts rising inflation and
interest rates, or monetary policy changes), capital budgets, anticipated cost savings from the implementation of our platforms, potential
preference for such customer’s internally-developed software solutions, perceptions about our business and platforms, more favorable
terms offered by potential competitors, and previous technology investments. In addition, certain decision makers and other stakeholders
within our potential customers tend to have vested interests in the continued use of internally developed or existing software, which
may make it more difficult for us to sell our platforms and services. As a result of these and other factors, our sales efforts typically
require an extensive effort throughout a customer’s organization, a significant investment of human resources, expense and time,
including by our senior management, and there can be no assurances that we will be successful in making a sale to a potential customer.
If our sales efforts to a potential customer do not result in sufficient revenue to justify our investments, including in our growing
direct sales force, our business, financial condition, and results of operations could be adversely affected.
A
limited number of customers account for a substantial portion of our revenue. If existing customers do not make subsequent purchases
from us or renew their contracts with us, or if our relationships with its largest customers are impaired or terminated, our revenue
could decline, and its results of operations would be adversely impacted.
We
derive a significant portion of our revenue from existing customers that expand their relationships with us. Increasing the size and
number of the deployments of our existing customers is a major part of our growth strategy. We may not be effective in executing this
or any other aspect of our growth strategy.
For
the year ended December 31, 2025 and 2024, two customers represented approximately 30% and 23%, respectively, of our total revenue.
The loss of one or more significant customers or a reduction in the amount of revenue we derive from any such customer could significantly
and adversely affect our business, financial condition and results of operations. Our top customers by revenue have been long term customers.
From time to time, we may lose a major customer. It is not possible for us to predict the future level of demand from our larger customers
for our platforms and applications.
We
generally offer contract terms of up to one year in length, which may not provide for automatic renewal and may require the customer
to opt-in to extend the term. Our customers have no obligation to renew, upgrade, or expand their agreements with us after the terms
of their existing agreements have expired. In addition, many of our customer contracts permit the customer to terminate their contracts
with us with notice periods ranging from 60 to 90 days. If one or more of our customers terminate their contracts with us, whether for
convenience, for default in the event of a breach by us, or for other reasons specified in our contracts, as applicable; if our customers
elect not to renew their contracts with us; if our customers renew their contractual arrangements with us for shorter contract lengths
or for a reduced scope; or if our customers otherwise seek to renegotiate terms of their existing agreements on terms less favorable
to us, our business and results of operations could be adversely affected. This adverse impact would be even more pronounced for customers
that represent a material portion of our revenue or business operations.
7
Our
ability to renew or expand our customer relationships may decrease or vary as a result of a number of factors, including our customers’
satisfaction or dissatisfaction with our platforms and services, the frequency and severity of software and implementation errors, our
platforms’ reliability, our pricing, the effects of general economic conditions, competitive offerings or alternatives, or reductions
in our customers’ spending levels. If our customers do not renew or expand their agreements with us or if they renew their contracts
for shorter lengths or on other terms less favorable to us, our revenue may grow more slowly than expected or decline, and our business
could suffer. Our business, financial condition, and results of operations would also be adversely affected if we face difficulty collecting
our accounts receivable from our customers.
Achieving
renewal or expansion of deployments may require us to increasingly engage in sophisticated and costly sales efforts that may not result
in additional sales. In addition, our customers’ decisions to expand the deployment of our platforms depends on a number of factors,
including general economic conditions, the functioning of our platforms, the ability of our forward-deployed engineers to assist our
customers in identifying new use cases, enabling the simplification and acceleration of rapidly building applications, and our customers’
satisfaction with our services. If our efforts to expand within our existing customer base are not successful, our business may suffer.
If
we do not successfully develop and deploy new technologies to address the needs of its customers, its business and results of operations
could suffer.
Our
success has been based on our ability to design products that enables our customers to rapidly develop, deploy, and operate large-scale
enterprise AI applications. We spend substantial amounts of time and money researching and developing new technologies and enhanced versions
of existing features to meet our customers’ and potential customers’ rapidly evolving needs. There is no assurance that our
enhancements to our platforms or our new product features, capabilities, or offerings, will be compelling to our customers or gain market
acceptance. If our research and development investments do not accurately anticipate customer demand or if we fail to develop our platforms
in a manner that satisfies customer preferences in a timely and cost-effective manner, we may fail to retain our existing customers or
increase demand for our platforms.
The
introduction of new products and services by competitors or the development of entirely new technologies to replace existing offerings
could make our platforms obsolete or adversely affect our business, financial condition, and results of operations. We may experience
difficulties with software development, design, or marketing that delay or prevent our development, introduction, or implementation of
new platforms, features, or capabilities. We have in the past experienced delays in our internally planned release dates of new features
and capabilities, and there can be no assurance that new platforms, features, or capabilities will be released according to schedule.
Any delays could result in adverse publicity, loss of revenue or market acceptance, or claims by customers brought against us, any of
which could harm our business. Moreover, the design and development of new platforms or new features and capabilities to our existing
platforms may require substantial investment, and we have no assurance that such investments will be successful. If customers do not
widely adopt our new platforms, experiences, features, and capabilities, we may not be able to realize a return on our investment and
our business, financial condition, and results of operations may be adversely affected.
Our
new and existing platforms and changes to our existing platforms could fail to attain sufficient market acceptance for many reasons,
including:
●
our
failure to predict market demand accurately in terms of product functionality and to supply offerings that meet this demand in a
timely fashion;
●
product
defects, errors, or failures or our inability to satisfy customer service level requirements;
●
negative
publicity or negative private statements about the security, performance, or effectiveness of our platforms or product enhancements;
●
delays
in releasing to the market our new offerings or enhancements to our existing offerings;
●
introduction
or anticipated introduction of competing platforms or functionalities by our competitors;
●
inability
of our platforms or product enhancements to scale and perform to meet customer demands;
●
receiving
qualified or adverse opinions in connection with security or penetration testing, certifications or audits, such as those related
to IT controls and security standards and frameworks or compliance;
8
●
poor
business conditions for our customers, causing them to delay software purchases;
●
reluctance
of customers to purchase proprietary software products;
●
reluctance
of our customers to purchase products hosted by our vendors and/or service interruption from such providers; and
●
reluctance
of customers to purchase products incorporating open source software.
If
we are not able to continue to identify challenges faced by our customers and develop, license, or acquire new features and capabilities
to our platforms in a timely and cost-effective manner, or if such enhancements do not achieve market acceptance, our business, financial
condition, results of operations, and prospects may suffer and our anticipated revenue growth may not be achieved. Because we derive,
and expect to continue to derive, substantially all of our revenue from customers purchasing our platforms and products, market acceptance
of these platforms and products, and any enhancements or changes thereto, is critical to our success.
Our
ability to sell its products and satisfy its customers is dependent on the quality of our services, and our failure to offer high quality
services could have a material adverse effect on its sales and results of operations.
Once
our platforms are deployed and integrated with our customers’ existing information technology investments and data, our customers
will depend on our support and maintenance services to resolve any issues relating to our platforms. In the future, our platforms may
be deployed in large-scale, complex technology environments, and we believe our future success will depend on our ability to increase
sales of our platforms for use in such deployments. Further, our ability to provide effective ongoing services, or to provide such services
in a timely, efficient, or scalable manner, may depend in part on our customers’ environments and their upgrading to the latest
versions of our platforms and participating in our centralized platform management and services.
In
addition, our ability to provide effective services is largely dependent on our ability to attract, train, and retain qualified personnel
with experience in supporting customers on platforms such as ours. We may be unable to respond quickly enough to accommodate short-term
increases in customer demand for our services. We also may be unable to modify the future scope and delivery of our services to compete
with changes in the services provided by our competitors. Increased customer demand for support, without corresponding revenue, could
increase costs and negatively affect our business and results of operations.
Our
customers may in the future need training in the proper use of and the variety of benefits that can be derived from our platforms to
maximize the potential of our platforms. If we do not effectively deploy, update, or upgrade our platforms, succeed in helping our customers
quickly resolve post-deployment issues, and provide effective ongoing services, our ability to sell additional products and services
to existing customers could be adversely affected, we may face negative publicity, and our reputation with potential customers could
be damaged. As a result, our failure to maintain high quality services may have a material adverse effect on our business, financial
condition, results of operations, and growth prospects.
If
we are not able to maintain and enhance its brand and reputation, our relationships with our customers, partners, and employees may be
harmed, and its business and results of operations may be adversely affected.
We
believe that maintaining and enhancing our brand identity and reputation is important to our relationships with, and to our ability to
attract and retain customers, partners, investors, and employees. The successful promotion of our brand depends upon our ability to continue
to offer high-quality software, maintain strong relationships with our customers, the community, and others, while successfully differentiating
our platforms from those of our competitors. Unfavorable media coverage may adversely affect our brand and reputation. We anticipate
that as our market becomes increasingly competitive, maintaining and enhancing our brand may become increasingly difficult and expensive.
If we do not successfully maintain and enhance our brand identity and reputation, we may fail to attract and retain employees, customers,
investors, or partners, grow our business, or sustain pricing power, all of which could adversely impact our business, financial condition,
results of operations, and growth prospects. Additionally, despite our internal safeguards and efforts to the contrary, we cannot guarantee
that our customers will not ultimately use our platforms for purposes inconsistent with our company values, and such uses may harm our
brand and reputation.
9
If
the market for our platforms and services develops more slowly than we expect, our growth may slow or stall, and our business, financial
condition, and results of operations could be harmed.
The
market for our platforms is rapidly evolving. Our future success will depend in large part on the growth and expansion of this market,
which is difficult to predict and relies on a number of factors, including customer adoption, customer demand, changing customer needs,
the entry of competitive products, the success of existing competitive products, potential customers’ willingness to adopt an alternative
approach to developing, deploying, and operating enterprise AI, and their willingness to invest in new software after significant prior
investments in legacy software. The estimates and assumptions that are used to calculate our market opportunity are subject to change
over time, and there is no guarantee that any particular number or percentage of the organizations covered by our market opportunity
estimates will pay for our platforms and services at all or generate any particular level of revenue for us. Even if the market in which
we compete meets the size estimates and growth forecasts, our business could fail to grow at the levels we expect or at all for a variety
of reasons outside our control, including competition in our industry. Further, if we or other enterprise AI companies experience security
breaches or incidents, loss, corruption, or unavailability of or unauthorized access to customer data, disruptions in delivery, or other
problems, this market as a whole, including our platforms, may be negatively affected. If software for the challenges that we address
does not achieve widespread adoption, or if there is a reduction in demand caused by a lack of customer acceptance, technological challenges,
weakening economic conditions (including the occurrence of natural disasters, pandemics, geopolitical tensions (particularly those relating
to the People’s Republic of China), military conflicts, rising inflation and interest rates, and monetary policy changes), security
or privacy concerns, competing technologies and products, decreases in corporate spending, or otherwise, or, alternatively, if the market
develops but we are unable to continue to penetrate it due to the cost, performance, and perceived value associated with our platforms,
or other factors, it could result in decreased revenue and our business, financial condition, and results of operations could be adversely
affected.
Issues
raised by the use of AI (including machine learning) in our platforms may result in reputational harm or liability.
AI
is enabled by or integrated into our technology platforms and is a significant element of our business. As with many developing technologies,
AI presents risks and challenges that could affect its further development, adoption, and use, and therefore our business. AI algorithms
may be flawed. Datasets in AI training, development, or operations may be insufficient, of poor quality, or reflect unwanted forms of
bias. Inappropriate or controversial data practices by, or practices reflecting inherent biases of, data scientists, engineers, and end-users
of our systems could impair the acceptance of AI solutions. If the recommendations, forecasts, or analyses that AI applications assist
in producing are deficient or inaccurate, we could be subjected to competitive harm, potential legal liability, including under new proposed
legislation regulating AI in jurisdictions such as the United States and the European Union and brand or reputational harm. The European
Union has enacted the EU AI Act, which imposes significant compliance obligations on providers of AI systems, including requirements
for transparency, human oversight, and conformity assessments for high-risk AI applications. In the United States, various states have
enacted or proposed AI-specific legislation, and federal agencies are increasing their focus on AI governance. Compliance with these
evolving and potentially conflicting regulatory frameworks may require substantial investment in compliance infrastructure, modification
of our products and services, and could limit our ability to offer certain AI capabilities. Failure to comply with applicable AI regulations
could result in significant fines, restrictions on our business, reputational harm, and civil or criminal liability.
Some
AI scenarios present ethical issues. Though our technologies and business practices are designed to mitigate many of these risks, if
we enable or offer AI solutions that are controversial or problematic because of their purported or real impact on human rights, privacy,
employment, or other social issues, we may experience brand or reputational harm, as well as regulatory or legal scrutiny.
Real
or perceived errors, failures, defects, or bugs in our products, or platforms could adversely affect our results of operations and growth
prospects.
Because
we offer complex technology products, undetected errors, defects, failures, or bugs may in the future occur, especially when products
or capabilities are first introduced or when new versions or other product or infrastructure updates are released. Our platforms are
often installed and used in large-scale computing environments with different operating systems, software products and equipment, and
data source and network configurations, which may cause errors or failures in our platforms or may expose undetected errors, failures,
or bugs in our platforms. Despite testing by us, errors, failures, or bugs may not be found in new software or releases until after commencement
of platform implementation. Errors may affect the performance of our platforms and may also delay the development or release of new platforms
or capabilities or new versions of platforms, adversely affect our reputation and our customers’ willingness to buy platforms from
us, and adversely affect market acceptance or perception of our platforms. Many of our customers use our platforms in applications that
are critical to their businesses or missions and may have a lower risk tolerance to defects in our platforms than to defects in other,
less critical, software products. Any errors or delays in releasing new software or new versions of platforms or allegations of unsatisfactory
performance, errors, defects, or failures in released software could cause us to lose revenue or market share, increase our service costs,
cause us to incur substantial costs in redesigning the software, cause us to lose significant customers, subject us to liability for
damages and divert our resources from other tasks, any one of which could materially and adversely affect our business, results of operations
and financial condition. In addition, our platforms could be perceived to be ineffective for a variety of reasons outside of our control.
Hackers or other malicious parties could circumvent our or our customers’ security measures, and customers may misuse our platforms
resulting in a security breach or perceived product failure. Alleviating any of these problems could require additional significant expenditures
of our capital and other resources and could cause interruptions, delays, or cessation of our product licensing, which could cause us
to lose existing or potential customers and could adversely affect our business, financial condition, results of operations, and growth
prospects.
10
We
have not been profitable in the past and may not achieve or maintain profitability in the future.
We
had a comprehensive loss of approximately $0.93 million and $15.3 million for the years ended December 31, 2025 and December 31, 2024,
respectively.
There
can be no assurance that Fusemachines will ever achieve the level of revenues needed to be profitable in the future and if profitability
is achieved, that it will be sustained. Our revenues have fluctuated and are likely to continue to fluctuate significantly from quarter
to quarter and from year to year. Fusemachines will need to obtain additional capital and increase sales to become profitable.
We
require substantial additional funding, which may not be available to us on acceptable terms, or at all, and, if not so available, may
require Fusemachines to delay, limit, reduce or cease its operations.
We
have limited financial resources. There can be no assurance that sufficient funding will be available to us to fund our operating expenses
and to further develop our business. Unless we achieve substantial profitability, we anticipate that we will likely need to raise additional
capital to fund our operations while we implement and execute our business plan. We currently do not have any contracts or commitments
for additional financing. In addition, any additional equity financing may involve substantial dilution to our existing shareholders.
There can be no assurance that such additional capital will be available on a timely basis or on terms that will be acceptable to us.
Failure to obtain such additional financing could result in delay or indefinite postponement of operations or the further development
of our business. If adequate funds are not available or are not available on acceptable terms, we may not be able to further fund our
business or the expansion thereof, take advantage of strategic acquisitions or investment opportunities or respond to competitive pressures.
Such inability to obtain additional financing when needed could have a material adverse effect on our business, results of operations,
cash flow, financial condition and prospects.
Our
independent registered public accounting firm’s report for the year ended December 31, 2025 contains an explanatory paragraph that
expresses substantial doubt about our ability to continue as a “going concern.”
As
of December 31, 2025, we had cash of approximately $4,221 thousand. For the year ended December 31, 2025, we used approximately $5,529
thousand in cash for operating activities. Historically, we have incurred recurring net losses from operations and negative cash flows
from operating activities. As of December 31, 2025, we had an accumulated deficit of approximately $35,145 thousand. These factors raise
substantial doubt regarding our ability to continue as a going concern within one year of the date these consolidated financial statements
were issued.
Our
indebtedness could adversely affect our business and growth prospects.
We
have existing indebtedness, and we may be able to incur additional debt from time to time to finance working capital, capital expenditures,
investments or acquisitions, or for other purposes.
We
face intense competition within our industry and are subject to the effects of technological change.
The
industry in which we are engaged is subject to rapid and significant technological change. There can be no assurance that our systems
can be upgraded to meet future innovations in the industry or that new technologies will not emerge, or existing technologies will not
be improved, which would render our offerings obsolete or non-competitive. Many of the companies we compete with enjoy significant competitive
advantages over us, including greater name recognition; greater financial, technical and service resources; established networks; additional
product offerings; and greater resources for product development and sales and marketing. In addition, there can be no assurance that
other established technology companies, any of which would likely have greater resources than Fusemachines, will not enter the market.
There can be no assurance that Fusemachines will be able to compete successfully against any of its competitors.
Our
proprietary products and services and service delivery may not operate properly, which could damage its reputation, give rise to claims
against us, or divert application of its resources from other purposes, any of which could harm its business and operating results.
We
may encounter supply chain, human, or technical obstacles that prevent our products and services from operating properly. If our offerings
do not function reliably or fail to achieve customer expectations in terms of performance, customers could assert liability claims against
us or cancel their contracts with us. This could damage our reputation and impair our ability to attract or maintain customers. We cannot
assure you that material performance problems or defects in our products will not arise in the future. Errors may result from receipt
and interpretation of customer data or from interface of our services. These defects and errors and any failure by us to identify and
address them could result in loss of revenue or market share, liability to customers or others, failure to achieve market acceptance
or expansion, diversion of development resources, injury to our reputation, and increased service and maintenance costs. The costs incurred
in correcting any defects or errors or in responding to resulting claims or liability may be substantial and could adversely affect our
operating results.
11
If
critical components used in our products become scarce or unavailable, we may incur delays in delivering our products and providing services,
which could damage its business. We rely on a sustainable supply chain. Any issues with this supply chain could adversely affect daily
business operations and profitability.
We
depend on third party providers, suppliers and licensors to supply some of the hardware, software and support necessary to provide some
of our products and services. We obtain these materials from a limited number of vendors, some of which do not have a long operating
history, or which may not be able to continue to supply the equipment, supplies, and services we desire. If demand exceeds these vendors’
capacity or if these vendors experience operating or financial difficulties or are otherwise unable to provide the equipment or services
we need in a timely manner, at our specifications and at reasonable prices, our ability to provide some services might be materially
adversely affected, or the need to procure or develop alternative sources of the affected materials or services might delay our ability
to serve our customers. These events could materially and adversely affect our ability to retain and attract customers, and have a material
negative impact on our operations, business, financial results and financial condition.
If
our security measures are breached or fail and unauthorized access is obtained to a customer’s data, our service may be perceived
as insecure, the attractiveness of our services to current or potential customers may be reduced, and we may incur significant liabilities.
Our
services involve the web-based and data storage and transmission of customers’ information. We rely on proprietary and commercially
available systems, software, tools and monitoring, as well as other processes, to provide security for processing, transmission and storage
of such information. Because of the sensitivity of this information and due to requirements under applicable laws and regulations, the
effectiveness of our security efforts is very important. If our security measures are breached or fail as a result of third-party action,
acts of terror, social unrest, employee error, malfeasance or for any other reasons, someone may be able to obtain unauthorized access
to customer data. Improper activities by third-parties, advances in computer and software capabilities and encryption technology, new
tools and discoveries and other events or developments may facilitate or result in a compromise or breach of our security systems. Our
security measures may not be effective in preventing unauthorized access to the customer data stored on our servers. If a breach of our
security occurs, we could face damages for contract breach, penalties for violation of applicable laws or regulations, possible lawsuits
by individuals affected by the breach and significant remediation costs and efforts to prevent future occurrences. In addition, whether
there is an actual or a perceived breach of our security, the market perception of the effectiveness of our security measures could be
harmed and we could lose current or potential customers.
We
depend on key information systems and third party service providers.
We
depend on key information systems to transact our business accurately and efficiently. These systems and services are vulnerable to interruptions
or other failures resulting from, among other things, pandemics, epidemics, natural disasters, terrorist attacks, software or equipment
failures, processing errors, computer viruses, other security issues or supplier defaults. Security, backup and disaster recovery measures
may not be adequate or implemented properly to avoid such disruptions or failures. Any disruption or failure of these systems or services
could cause substantial errors, processing inefficiencies, security breaches, inability to use the systems or process transactions, loss
of customers or other business disruptions, all of which could negatively affect our business and financial performance.
As
cybersecurity attacks continue to evolve and increase, our information systems could also be penetrated or compromised by internal and
external parties’ intent on extracting confidential information, disrupting business processes or corrupting information. These
risks could arise from external parties or from acts or omissions of internal or service provider personnel. Such unauthorized access
could disrupt our business and could result in the loss of assets, litigation, remediation costs, damage to our reputation and failure
to retain or attract customers following such an event, which could adversely affect our business.
Cyber-attacks
and security vulnerabilities could lead to reduced revenue, increased costs, liability claims, or harm to our competitive position.
Increased
sophistication and activities of perpetrators of cyber-attacks have resulted in an increase in information security risks in recent years.
Hackers develop and deploy viruses, worms, and other malicious software programs that attack products and services and gain access to
networks and data centers. If we experience difficulties maintaining existing systems or implementing new systems, we could incur significant
losses due to disruptions in our operations. Additionally, these systems contain valuable proprietary and confidential information and
may contain personal data of our customers. A security breach could result in disruptions of our internal systems and business applications,
harm to our competitive position from the compromise of confidential business information, or subject us to liability under laws that
protect personal data. As cyber threats continue to evolve, we may be required to expend additional resources to continue to enhance
our information security measures and/or to investigate and remediate any information security vulnerabilities. Any of these consequences
would adversely affect our revenue and margins.
12
We
may not be able to adequately protect or enforce our intellectual property rights or prevent unauthorized parties from copying or reverse
engineering our solutions. Our efforts to protect and enforce our intellectual property rights and prevent third parties from violating
its rights may be costly.
The
success of our services and its business depends, in part, on our ability to obtain patents and other intellectual property rights and
maintain adequate legal protection for its products in the United States and other international jurisdictions. We cannot be certain
that the steps it has taken will prevent unauthorized use of its technology or the reverse engineering of its technology. Moreover, others
may independently develop technologies that are competitive to Fusemachines or infringe our intellectual property.
Protecting
against the unauthorized use of our intellectual property, products and other proprietary rights is expensive and can be difficult, particularly
with respect to international jurisdictions. Unauthorized parties may attempt to copy or reverse engineer our solutions or certain aspects
of our solutions that are considered proprietary. Litigation may be necessary in the future to enforce or defend our intellectual property
rights, to prevent unauthorized parties from copying or reverse engineering our solutions, to determine the validity and scope of the
proprietary rights of others or to block the importation of infringing products into the U.S. Any such litigation, regardless of merit,
could be costly, divert the attention of management and may not ultimately be resolved in our favor.
Effective
patent, trademark, service mark, copyright and trade secret protection may not be available or applied for in every country in which
our products are available and competitors based in other countries may sell infringing products in one or more markets. An inability
to adequately protect and enforce our intellectual property and other proprietary rights or an inability to prevent authorized parties
from copying or reverse engineering its technology solutions or certain aspects of its solutions that we considers proprietary could
adversely affect its business, operating results, financial condition and prospects.
We
rely on unpatented proprietary information, trade secrets, processes and know-how, as well as open source software in certain instances.
Our failure to protect our confidential information, trade secrets, processes and know-how, and our reliance on open source solutions,
could negatively impact our business and results of operations.
We
rely on proprietary information (such as trade secrets, know-how and confidential information) to protect intellectual property that
may not be patentable or subject to copyright, trademark, trade dress or service mark protection.
We
generally seek to protect this proprietary information by entering into confidentiality agreements, or consulting, services or employment
agreements that contain non-disclosure and non-use provisions with its employees, consultants, contractors and third parties. However,
we may fail to enter into the necessary agreements and, even if entered into, these agreements may be breached or may otherwise fail
to prevent disclosure, third-party infringement or misappropriation of its proprietary information, may be limited as to their term and
may not provide an adequate remedy in the event of unauthorized disclosure or use of proprietary information. Fusemachines has limited
control over the protection of trade secrets used by its current or future manufacturing partners and suppliers and could lose future
trade secret protection if any unauthorized disclosure of such information occurs. In addition, our proprietary information may otherwise
become known or be independently developed by its competitors or other third parties. To the extent that its employees, consultants,
contractors, advisors and other third parties use intellectual property owned by others in their work for us, disputes may arise as to
the rights in related or resulting know-how and inventions. Costly and time-consuming litigation could be necessary to enforce and determine
the scope of our proprietary rights, and failure to obtain or maintain protection for its proprietary information could adversely affect
its competitive business position. Furthermore, laws regarding trade secret rights in certain markets where we operate may afford limited
or no protection for its trade secrets.
We
also rely on physical and electronic security measures to protect its proprietary information, but it cannot provide assurance that these
security measures will not be breached or that these measures will provide adequate protection. There is a risk that third parties may
obtain and improperly utilize our proprietary information to its competitive disadvantage. We may not be able to detect or prevent the
unauthorized use of such information or take appropriate and timely steps to enforce our intellectual property rights.
In
addition, while the majority of our algorithms utilized for its products are proprietary, including those most critical to the company’s
products, certain algorithms which form a part of these products are made available under “open source” licenses. We expect
to continue to incorporate open source software in the company’s solutions in the future. Open source software is typically freely
available, but is licensed under various requirements that bind the licensee. While the use of open source software may reduce development
costs and speed up the development process, it may also present certain risks, that may be greater than those associated with the use
of third-party commercial software, including but not limited to potential non-compliance with these licenses. Further, depending on
the manner in which such licenses were interpreted and applied to software code that combines proprietary and open source software and
source code, companies have in the past faced restrictions on their ability to commercialize certain of our products, and it is possible
that we could be subject to similar restrictions in the future.
13
Algorithms
embedded in AI solutions, and AI datasets, often suffer from lack of transparency, bias, and risks of inadvertent disclosure of information,
which could subject us to adverse consequences.
AI
systems are created with a variety of tools including machine learning, natural language processing, computer vision, and neural networks.
AI systems are capable of behaving in ways that mimic human capabilities, and AI therefore refers to the ability of computers to emulate
human thought and perform tasks that are usually performed by humans; it refers to the technologies and algorithms that enable systems
to identify patterns, make decisions and could learn from data without being explicitly programmed. Challenges related to AI are numerous,
and include biases and lack of transparency embedded in AI solutions, and inadvertent disclosure of information.
Many
current AI models are closed, meaning it is unclear how they are trained, and even where open-source AI models are used, the risk of
bias and inadvertent disclosure of information can remain, depending on the humans developing the models and the way in which these models
are used. Use of closed AI models, where such a lack of transparency exists as to sources of data used to train or develop such technologies
or how inputs are converted to outputs, may make it difficult to fully validate the process and can raise issues with trust, accountability,
and ethics. Whether or not AI systems are closed, or open-source and available to review, the algorithms and models utilized in AI systems
may have limitations, including biases, vulnerabilities, errors, or inability to handle certain data types or scenarios. Any deficiencies
could, despite our efforts, undermine the decisions, predictions or analysis AI applications produce, or give rise to risks related to
harmful content, accuracy, bias, discrimination, toxicity, intellectual property infringement or misappropriation, defamation, data privacy,
and cybersecurity, among others. Any cybersecurity incidents related to our use of AI applications to analysis personal data could adversely
affect our reputation and results of operations.
Further,
AI solutions and models are part of a new and expanding industry, and our use and implementation of such models now and in the future,
could subject us to any of the foregoing, or additional risks, which could impact our business, results of operations, or result in brand
or reputational harm, competitive harm, or legal liability.
Use
of open source software creates inherent risk and could subject us to adverse consequences.
The
use of open source software, including algorithms, involves a number of risks, many of which cannot be eliminated and could negatively
affect our business. For example:
●
The
terms of various open source licenses have not been interpreted by United States courts, and there is a risk that such licenses could
be construed in a manner that imposes unanticipated conditions or restrictions on our ability to market our platform. By the terms
of certain open source licenses, if we combine our proprietary software with open source software in a certain manner, we could be
required to release the source code of our proprietary software and to make our proprietary software available under open source
licenses.
●
We
may face claims alleging noncompliance with open source license terms or misappropriation or other violation of open source technology.
These claims could result in litigation, damage our reputation in the open-source community, or require us to purchase a costly license,
devote additional research or development resources to re-engineer our products or services, discontinue the sale of our products
if re-engineering could not be accomplished on a timely or cost-effective basis, require us to make the source code of our proprietary
code generally available, or result in us being enjoined from the offering of components of our platform that contained the open
source software, any of which would have a negative effect on our business and operating results.
●
We
also could be subject to lawsuits from other parties claiming ownership of what we believe to be open source software. Litigation
could be costly for us to defend, have a negative effect on our operating results or financial condition, and could require us to
devote additional research and development resources to re-engineer our platform. In addition to risks related to license requirements,
usage of open source software can lead to greater risks than use of third-party commercial software, as open source licensors generally
do not provide warranties or controls on the origin of the software.
Claims
by others that we infringe upon their intellectual property could force us to incur significant costs or revise the way we conduct our
business.
Our
competitors protect their proprietary rights by means of patents, trade secrets, copyrights, trademarks and other intellectual property.
We have not conducted an independent review of patents and other intellectual property issued to third-parties (often referred to as
a freedom to operate search), who may have patents or patent applications relating to our proprietary technology. We may receive letters
from third parties alleging, or inquiring about, possible infringement, misappropriation or violation of their intellectual property
rights. Any party asserting that we infringe, misappropriate or violate proprietary rights may force us to defend ourselves, and potentially
our customers, against the alleged claim. These claims and any resulting lawsuit, if successful, could subject us to significant liability
for damages and/or invalidation of our proprietary rights or interruption or cessation of our operations. Any such claims or lawsuit
could:
●
be
time-consuming and expensive to defend, whether meritorious or not;
●
require
us to stop providing products or services that use the technology that allegedly infringes the other party’s intellectual property;
14
●
divert
the attention of our technical and managerial resources;
●
require
us to enter into royalty or licensing agreements with third-parties, which may not be available on terms that we deem acceptable;
●
prevent
us from operating all or a portion of our business or force us to redesign our products, services or technology platforms, which
could be difficult and expensive and may make the performance or value of our product or service offerings less attractive;
●
subject
us to significant liability for damages or result in significant settlement payments; or
●
require
us to indemnify our customers.
Furthermore,
during the course of litigation, confidential information may be disclosed in the form of documents or testimony in connection with discovery
requests, depositions or trial testimony. Disclosure of our confidential information and our involvement in intellectual property litigation
could materially adversely affect our business. Some of our competitors may be able to sustain the costs of intellectual property litigation
more effectively than we can because they have substantially greater resources. In addition, any litigation could significantly harm
our relationships with current and prospective customers. Any of the foregoing could disrupt our business and have a material adverse
effect on our business, operating results and financial condition.
We
depend on our management team and other key employees, and the loss of one or more of these employees or an inability to attract and
retain highly skilled employees could adversely affect its business.
Our
future success depends, in part, on our ability to continue to attract and retain highly skilled personnel. The loss of the services
of any of our key personnel, the inability to attract or retain qualified personnel, or delays in hiring required personnel, particularly
in engineering and sales, may seriously and adversely affect our business, financial condition and results of operations. Although we
have entered into employment or consulting agreements with our personnel, their employment is generally for no specific duration.
Our
future performance also depends on the continued services and continuing contributions of our senior management team, including Sameer
Maskey, our Chief Executive Officer, to execute on our business plan and to identify and pursue new opportunities and product innovations.
The loss of services of our senior management team, particularly our Chief Executive Officer, could significantly delay or prevent the
achievement of our development and strategic objectives, which could adversely affect our business, financial condition and results of
operations.
We
are subject to evolving laws and regulations that could impose substantial costs, legal prohibitions or unfavorable changes upon our
operations or products, and may be a party to material legal proceedings in the future.
We
are or will be subject to complex laws and regulations at numerous jurisdictional levels in the U.S., and other locations abroad. New,
or changes in such regulations or rules could also lead to increased costs of compliance, including remediations of any discovered issues
in our products, and changes to our operations, which may be significant, and any failures to comply could result in significant expenses,
delays or fines. In addition, we may become a party to material legal proceedings, or governmental investigations, in the future. If
we are unable to successfully defend ourselves in such proceedings or government investigations, it may harm our brand, ability to attract
and retain qualified employees, business and financial condition.
Our
management team has limited experience managing a public company and regulatory compliance may divert their attention from the day-to-day
management of our business.
Our
management team has limited experience managing a publicly-traded company and limited experience complying with the increasingly complex
laws pertaining to public companies. These obligations typically require substantial attention from our senior management and could divert
their attention away from the day-to-day management of our business.
Material
adverse developments in domestic and global economic conditions, or the occurrence of other world events, could materially adversely
affect our revenue and results of operations.
Various
factors contribute to the uncertain economic environment, the occurrence of natural disasters, pandemics, geopolitical tensions (particularly
those relating to the People’s Republic of China), military conflicts, the increase in, and volatility of, interest rates, high
inflation, an actual recession or fears of a recession, trade policies and tariffs and geopolitical tensions. Our inability to offset
price inflation in our materials, components, shipping, or labor through increased prices to customers with long-term fixed contracts
and formula-based or long-term fixed price contracts with suppliers could adversely affect our business, financial condition and results
of operations. Global supply chain and labor market challenges could also negatively affect our performance as well as the performance
of our suppliers. Interest rate increases have also created financial market volatility and could further negatively impact financial
markets, lead to an economic downturn or recession or have an adverse effect on our operating results. In addition, geopolitical risks
could affect our customers’ budgets and policies. These and other factors may adversely affect customer demand and ability to pay,
cause decrease in sales, and negatively impact the realizability of our accounts and notes receivable and contract assets.
15
Our
business is heavily dependent upon our international operations, particularly in Nepal, and any disruption to those operations would
adversely affect us.
Our
business and future growth depend largely on continued demand for our services performed from Nepal. Various factors, such as changes
in the governments, could trigger significant changes in Nepal’s economic liberalization and deregulation policies and disrupt
business and economic conditions in Nepal generally and our business in particular. Our business and our international operations may
also be affected by actual or threatened trade war or tariffs or other trade controls. If we are unable to continue to leverage the skills
and experience of our international workforce, particularly in Nepal, we may be unable to provide our solutions at an attractive price
and our business could be materially and negatively impacted.
We
have significant fixed costs related to lease facilities.
We
have made and continue to make significant contractual commitments related to our leased facilities. These expenses will have a significant
impact on our fixed costs, and if we are unable to grow our business and revenue proportionately, our operating results may be negatively
affected.
Our
sites operate on leasehold property, and our inability to renew our leases on commercially acceptable terms or at all may adversely affect
our results of operations.
Our
sites operate on leasehold property. Our leases are subject to renewal and we may be unable to renew such leases on commercially acceptable
terms or at all, which may have an adverse impact on our operations. In addition, in the event of non-renewal of our leases, we may be
unable to locate suitable replacement properties for our sites or we may experience delays in relocation that could lead to a disruption
in our operations.
Catastrophic
events, including those which impact third parties on which we materially rely, could materially adversely affect our business, results
of operations and/or financial condition.
A
disruption or failure of our systems or operations, or the systems or operations of a third party on which we materially rely, such as
in the event of a major earthquake, weather event, fire, explosion, failure to contain hazardous materials, industrial accident, utility
failure, cyber-attack, IT failure, terrorist attack, public health crisis, pandemic, or other catastrophic event could cause delays in
completing sales, providing services, or performing other mission-critical functions. A catastrophic event that results in the destruction
or disruption of any of our critical business or information technology systems could harm our ability to conduct normal business operations
and our operating results as well as expose us to claims, litigation and governmental investigations and fines.
If
our backup and mitigation plans are not sufficient to minimize business disruption, our financial results could be adversely affected.
We are continuously monitoring our operations and intend to take appropriate actions to mitigate the risks arising from catastrophic
events, but there can be no assurances that we will be successful in doing so.
We
have identified material weaknesses and significant deficiencies related in our internal control over financial reporting. If we fail
to remediate these material weaknesses, maintain effective internal control over financial reporting or identify additional material
weakness or significant deficiency in its internal control over financial reporting, our ability to report our financial condition and
results of operations in a timely and accurate manner could be adversely affected, investor confidence in our company could diminish,
and the value of our stock may decline.
Preparing
our consolidated financial statements involves a number of complex manual and automated processes, which are dependent upon individual
data input or review and require significant management judgment. One or more of these processes may result in errors that may not be
detected and could result in a material misstatement or other errors of our consolidated financial statements. Such errors may be more
likely to occur when implementing new systems and processes, particularly when implementing evolving and complex accounting rules. The
Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) requires, among other things, that as a publicly-traded company we
disclose whether our internal control over financial reporting and disclosure controls and procedures are effective. While we continually
undertake steps to improve our internal control over financial reporting as our business changes, we may not be successful in making
the improvements and changes necessary to be able to identify and remediate control deficiencies or material weaknesses on a timely basis.
If we are unable to successfully remediate any current or future material weaknesses in our internal control over financial reporting,
the accuracy and timing of our financial reporting may be adversely affected; our liquidity, access to capital markets and perceptions
of our creditworthiness may be adversely affected; we may be unable to maintain compliance with securities laws, stock exchange listing
requirements and debt instruments covenants regarding the timely filing of periodic reports; we may be subject to regulatory investigations
and penalties; investors may lose confidence in our financial reporting; we may suffer defaults under our debt instruments; and our stock
price may decline.
16
As
a privately-held company, Fusemachines was not required to evaluate its internal control over financial reporting in a manner that meets
the standards of publicly traded companies required by Section 404(a) of the Sarbanes-Oxley Act.
In
connection with the preparation and audit of our consolidated financial statements as of and for the years ended December 31, 2025 and
2024, material weaknesses were identified in its internal control over financial reporting. A material weakness is a deficiency, or combination
of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement
of the financial statements will not be prevented or detected on a timely basis. The following material weaknesses were identified:
●
Fusemachines
did not maintain a sufficient complement of personnel with accounting knowledge, experience and training to appropriately analyze,
record and disclose accounting matters to provide reasonable assurance of preventing material misstatements.
●
Fusemachines
did not maintain an effective process over the revenue cycle, including not properly maintaining adequate books and records over
client projects and billing which ultimately resulted in improper revenue recognition.
●
Fusemachines
did not maintain effective controls over certain information technology (“ IT ”) general controls for information
systems that are relevant to the preparation of its consolidated financial statements. Specifically, Fusemachines currently relies
on QuickBooks for its books and records as well as financial reporting needs. Because QuickBooks lacks robust financial reporting
capabilities as well as certain controls, the close process was manually intensive. This process resulted in significant delays and
errors in the preparation of its consolidated financial statements. In addition, Fusemachines did not design and maintain user access
controls to ensure appropriate segregation of duties and restrict user access to its financial applications to appropriate company
personnel.
Management
expects to address these deficiencies by implementing remediation measures, including those that have already been taken to date.
We
filed a Quarterly Report on Form 10-Q for the period ended September 30, 2025 later than required, and any failure to timely file our
periodic reports in the future could adversely affect our compliance with securities laws and exchange listing standards, impair our
access to capital, increase regulatory scrutiny and litigation risk, and negatively impact our business and the market price of our securities.
We
are required to file periodic reports with the SEC within prescribed deadlines. We did not file our most recent Quarterly Report on Form
10-Q, which included the financial information solely of CSLM, within the required timeframe. Although we ultimately filed the report,
our failure to file timely evidences vulnerabilities in our reporting processes and controls and may subject us to additional regulatory
and market risks. As a former special purpose acquisition company that recently completed a business combination, our financial reporting
environment is undergoing significant changes and integration, which increases the complexity of our reporting obligations and the risk
of future delays.
Delayed
SEC filings can result in non-compliance with applicable stock exchange listing requirements, and our securities exchange may issue deficiency
notices or take other actions, including initiating delisting procedures, if we do not timely cure any reporting delinquency. A late
filing can also adversely affect our eligibility to use short-form registration statements on Form S-3, limit our status under shelf
registration rules, and restrict our ability to access the capital markets efficiently. In addition, late or incomplete filings can trigger
contractual penalties, liquidated damages, or other remedies under registration rights, financing agreements, and other commercial contracts
that require us to maintain effective registration statements or timely reports, which could increase our costs or limit our financing
flexibility. Delays in reporting may also elevate the risk of restatements, material weaknesses in internal control over financial reporting,
and increased audit fees and remediation expenses.
Further,
failure to timely file periodic reports may subject us to heightened SEC scrutiny and enforcement risk, harm investor and analyst confidence,
and increase the likelihood of stock price volatility, securities class actions, and derivative litigation. The reputational impact of
a late filing can be significant, particularly for companies that have recently merged with a SPAC, which commonly face greater market
and regulatory attention. If we experience additional delays in future filings, or if our remediation efforts are not effective, we could
face additional compliance challenges, suffer reduced liquidity and a higher cost of capital, and our business, financial condition,
results of operations, and the market price of our securities could be materially and adversely affected.
17
Changes
in accounting principles or their application to Fusemachines could result in unfavorable accounting charges or effects, which could
adversely affect our results of operations and growth prospects.
We
prepare our consolidated financial statements in accordance with GAAP. In particular, we make certain estimates and assumptions related
to the adoption and interpretation of these principles including the recognition of our revenue and the accounting for our provision
for income taxes. If these assumptions turn out to be incorrect, our financial results and position could materially differ from our
expectations and could be materially adversely affected. A change in any of these principles or guidance, or in their interpretations
or application to us, may have a significant effect on our reported results, as well as our processes and related controls, and may retroactively
affect previously reported results or our forecasts, which may negatively impact our financial statements.
If
our judgments or estimates relating to its critical accounting policies are based on assumptions that change or prove to be incorrect,
our results of operations could fall below expectations of securities analysts and investors, resulting in a decline in its stock price.
The
preparation of our financial statements in conformity with GAAP requires management to make judgments, estimates, and assumptions that
affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience
and on various other assumptions that we believe to be reasonable under the circumstances, as provided in the section titled “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” the results of which form the basis for making judgments
about the carrying values of assets, liabilities, and equity, and the amount of revenue and expenses that are not readily apparent from
other sources. Our results of operations may be adversely affected if our assumptions change or if actual circumstances differ from those
in our assumptions, which could cause our results of operations to fall below the expectations of securities analysts and investors,
resulting in a decline in the trading price of the combined company’s securities. Significant judgments, estimates, and assumptions
used in preparing our consolidated financial statements include, or may in the future include, those related to revenue recognition and
income taxes.
Our
results of operations could be affected by currency fluctuations.
Our
global operations are conducted predominantly in U.S. dollars. While revenue is generated in U.S. dollars, Fusemachines incurs expenses
in other currencies, principally, Nepalese rupees and Canadian dollars. The Company’s international operations expose it to risk
of adverse fluctuations in foreign currency exchange rates through the remeasurement of foreign currency denominated assets and liabilities
(both third-party and intercompany) and translation of earnings and cash flows into U.S. dollars. Accordingly, the results of our operations
are subject to currency exchange risks. To date, we have not engaged in any formal hedging program to mitigate these risks. The fluctuations
in currency exchange rates may significantly impact our financial position and results of operations in the future.
Fusemachines
has limited insurance which may not cover claims by third parties against Fusemachines or its officers and directors.
We
have directors’ and officers’ liability insurance and commercial liability insurance policies. Claims, however, by third
parties against us may exceed policy amounts and we may not have amounts to cover these claims. Any significant claims would have a material
adverse effect on our business, financial condition and results of operations. In addition, our limited directors’ and officers’
liability insurance may affect our ability to attract and retain directors and officers.
Fusemachines
could be subject to additional tax liabilities.
We
are subject to federal, state, and local income taxes in the United States and foreign jurisdictions. Determining our provision for income
taxes requires significant management judgment, and the ultimate tax outcome may be uncertain. In addition, our provision for income
taxes is subject to volatility and could be adversely affected by many factors, including, among other things, changes to our operating
or holding structure, changes in the amounts of earnings in jurisdictions with differing statutory tax rates, changes in the valuation
of deferred tax assets and liabilities, and changes in U.S. and foreign tax laws. Moreover, we are subject to the examination of our
income tax returns by tax authorities in the United States and various foreign jurisdictions, which may disagree with our calculation
of research and development tax credits, cross-jurisdictional transfer pricing, or other matters and assess additional taxes, interest
or penalties. While we regularly assess the likely outcomes of these examinations to determine the adequacy of our provision for income
taxes and we believe that our financial statements reflect adequate reserves to cover any such contingencies, there can be no assurance
that the outcomes of such examinations will not have a material impact on our results of operations and cash flows. If U.S. or other
foreign tax authorities change applicable tax laws, our overall taxes could increase, and our financial condition or results of operations
may be adversely impacted.
Provisions
enacted by the 2017 Tax Cuts and Jobs Act related to the capitalization for tax purposes of research and experimental (“R&E”)
expenditures became effective on January 1, 2022. Beginning January 1, 2022, all U.S. and non-U.S. based R&E expenditures must be
capitalized and amortized over five years and 15 years, respectively.
The
Company capitalizes certain costs related to internal use software acquired, modified, or developed related to the Company’s services.
These capitalized costs are primarily related to salaries and other personnel costs. Costs incurred in the preliminary stages of development
are expensed as incurred. Once the application development stage has been reached, internal and external costs, if direct and incremental,
are capitalized until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of
all substantial testing. Maintenance and training costs are expensed as incurred. Capitalized software is amortized on a straight-line
basis over its useful life.
18
Ongoing
and escalating political volatility in Nepal may adversely affect our business, financial condition, and results of operations.
Nepal
has experienced significant governmental turnover since the 2008 abolition of the country’s monarchy government. Beginning on September
8, 2025, thousands of demonstrators converged on central Kathmandu to protest alleged entrenched corruption, high unemployment, and perceived
democratic backsliding. Security forces responded violently. Parallel and subsequent protests, demonstrations, and work stoppages have
disrupted transportation and public services nationwide. Should similar or further unrest occur, we could face, among other things: restrictions
on the movement of personnel and goods; interruptions to supply chains; delays in permitting or licensing; selective enforcement or abrupt
changes in tax, labor, foreign-exchange, or investment regulations; increased security costs; and reputational damage. There can be no
assurance that Nepal’s government will stabilize, that further violent protests will not occur, or that new regulations or emergency
decrees will not materially impair our operations in the country. Any of the foregoing events, individually or in the aggregate, could
have a material adverse effect on our business, financial condition, and results of operations.
Risks
Related to Ownership of Our Securities
The
price of our Common Stock may be volatile.
The
market price of our Common Stock is likely to be highly volatile and could fluctuate widely in price in response to various factors,
many of which are beyond our control, including the following:
●
the
concentration of the ownership of our shares by a limited number of affiliated stockholders may limit interest in our securities;
●
limited
“public float” with a small number of persons whose sales or lack of sales could result in positive or negative pricing
pressure on the market price for the Common Stock;
●
additions
or departures of key personnel;
●
loss
of a strategic relationship;
●
variations
in operating results from the expectations of securities analysts or investors;
●
announcements
of new products or services by us or our competitors;
●
reductions
in the market share of our products;
●
announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;
●
investor
perception of our industry or prospects;
●
insider
selling or buying;
●
investors
entering into short sale contracts;
●
regulatory
developments affecting our industry;
●
changes
in our industry;
●
competitive
pricing pressures;
●
our
ability to obtain working capital financing;
●
sales
of the Common Stock;
●
our
ability to execute our business plan;
●
operating
results that fall below expectations;
19
●
revisions
in securities analysts’ estimates or reductions in security analysts’ coverage; and
●
economic
and other external factors.
Many
of these factors are beyond our control and may decrease the market price of the Common Stock, regardless of our operating performance.
We cannot make any predictions or projections as to what the prevailing market price for the Common Stock will be at any time, including
as to whether the Common Stock will sustain current market prices, or as to what effect that the sale of shares or the availability of
the Common Stock for sale at any time will have on the prevailing market price.
In
addition, the securities markets have from time-to-time experienced significant price and volume fluctuations that are unrelated to the
operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price of
the Common Stock.
Our
executive officers and directors exercise significant control over the company, which may limit your ability to influence corporate matters
and could delay or prevent a change in corporate control.
Sameer
Maskey, our Chief Executive Officer, beneficially owns approximately 20.36% of the combined voting power for the election of directors
to the Company’s board of directors. As a result, this stockholder will be able to influence our management and affairs and control
the outcome of matters submitted to our stockholders for approval, including the election of directors and any sale, merger, consolidation,
or sale of all or substantially all of our assets.
This
stockholder may have interests, with respect to his Common Stock, which are different from those of the public investors and the concentration
of voting power among this stockholder may have an adverse effect on the price of the Common Stock.
In
addition, this concentration of ownership might adversely affect the market price of the Common Stock by: (1) delaying, deferring or
preventing a change of control; (2) impeding a merger, consolidation, takeover or other business combination involving us; or (3) discouraging
a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.
The
requirements of being a public company may strain the Company’s resources and distract management and we will incur substantial
costs as a result of being a public company.
The
Company is subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, and the Securities Act. These rules, regulations
and requirements are extensive. We will incur significant costs associated with our public company corporate governance and reporting
requirements. The Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business
and operating results. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures
and internal control over financial reporting. In order to maintain and, if required, improve our disclosure controls and procedures
and internal control over financial reporting to meet this standard, significant resources and management oversight may be required.
As a result, management’s attention may be diverted from other business concerns, which could adversely affect our business and
operating results. We may need to hire more corporate employees to comply with these requirements or engage outside consultants, which
would increase our costs and expenses. This may divert management’s attention from other business concerns, which could have a
material adverse effect on our business, financial condition and results of operations. These applicable rules and regulations may make
it more difficult and more expensive for us to obtain director and officer liability insurance and it may be required to accept reduced
policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult
for us to attract and retain qualified individuals to serve on the Company’s board of directors or as executive officers.
In
addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for
public companies, increasing legal and financial compliance costs and making some activities more time-consuming. These laws, regulations
and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application
in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty
regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to
invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative
expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If our
efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due
to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business
may be adversely affected.
As
a result of disclosure of information in this Annual Report on Form 10-K and in the filings that we are required to make as a public
company, our business, operating results and financial condition have become more visible, which may result in threatened or actual litigation,
including by competitors and other third parties. If any such claims are successful, our business, operating results and financial condition
could be adversely affected, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time
and resources necessary to resolve them, could divert the resources of our management and adversely affect our business, operating results
and financial condition.
20
Sales
of a substantial amount of Common Stock in the public market, particularly sales by our executive officers, directors and significant
stockholders, or the perception that these sales could occur, could cause the market price of the Common Stock to decline.
Sales
of a substantial number of shares of Common Stock in the public market, particularly sales by our executive officers, directors and principal
stockholders, or the perception that these sales might occur, could cause the market price of the Common Stock to decline. Holders of
a substantial number of shares of the Common Stock following the Business Combination are subject to lock-up provisions in our bylaws,
as amended and restated (the “Bylaws”) in that, for a period of at least one year from the date of closing of the Business
Combination, subject to certain exceptions, prohibit them from offering for sale, selling, contracting to sell, granting any option for
the sale of, transferring or otherwise disposing of any shares of the Common Stock and of any securities convertible into or exercisable
for the Common Stock, unless waived, amended, or repealed by the Company’s board of directors.
When
the applicable lock-up periods expire, our security holders subject to the lock-up provisions will be able to sell shares of Common Stock
in the public market. In addition, the Company’s board of directors may, in its discretion, permit our security holders to sell
shares prior to the expiration of the restrictive provisions contained in the Bylaws. Pursuant to Section 7.14(d) of the Bylaws, the
Company’s board of directors may also waive, amend or repeal the terms of the lock-up provision in the Bylaws for any reason, including
in order to meet or maintain the Nasdaq listing requirements, which would allow the holders of any securities held by the parties to
such lock-up agreements. to sell our shares without restriction, subject to applicable securities laws. Sales of a substantial number
of such shares upon expiration of the lock-up provisions, the perception that such sales may occur or early release of these provisions
could cause our market price to fall or make it more difficult for you to sell your common stock at a time and price that you deem appropriate.
In
addition, we may file a registration statement to register shares reserved for future issuance under our equity compensation plans. Subject
to the satisfaction of applicable vesting requirements and expiration of the lock-up provisions referred to above, the shares issued
upon exercise of outstanding stock options would be available for immediate resale in the open market.
A
decline in the price of the Common Stock could affect the company’s ability to raise working capital and adversely impact the company’s
ability to continue operations.
A
prolonged decline in the price of the Common Stock could result in a reduction in the liquidity of the common stock and a reduction in
our ability to raise capital. A decline in the price of the Common Stock could be especially detrimental to our liquidity, operations
and strategic plans. Such reductions may force us to reallocate funds from other planned uses and may have a significant negative effect
on our business plan and operations, including our ability to develop new products and services and continue current operations. If the
Common Stock’s price declines, we can offer no assurance that we will be able to raise additional capital or generate funds from
operations sufficient to meet our obligations. If we are unable to raise sufficient capital in the future, we may not be able to have
the resources to continue our normal operations.
Fusemachines
does not intend to pay any cash dividends in the foreseeable future and, therefore, any return on your investment in the company’s
capital stock must come from increases in the fair market value and trading price of the capital stock.
We
have not paid any cash dividends on the Common Stock and do not intend to pay cash dividends on the Common Stock in the foreseeable future.
We intend to retain future earnings, if any, for reinvestment in the development and expansion of our business. Any credit agreements,
which we may enter into with institutional lenders, may restrict our ability to pay dividends. Whether we pay cash dividends in the future
will be at the discretion of the Company’s board of directors and will be dependent upon our financial condition, results of operations,
capital requirements and any other factors that the Company’s board of directors decides is relevant. Therefore, any return on
your investment in our capital stock must come from increases in the fair market value and trading price of the capital stock.
If
the price of the Common Stock fluctuates, you could lose a significant part of your investment.
The
market price of the Common Stock could be subject to wide fluctuations in response to, among other things, the risk factors described
herein, and other factors beyond our control, such as fluctuations in the valuation of companies perceived by investors to be comparable
to us. Furthermore, the stock markets have experienced price and volume fluctuations that have affected and continue to affect the market
prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance
of those companies. These broad market and industry fluctuations, as well as general economic, political, and market conditions, such
as the occurrence of natural disasters, pandemics, geopolitical tensions (particularly those relating to the People’s Republic
of China), military conflicts, recessions, inflation, interest rate changes or international currency fluctuations, may negatively affect
the market price of our common stock. In the past, many companies that have experienced volatility in the market price of their stock
have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation
against us could result in substantial costs and divert our management’s attention from other business concerns, which could seriously
harm our business.
21
The
public stockholders will experience immediate dilution as a consequence of future issuances of Common Stock pursuant to the Fusemachines
Equity Incentive Plan.
Fusemachines
employees and consultants hold, and in the future may be granted, equity awards under equity incentive plans. You will experience additional
dilution when those equity awards and purchase rights become vested and settled or exercisable, as applicable, for shares of the Common
Stock.
The
future exercise of registration rights may adversely affect the market price of the Common Stock.
Pursuant
to the Amended and Registration Rights Agreement (as defined below), the Company has agreed to register for resale, pursuant to Rule
415 under the Securities Act, certain shares of Common Stock and other equity securities of the Company that are held by the Selling
Stockholders, from time to time.
The
registration of these securities will permit the public resale of such securities, subject to any applicable contractual lock-up obligation.
The registration and availability of a significant number of securities for trading in the public market may have an adverse effect on
the market price of the Common Stock.
The
Public Warrants may never be in the money, and they may expire worthless and the terms of the warrants may be amended in a manner adverse
to a holder if holders of at least 50% of the then outstanding Public Warrants approve of such amendment.
The
exercise price for the outstanding Public Warrants is $11.50 per share. There can be no assurance that the Public Warrants will be in
the money prior to their expiration and as such, the Public Warrants may expire worthless.
The
Public Warrants were issued in registered form under a Warrant Agreement between us and Continental Stock Transfer & Trust
Company, as warrant agent, originally executed January 12, 2022 between the warrant agent and CSLM Acquisition, Corp.
(CSLM ) (“now known as Fusemachines Inc.”) and amended at Closing (the “Warrant Agreement”). The
Warrant Agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or
correct any defective provision, but requires the approval by the holders of at least 50% of the then outstanding Public Warrants to
make any change that increases the exercise price or shortens the exercise period of the Public Warrants.
Accordingly,
we may amend the terms of the Public Warrants in a manner adverse to a holder if holders of at least 50% of the then outstanding Public
Warrants approve of such amendment. Although our ability to amend the terms of the Public Warrants with the consent of at least 50% of
the then outstanding Public Warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the
exercise price of the warrants, shorten the exercise period or decrease the number of shares of Common Stock purchasable upon exercise
of a warrant.
The
Company may redeem your unexpired Public Warrants prior to their exercise at a time that is disadvantageous to you, thereby making your
Public Warrants worthless.
We
have the ability to redeem outstanding Public Warrants at any time and prior to their expiration, at a
price of $0.01 per warrant, provided that the closing price of the Common Stock equals or exceeds $18.00 per share (as adjusted for share
sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any twenty (20) trading days within a thirty
(30) trading-day period ending on the third trading day prior to the date on which we give proper notice of such redemption to the warrants
holders and provided certain other conditions are met. We will not redeem the Public Warrants unless an effective registration statement
under the Securities Act covering the shares issuable upon exercise of the warrants is effective and a current prospectus relating to
those shares is available throughout the thirty (30)-day redemption period, except if we elect to require the warrants to be exercised
on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the Public Warrants
become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities
for sale under all applicable state securities laws. Redemption of the outstanding warrants could force you to accept the nominal redemption
price which, at the time the outstanding warrants are called for redemption, is likely to be substantially less than the market value
of your warrants, if you do not otherwise exercise you warrants, as permitted under the Warrant Agreement, before the redemption date.
None of the Private Placement Warrants will be redeemable by us so long as they are held by the Sponsor or any of its permitted transferees.
22
In
addition, we have the ability to redeem the outstanding Public Warrants at any time prior to their
expiration, at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption if the closing price
of the Common Stock equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) for any twenty (20) trading days within a thirty (30) day trading-day period ending on the third day
prior to proper notice of such redemption and provided that certain other conditions are met, including that holders will be able to
exercise their warrants on a cashless basis prior to redemption for a number of shares of Common Stock determined based on the redemption
date and fair market value of the Common Stock. The value received upon exercise of the warrants (1) may be less than the value the holders
would have received if they had been able to exercise their warrants at a later time at which the underlying share price is higher and
(2) may not compensate the holders for the value of the warrants. In addition, such redemptions may occur at a time when the Public Warrants
are “out-of-the-money,” in which case holders thereof would lose any potential embedded value from a subsequent increase
in the value of the Common Stock had such Public Warrants remained outstanding. If the price of the Common Stock is less than $18.00
and we seek redemption of the Public Warrants, we must call the Private Placement Warrants for redemption on the same terms.
In
the event that the Company determines to redeem the Public Warrants when the closing price of the shares of Common Stock equals or exceeds
$18.00 per share, pursuant to Section 6.2 of the Warrant Agreement, respectively, the Company will fix a date for the redemption. Notice
of redemption will be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the redemption
date to the registered holders of the Public Warrants to be redeemed at their last addresses as they appear on the registration books.
Any notice mailed in the manner herein provided will be conclusively presumed to have been duly given whether or not the registered holder
received such notice.
Public
Warrant holders will only be able to exercise their Public Warrants on a “cashless basis” under certain circumstances, and
if they do so, they will receive fewer shares of Common Stock from such exercise than if such warrants were exercised for cash.
The
Public Warrants generally may not be exercised on a “cashless basis”, except as described below. In contrast, the Private
Placement Warrants, for so long as they are held by the Sponsor and certain permitted transferees, may be exercised on a “cashless
basis”.
The
Warrant Agreement provides that in the following circumstances holders of Public Warrants who seek to exercise their Public Warrants
will not be permitted to do for cash and will, instead, be required to do so on a cashless basis in accordance with Section 3(a)(9) of
the Securities Act: (i) if the Common Stock issuable upon exercise of the warrants are not registered under the Securities Act in accordance
with the terms of the Warrant Agreement; (ii) if we have so elected and the Common Stock are at the time of any exercise of a warrant
not listed on a national securities exchange such that they satisfy the definition of “covered securities” under Section
18(b)(1) of the Securities Act; and (iii) if we have so elected and we call the Public Warrants for redemption. If you exercise your
Public Warrants on a cashless basis, you would pay the warrant exercise price by surrendering the warrants for that number of shares
of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Public
Warrants, multiplied by the excess of the “fair market value” of the shares of Common Stock (as defined in the next sentence)
over the exercise price of the warrants by (y) the fair market value. The “fair market value” is the average reported closing
price of the shares of Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which the notice
of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable.
As a result, a holder of Public Warrants would receive fewer shares of Common Stock from such exercise than if such warrants were exercised
for cash.
The
Warrant Agreement will designate the courts of the State of New York or the United States District Court for the Southern District of
New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of the warrants,
which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes.
The
Warrant Agreement provides that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating
in any way to the Warrant Agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New
York or the United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction,
which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive
jurisdiction and that such courts represent an inconvenient forum.
23
Notwithstanding
the foregoing, these provisions of the Warrant Agreement will not apply to suits brought to enforce any liability or duty created by
the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive
forum. Any person or entity purchasing or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and
to have consented to the forum provisions in our warrant agreement. If any action, the subject matter of which is within the scope the
forum provisions of the Warrant Agreement, is filed in a court other than a court of the State of New York or the United States District
Court for the Southern District of New York (a “foreign action”) in the name of any holder of our warrants, such holder shall
be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection
with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service
of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign
action as agent for such warrant holder.
This
choice-of-forum provision may limit a warrant holder’s ability to bring a claim in a judicial forum that it finds favorable for
disputes, which may discourage such lawsuits and result in increased costs to warrant holders to bring a lawsuit. Alternatively, if a
court were to find this provision of our Warrant Agreement inapplicable or unenforceable with respect to one or more of the specified
types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could
materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and
resources of our management and board.
The
historical financial results of Legacy Fusemachines may not be indicative of what the Company’s actual financial position or results
of operations would have been.
The
historical financial results of Legacy Fusemachines included in this Annual Report on Form 10-K do not reflect the financial condition,
results of operations or cash flows they would have achieved as a standalone public company during the periods presented or those the
Company will achieve in the future. This is primarily the result of the following factors: (i) the Company will incur additional ongoing
costs, including costs related to public company reporting, investor relations and compliance with the Sarbanes-Oxley Act; and (ii) the
Company’s capital structure is different from that reflected in Legacy Fusemachines’ historical financial statements. The Company’s
financial condition and future results of operations could be materially different from amounts reflected in its historical financial
statements included elsewhere in this Annual Report on Form 10-K, so it may be difficult for investors to compare the Company’s
future results to historical results or to evaluate its relative performance or trends in its business.
We
are currently an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and to the extent
we have taken advantage of certain exemptions from disclosure requirements available to emerging growth companies or smaller reporting
companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with
other public companies.
We
are currently an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we
may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not
emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section
404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,
and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved. Additionally, we are a “smaller reporting company” as defined in Item
10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among
other things, providing only two years of audited financial statements. As a result, our shareholders may not have access to certain
information they may deem important. We cannot predict whether investors will find our securities less attractive because we will rely
on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading
prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and
the trading prices of our securities may be more volatile.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard. This may make comparison of our financial statements with another public company, which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accountant standards used. Once we lose our “emerging growth company” and “smaller reporting company”
status, we will no longer be able to take advantage of certain exemptions from reporting, and we will also be required to comply with
the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. We will incur additional expenses in connection with such
compliance and our management will need to devote additional time and effort to implement and comply with such requirements.
24
We
will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held
by non-affiliates exceeds $250 million as of the prior June 30, or (2) our annual revenues exceeded $100 million during such completed
fiscal year and the market value of our common stock held by non-affiliates exceeds $700 million as of the prior June 30.
We
will remain an emerging growth company until the earlier of: (1) the last day of the fiscal year (a) following the fifth anniversary
of the closing of CSLM’s IPO, (b) in which we have total annual gross revenue of at least $1.23 billion, or (c) in which we are
deemed to be a large accelerated filer, which means the market value of our common equity that is held by non-affiliates exceeds $700
million as of the end of the prior fiscal year’s second fiscal quarter; and (2) the date on which we have issued more than $1.00
billion in non-convertible debt securities during the prior three-year period.
We
may be subject to the Excise Tax included in the Inflation Reduction Act of 2022 in connection with redemptions of shares of public common
stock.
The
Inflation Reduction Act of 2022 imposes a 1% U.S. federal excise tax on certain repurchases (including redemptions) of stock by publicly
traded U.S. corporations beginning January 1, 2023. Because we are a Delaware corporation and our common stock is publicly traded, we
are a “covered corporation” for purposes of the excise tax.
Although
redemptions of our common stock that occurred in connection with the business combination closed in October 2025 may be netted
against equity issuances occurring during the same taxable year, we could nevertheless incur excise tax liability for the 2025 taxable
year. In addition, any future repurchases or redemptions of our common stock, whether conducted through open-market repurchases, tender
offers, redemptions, net settlements of equity awards, or other transactions, may also be subject to the excise tax, unless an exemption
applies.
The
U.S. Department of the Treasury has finalized certain procedural regulations but the substantive rules governing the computation of the
tax remain in proposed form and are subject to change. As a result, the application of the excise tax is uncertain and could materially
increase the cost of future share repurchases or other capital-allocation strategies.
Delaware
law and the Company’s Organizational Documents contain certain provisions, including anti-takeover provisions that limit the ability
of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.
The
Company’s amended and restated certificate of incorporation, as amended and restated (the “Certificate of Incorporation”)
and Bylaws (together, the “Organizational Documents”), and the DGCL, contain provisions that could have the effect of rendering
more difficult, delaying, or preventing an acquisition that stockholders may consider favorable, including transactions in which stockholders
might otherwise receive a premium for their shares. These provisions could also limit the price that investors might be willing to pay
in the future for shares of our common stock, and therefore depress the trading price of the Common Stock. These provisions could also
make it difficult for stockholders to take certain actions, including electing directors who are not nominated by the current members
of the Company’s board of directors or taking other corporate actions, including effecting changes in our management. Among other
things, the Organizational Documents include provisions regarding:
●
the
ability of the Company’s board of directors to issue shares of preferred stock, including “blank check” preferred
stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval,
which could be used to significantly dilute the ownership of a hostile acquirer;
●
the
Certificate of Incorporation prohibits cumulative voting in the election of directors, which limits the ability of minority stockholders
to elect director candidates;
●
the
limitation of the liability of, and the indemnification of, the Company’s directors and officers;
●
the
ability of the Company’s board of directors to amend the Bylaws, which may allow the Company’s board of directors to
take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the Bylaws to facilitate
an unsolicited takeover attempt; and
●
advance
notice procedures with which stockholders must comply to nominate candidates to the Company’s board of directors or to propose
matters to be acted upon at a stockholders’ meeting, which could preclude stockholders from bringing matters before annual
or special meetings of stockholders and delay changes in the Company’s board of directors and also may discourage or deter
a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise
attempting to obtain control of the Company.
These
provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in the Company’s board
of directors or management.
25
The
provisions of the Certificate of Incorporation requiring exclusive forum in the Court of Chancery of the State of Delaware and the federal
district courts of the United States for certain types of lawsuits may have the effect of discouraging lawsuits against our directors
and officers.
The
Company’s Certificate of Incorporation provides that, to the fullest extent permitted by law, and unless the Company consents in
writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, in the event that the Chancery
Court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware)
will be the sole and exclusive forum for (i) any derivative action, suit or proceeding brought on the Company’s behalf, (ii) any
action, suit or proceeding asserting a claim of breach of a fiduciary duty owed by any director, officer or stockholder of the Company
to the Company or the Company’s stockholders, (iii) any action, suit or proceeding arising pursuant to any provision of the DGCL
or the Organizational Documents (as each may be amended from time to time), (iv) any action, suit or proceeding as to which the DGCL
confers jurisdiction on the Court of Chancery of the State of Delaware, or (v) any action, suit or proceeding asserting a claim against
the Company or any current or former director, officer or stockholder governed by the internal affairs doctrine.
Section
22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability
created by the Securities Act or the rules and regulations thereunder. Accordingly, both state and federal courts have jurisdiction to
entertain such Securities Act claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or
contrary rulings by different courts, among other considerations, the Certificate of Incorporation provides that, unless the Company
consents in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of
the United States of America will be the exclusive forum for the resolution of any complaint asserting a cause of action arising under
the Securities Act; however, there is uncertainty as to whether a court would enforce such provision, and investors cannot waive compliance
with federal securities laws and the rules and regulations thereunder. Notwithstanding the foregoing, the Certificate of Incorporation
provides that the exclusive forum provision will not apply to suits brought to enforce any cause of action arising under the Securities
Act, any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Section
27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the
Exchange Act or the rules and regulations thereunder.
These
provisions may have the effect of discouraging lawsuits against the Company’s directors and officers. The enforceability of similar
choice of forum provisions in other companies’ certificates of incorporation has been challenged in legal proceedings, and it is
possible that, in connection with any applicable action brought against the Company, a court could find the choice of forum provisions
contained in the Certificate of Incorporation to be inapplicable or unenforceable in such action.
Risks
Related to Being a Public Company
We
will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies ,
which could adversely affect our business , financial condition , and results of operations .
As
a public company, we are and will continue to be subject to the reporting requirements of the Exchange Act, the listing standards of
Nasdaq and other applicable securities rules and regulations. We expect that the requirements of these rules and regulations will continue
to increase our legal, accounting, and financial compliance costs, make some activities more difficult, time-consuming and costly, and
place significant strain on our personnel, systems, and resources. For example, the Exchange Act requires, among other things, that we
file annual, quarterly, and current reports with respect to our business and results of operations. As a result of the complexity involved
in complying with the rules and regulations applicable to public companies, our management’s attention may be diverted from other
business concerns, which could harm our business, financial condition, and results of operations, although we have already hired additional
employees to assist us in complying with these requirements, we may need to hire more employees in the future or engage outside consultants,
which will increase our operating expenses.
In
addition, changing laws, regulations, and standards relating to corporate governance and public disclosure are creating uncertainty for
public companies, increasing legal and financial compliance costs, and making some activities more time-consuming. These laws, regulations
and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application
in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty
regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to
invest substantial resources to comply with evolving laws, regulations, and standards, and this investment may result in increased general
and administrative expenses and a diversion of management’s time and attention from business operations to compliance activities.
If our efforts to comply with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies
due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our
business may be harmed.
26
These
factors could also make it more difficult for us to attract and retain qualified members of our board of directors, particularly to serve
on our audit committee and compensation committee, and qualified executive officers.
As
a result of disclosure of information in filings required of a public company, our business and financial condition will become more
visible, which may result in an increased risk of threatened or actual litigation, including by competitors and other third parties.
If such claims are successful, our business, financial condition, and results of operations could be harmed, and even if the claims do
not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert
the resources of our management and harm our business, financial condition, and results of operations.
If
we fail to maintain an effective system of disclosure controls and internal control over financial reporting , our ability to produce
timely and accurate financial statements or comply with applicable regulations could be impaired .
As
a public company, we are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act and the rules and regulations
of the applicable listing standards of Nasdaq. We expect that the requirements of these rules and regulations will continue to increase
our legal, accounting and financial compliance costs, make some activities more difficult, time-consuming and costly and place significant
strain on our personnel, systems and resources.
The
Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over
financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that are designed to ensure
that information required to be disclosed by us in the reports that we will file with the SEC is recorded, processed, summarized and
reported within the time periods specified in SEC rules and forms and that information required to be disclosed in reports under the
Exchange Act is accumulated and communicated to our principal executive and financial officers. We are also continuing to improve our
internal control over financial reporting, which includes hiring additional accounting and financial personnel to implement such processes
and controls. In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal control over
financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related
costs and significant management oversight. If any of these new or improved controls and systems do not perform as expected, we may experience
material weaknesses in our controls.
Our
current controls and any new controls that we develop may become inadequate because of changes in conditions in our business. Further,
weaknesses in our disclosure controls and internal control over financial reporting may be discovered in the future. Any failure to develop
or maintain effective controls or any difficulties encountered in their implementation or improvement could harm our results of operations
or cause us to fail to meet our reporting obligations and may result in a restatement of our financial statements for prior periods.
Any failure to implement and maintain effective internal control over financial reporting also could adversely affect the results of
periodic management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness
of our internal control over financial reporting that we will eventually be required to include in our periodic reports that will be
filed with the SEC. Ineffective disclosure controls and procedures and internal control over financial reporting could also cause investors
to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of
our common stock. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on Nasdaq.
We are not currently required to comply with the SEC rules that implement Section 404 of the Sarbanes-Oxley Act and are therefore not
required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. As a public
company, we will be required to provide an annual management report on the effectiveness of our internal control over financial reporting
commencing with our second annual report on Form 10-K.
Our
independent registered public accounting firm is not required to formally attest to the effectiveness of our internal control over financial
reporting until after we are no longer an “emerging growth company” as defined in the JOBS Act. At such time, our independent
registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal
control over financial reporting is documented, designed or operating. Any failure to maintain effective disclosure controls and internal
control over financial reporting could have an adverse effect on our business and results of operations and could cause a decline in
the price of our common stock.
27
Our
business , financial condition , and results of operations may fluctuate on a quarterly and annual basis , which may
result in a decline in our stock price if such fluctuations result in a failure to meet the expectations of securities analysts or investors .
Our
operating results have in the past and could in the future vary significantly from quarter-to-quarter and year-to-year and may fail to
match our past performance, our projections or the expectations of securities analysts because of a variety of factors, many of which
are outside of our control and, as a result, should not be relied upon as an indicator of future performance. As a result, we may not
be able to accurately forecast our operating results and growth rate. Any of these events could cause the market price of our common
stock to fluctuate. Factors that may contribute to the variability of our operating results include, but are not limited to: our ability
to attract new clients and partners, retain existing clients and partners and maximize engagement and enrollment with existing and future
clients; changes in our sales and implementation cycles, especially in the case of our large clients; new solution introductions and
expansions, or challenges with such introductions; changes in our pricing or fee policies or those of our competitors; the timing and
success of new solution introductions by us or our competitors or announcements by competitors or other third parties of significant
new products or acquisitions or entrance into certain markets; any other change in the competitive landscape of our industry, including
consolidation among our competitors; increases in operating expenses that we may incur to grow and expand our operations and to remain
competitive; our ability to successfully expand our business, whether domestically or internationally; breaches of security or privacy;
changes in stock-based compensation expenses; the amount and timing of operating costs and capital expenditures related to the expansion
of our business; adverse litigation judgments, settlements, or other litigation-related costs; changes in the legislative or regulatory
environment, including with respect to privacy or data protection, or enforcement by government regulators, including fines, orders,
or consent decrees; the cost and potential outcomes of ongoing or future regulatory investigations or examinations, or of future litigation;
changes in our effective tax rate; our ability to make accurate accounting estimates and appropriately recognize revenue for our solutions
for which there are no relevant comparable products; changes in accounting standards, policies, guidance, interpretations, or principles;
instability in the financial markets; general economic conditions, both domestic and international; volatility in the global financial
markets; political, economic, and social instability, including terrorist activities and health epidemics (including the outbreak of
COVID-19), and any disruption these events may cause to the global economy; and changes in business or macroeconomic conditions. The
impact of one or more of the foregoing or other factors may cause our operating results to vary significantly.
Changes
in accounting principles may cause previously unanticipated fluctuations in our financial results , and the implementation of such
changes may impact our ability to meet our financial reporting obligations .
We
prepare our financial statements in accordance with GAAP, which are subject to interpretation or changes by the FASB, the SEC, and other
various bodies formed to promulgate and interpret appropriate accounting principles. New accounting pronouncements and changes in accounting
principles have occurred in the past and are expected to occur in the future which may have a significant effect on our financial results.
Furthermore, any difficulties in implementation of changes in accounting principles, including the ability to modify our accounting systems,
could cause us to fail to meet our financial reporting obligations, which could result in regulatory discipline and harm investors’
confidence in us.
If
our estimates or judgments relating to our critical accounting policies prove to be incorrect , our business , financial
condition , and results of operations could be adversely affected .
The
preparation of financial statements in conformity with GAAP and our key metrics require management to make estimates and assumptions
that affect the amounts reported in the consolidated financial statements and accompanying notes and amounts reported in our key metrics.
We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances,
as provided in the sections titled “ Management’s Discussion and Analysis of Financial Condition and Results of Operations ”
The results of these estimates form the basis for making judgments about the carrying values of assets, liabilities, and equity and the
amount of revenue and expenses that are not readily apparent from other sources. Significant assumptions and estimates used in preparing
our consolidated financial statements include those related to allowance for doubtful accounts, assessment of the useful life and recoverability
of long-lived assets, fair value of guarantees included in revenue arrangements and fair values of stock-based awards, warrants, contingent
consideration, and income taxes. Our results of operations may be adversely affected if our assumptions change or if actual circumstances
differ from those in our assumptions, which could cause our results of operations to fall below the expectations of securities analysts
and investors, resulting in a decline in the trading price of our common stock.
Risks
Related to an Investment in Our Securities
There
may not be an active trading market for our securities, which may make it difficult to sell shares of our common stock or warrants.
It
is possible that an active trading market for our securities will not develop or, if developed, that any market will not be sustained.
This would make it difficult for you to sell our securities at an attractive price or at all.
The
market price of our securities may be volatile, which could cause the value of your investment to decline.
The
price of our securities may fluctuate significantly due general market and economic conditions. An active trading market for our securities
may not develop or, if developed, it may not be sustained. In addition, fluctuations in the price of our securities could contribute
to the loss of all or part of your investment. Even if an active market for our securities develops and continues, the trading price
of our securities could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control.
Any of the factors listed below could have a material adverse effect on your investment in our securities and our securities may trade
at prices significantly below the price you paid for them. In such circumstances, the trading price of our securities may not recover
and may experience a further decline. Factors affecting the trading price of our securities may include, but are not solely limited to,
the risk factors identified herein.
In
addition, the stock market in general, and Nasdaq and technology and growth companies in particular, have experienced extreme price and
volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market
and industry factors may negatively affect the market price of our common stock, regardless of its actual operating performance. In the
past, securities class action litigation has often been instituted against companies following periods of volatility in the market price
of a company’s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of management’s
attention and resources, which would harm our business, operating results or financial condition.
28
There
can be no assurance that we will be able to comply with the continued listing standards of Nasdaq.
If
Nasdaq delists our securities from trading on its exchange for failure to meet their continued listing standards, the Company and its
stockholders could face significant negative consequences including:
●
Limited
availability of market quotations for the Company securities;
●
A
determination that our common stock is a “penny stock” which will require brokers trading in our securities to adhere
to more stringent rules;
●
Possibly
resulting in a reduced level of trading activity in the secondary trading market for shares of our common stock;
●
A
limited amount of analyst coverage; and
●
A
decreased ability to issue additional securities or obtain additional financing in the future.
Nasdaq
may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in its securities
and subject us to additional trading restrictions.
Currently,
our common stock and public warrants are listed on the Nasdaq Global Market under the symbols “FUSE” and “FUSEW.”
In order to continue the list of these securities on the Nasdaq Global Market, we are required to maintain certain financial, distribution
and stock price levels. On January 15, 2026, we received a notification letter from the Listing Qualifications Department of The Nasdaq
Stock Market indicating that we are not in compliance with the continued listing requirement to maintain a minimum Market Value of Publicly
Held Shares of $15,000,000 for the Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(C). In accordance with Nasdaq
Listing Rule 5810(c)(3)(D), we have 180 calendar days, or until July 14, 2026, to regain compliance with the MVPHS requirement. If at
any time before July 14, 2026, our MVPHS closes at or above $15,000,000 for a minimum of 10 consecutive business days, Nasdaq will provide
written confirmation that we have regained compliance. If Nasdaq delists our securities from trading on its exchange and we are not able
to list its securities on another national securities exchange, we expect our securities could be quoted on an over-the-counter market.
If this were to occur, we could face significant material adverse consequences, including:
● a
limited availability of market quotations for our securities;
● reduced
liquidity for our securities;
● a
determination that our common stock is a “penny stock” which will require brokers
trading in our common stock to adhere to more stringent rules and possibly result in a reduced
level of trading activity in the secondary trading market for our securities;
● a
limited amount of news and analyst coverage; and
● a
decreased ability to issue additional securities or obtain additional financing in the future.
The
National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the
sale of certain securities, which are referred to as “covered securities.” Since our common stock and public warrants are
listed on the Nasdaq Global Market, they are covered securities. However, if our securities were no longer listed on the Nasdaq Global
Market, they would not be covered securities and we would be subject to regulation in each state in which we offer our securities.
Because
we have no current plans to pay cash dividends on our common stock for the foreseeable future, you may not receive any return on investment
unless you sell your common stock for a price greater than that which you paid for it.
We
may retain future earnings, if any, for future operations, expansion and debt repayment and have no current plans to pay any cash dividends
for the foreseeable future. Any decision to declare and pay dividends as a public company in the future will be made at the discretion
of our board of directors and will depend on, among other things, our results of operations, financial condition, cash requirements,
contractual restrictions and other factors that our board of directors may deem relevant. As a result, you may not receive any return
on an investment in our Common Stock unless you sell the Common Stock for a price greater than that which you paid for it.
29
Sales
of a substantial number of shares of our Common Stock in the public market could cause our stock price to fall.
Sales
of a substantial number of shares of our Common Stock in the public market or the perception that these sales might occur, could depress
the market price of our Common Stock and could impair our ability to raise capital through the sale of additional equity securities.
We are unable to predict the effect that sales may have on the prevailing market price of our Common Stock. Sales of significant number
of shares of our Common Stock may make it more difficult for us to sell equity or equity-related securities in the future at a time and
price that it deems reasonable or appropriate, and make it more difficult for you to sell shares of our common stock. Certain holders
of our securities are entitled to rights with respect to the registration of the shares of our Common Stock under the Securities Act.
Any sales of securities by these stockholders could have a material adverse effect on the trading price of our Common Stock.
Future
sales and issuances of our Common Stock or rights to purchase Common Stock, including pursuant to our equity plans, could result in additional
dilution of the percentage ownership of our stockholders and could cause our stock price to fall.
We
expect that significant additional capital may be needed in the future to continue our planned operations, commercialization efforts,
expanded research and development activities and costs associated with operating as a public company. To raise capital, we may sell Common
Stock, convertible securities or other equity securities in one or more transactions at prices and in a manner it determines from time
to time. We may also sell our Common Stock as part of entering into strategic alliances, creating joint ventures or collaborations or
entering into additional licensing arrangements with third parties that we believe will complement or augment its development and commercialization
efforts. If we sell Common Stock, convertible securities or other equity securities, investors may be materially diluted by subsequent
sales. Such sales may also result in material dilution to existing stockholders, and new investors could gain rights, preferences and
privileges senior to the holders of our Common Stock.
Our
management has limited experience in operating a public company.
Our
executive officers have limited experience in the management of a publicly traded company subject to significant regulatory oversight
and reporting obligations under federal securities laws. Our management team may not successfully or effectively manage our transition
to a public company. Their limited experience in dealing with the increasingly complex laws pertaining to public companies could be a
significant disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities which will result
in less time being devoted to our management and growth. We may not have adequate personnel with the appropriate level of knowledge,
experience and training in the accounting policies, practices or internal controls over financial reporting required of public companies
in the United States. It is possible that will be required to expand its employee base and hire additional employees to support our operations
as a public company, which will increase its operating costs in future periods.
Item
1B. Unresolved Staff Comments.
None.
Item
1C. Cybersecurity.
Risk
management and strategy
We
recognize the critical importance of developing, implementing, and maintaining cybersecurity measures to safeguard our information systems
and protect the confidentiality, integrity , and availability of our data.
Managing
Material Risks & Integrated Overall Risk Management
We
have implemented tools, processes, and strategies to promote a company-wide culture of cybersecurity risk management. This ensures that
cybersecurity considerations are integrated into our decision-making processes to monitor and manage risk. Our IT Department works closely
with our leadership and key operating personnel to evaluate and address cybersecurity risks in alignment with our business objectives
and operational needs.
Engage
Third-parties on Risk Management
Due
to the complexity and evolving nature of cybersecurity threats, we engaged with a cybersecurity assessment firm as an external expert,
to evaluate and test our risk management systems. This partnership enables us to leverage specialized knowledge and insights, of dedicated
cybersecurity firms. Our collaborations with this third-party include regular system audits, threat assessments, 24-hour monitoring,
and consultation on security enhancements.
Oversee
Third-party Risk
Because
we are aware of the risks associated with third-party service providers, we conduct security assessments of all third-party providers
before engagement to ensure compliance with industry cybersecurity standards and frameworks. This includes assessments performed by our
Head of Technology, who oversees the Company’s cybersecurity function.
30
Risks
from Cybersecurity Threats
The
Company does not believe that it has experienced any cybersecurity threats or incidents that have materially affected or are reasonably
likely to materially affect the Company and its business strategy, results of operations and/or financial condition. These types of events,
which could lead to business disruptions, unplanned downtimes or outages, particularly in critical systems or services, may impact our
ability to operate efficiently, affecting business continuity.
Governance
We
have implemented standard operating procedures to define the channels by which cybersecurity threats are communicated to the Board. This
ensures that Board has oversight and effective governance in managing risks associated with cybersecurity threats.
Board
of Directors Oversight
The
Audit Committee is central to the Board’s oversight of cybersecurity risks and bears the primary responsibility for this domain.
The Audit Committee is composed of board members with diverse expertise including, risk management, and finance, which we believe equips
them to oversee cybersecurity and other risks effectively.
Management’s
Role Managing Risk
The
Head of Technology plays a pivotal role in informing the Audit Committee on cybersecurity risks. This role provides briefings to the
Audit Committee on a regular basis, with a minimum frequency of once per year. These briefings encompass a broad range of topics, including:
● current
cybersecurity landscape and emerging threats;
● status
of ongoing cybersecurity initiatives and strategies;
● incident
reports and learnings from any cybersecurity events; and
● compliance
with regulatory requirements and industry standards.
Risk
Management Personnel
Primary
responsibility for assessing, monitoring and managing our cybersecurity risks rests with the Head of Technology and department staff.
Our IT team oversees our governance programs, tests our compliance with standards, remediates known risks, stays informed of significant
developments in the cybersecurity domain, and leads our employee training program.
Monitor
Cybersecurity Incidents
The
Head of Technology is continually informed about the latest developments in cybersecurity, including potential threats and innovative
risk management techniques. This ongoing knowledge acquisition is crucial for the effective prevention, detection, mitigation, and remediation
of cybersecurity incidents. Under his direction, the IT department implements and oversees processes for the regular monitoring of our
information systems. This includes the deployment of advanced security measures and regular system audits to identify potential vulnerabilities.
In the event of a cybersecurity incident, the IT department is equipped with a well-defined written procedure. This plan includes immediate
actions to mitigate the impact and long-term strategies for remediation and prevention of future incidents.
Reporting
to Board of Directors
The
Head of Technology consistently communicates with the Audit Committee regarding critical cybersecurity risks and incidents, ensuring
that the organization’s highest governance bodies remain well-informed about our cybersecurity status and potential vulnerabilities.
Moreover, matters of significant cybersecurity importance, along with strategic risk management decisions, are promptly escalated to
the Board of Directors. This process ensures that the Board maintains thorough oversight and is equipped to offer informed guidance on
critical cybersecurity issues.
Item
2. Properties.
Corporate
Headquarters
The
Company leases its corporate headquarters located at 251 West 30th Street, 5th Floor, New York, New York 10001.
The
Company also leases approximately 11,000 square feet of office space in Nepal.
The Company believes
that its existing facilities and other available properties will be sufficient for its needs for the foreseeable future.
Item
3. Legal Proceedings.
We
are not currently a party to any material litigation, nor are we aware of any pending or threatened litigation against us that we believe
would materially affect our business, operating results, financial condition, or cash flows. Participants in our industry face frequent
claims and litigation, including securities litigation, claims regarding patent and other intellectual property rights, and other liability
claims. As a result, we may be involved in various legal proceedings from time to time in the future.
Item
4. Mine Safety Disclosures.
Not
Applicable.
31
PART
II
Item
5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market
Information
Our
common stock and public warrants are lis ted on
Nasdaq under the symbols “FUSE” and “FUSEW”, respectively. On March 25, 2026, the closing price of our
common stock was $1.26 per share and the closing price of our
public warrants was $0.09 per warrant.
Holders
of Our Common Stock
As
of March 26, 2026, we had 173 holders of
record of our common stock. Certain shares are held in “street” name and accordingly, the number of beneficial owners of
such shares is not known or included in the foregoing number. This number of holders of record also does not include stockholders
whose shares may be held in trust by other entities.
Dividend
Policy
We
currently intend to retain all available funds and any future earnings to fund the growth and development of our business. We have never
declared or paid any cash dividends on our capital stock. We do not intend to pay cash dividends to our stockholders in the foreseeable
future. Investors should not purchase our common stock with the expectation of receiving cash dividends.
Any
future determination to declare dividends will be made at the discretion of our board of directors and will depend on our financial condition,
operating results, capital requirements, general business conditions, and other factors that our board of directors may deem relevant.
Securities
Authorized for Issuance Under Equity Compensation Plans
The
information required by Item 5 of Form 10-K regarding equity compensation plans is incorporated herein by reference to Item 12 of Part
III of this Annual Report.
Recent
Sales of Unregistered Securities
All
sales of unregistered securities by us during the year ended December 31, 2025 have been included previously in a Quarterly Report on
Form 10-Q or in a Current Report on Form 8-K.
Purchases
of Equity Securities by the Issuer and Affiliated Purchasers
None.
Item
6. [Reserved].
32
Item
7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The
following discussion and analysis provides information that Fusemachines Inc. (“Pubco” or “Fusemachines”)
management believes is relevant to an assessment and understanding of Fusemachines consolidated results of operations and financial
condition as of December 31, 2025, and for the fiscal year ended December 31, 2025. The discussion should be read together with Fusemachines
consolidated financial statements and related notes that are included elsewhere in this annual report on Form 10-K (this “Annual
report”) as of and for the year ended December 31, 2025, and December 31, 2024. Capitalized and defined terms used in this section
shall have the meanings ascribed to them herein. Capitalized terms not defined in this section shall have the meanings ascribed to them
elsewhere in this annual report.
This
discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Fusemachines
actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including
those set forth under “Risk Factors” or in other parts of this annual report.
Company
Overview
We
are a leading provider of agentic AI solutions, offering innovative AI products and services to businesses. With over a decade of experience,
we help enterprises seamlessly integrate AI into their operations, enhancing efficiency, reducing costs, and driving innovation. Our
products and services are uniquely supported by a global talent pool, primarily sourced from underserved communities, allowing us to
deliver high- quality AI solutions at scale while fulfilling our mission of democratizing AI.
Our
clients have successfully utilized our AI solutions to solve critical business challenges such as improving sales forecasting accuracy,
eliminating manual data entry errors. Our commitment to delivering measurable business value has enabled us to build enduring partnerships
with these organizations, positioning Fusemachines as a trusted partner in their AI-driven transformation journeys.
In
addition to our agentic AI solutions, we are deeply invested in education and talent development. Our AI training programs, particularly
our flagship AI Fellowship Program, are designed to upskill students and professionals, providing them with hands-on experience in real-world
AI applications. To date, we have certified hundreds of AI Fellows across the United States, Nepal, and the Dominican Republic. These
programs not only empower individuals but also contribute to the global AI talent pool, which is critical given the current shortage
of AI professionals.
We
were originally incorporated under the name CSLM Acquisition Corp.(“CSLM” ) , as a Cayman Islands exempted Company,
as a special purpose acquisition company (“SPAC”) formed for the purpose of effecting a merger, share exchange, asset acquisition,
share purchase, reorganization or similar business combination with one or more businesses or entities.
In
January 2024, the Company entered into an Agreement and Plan of Merger (as amended in August 2024 and February 2025, the “Business
Combination Agreement”) with CSLM Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of CSLM (“Merger Sub”),
and Fusemachines USA, Inc. (formerly Fusemachines Inc.) (“Legacy Fusemachines”). On October 22, 2025, the Company consummated
the business combination whereby (a) CSLM merged with and into CSLM Holdings, Inc., a Delaware corporation and wholly owned subsidiary
of CSLM at which time the separate existence of CSLM ceased and CSLM Holdings became the surviving corporation (“Pubco”)
in accordance with the Delaware General Corporation Law (“DGCL”), the Cayman Islands Companies Act (As Revised) (the “Companies
Act”), the Certificate of Merger, (the “Certificate of Merger”), and the amended and restated memorandum and articles
of association of CSLM (the “Domestication”); (b) the merger (the “Merger”) of Merger Sub with and into Legacy
Fusemachines, pursuant to which, at the closing of the transactions contemplated by the Business Combination Agreement (the “Closing”),
the separate corporate existence of Merger Sub ceased and Legacy Fusemachines became the surviving corporation and a wholly-owned subsidiary
of Pubco, pursuant to the terms of the Business Combination Agreement and in accordance with the laws of the State of Delaware, as more
fully described elsewhere in the Proxy Statement/Prospectus; and (c) the other transactions contemplated by the Business Combination
Agreement and documents related thereto (such transactions, together with the Domestication and the Merger, the “Business Combination”).
In connection with the Business Combination, Pubco was renamed “Fusemachines Inc.” (the “Company”) and Fusemachines
Inc. was renamed “Fusemachines USA, Inc.” (“Legacy Fusemachines”).
The
common stock of the Company began trading on The Nasdaq Stock Market (Nasdaq Global Market) under the symbol “FUSE”, and
the warrants trade under the symbol “FUSEW”, beginning on October 23, 2025.
Throughout
the notes to the consolidated financial statements, unless otherwise noted or the context otherwise requires, the term “Company”
refers to Legacy Fusemachines and its subsidiaries prior to the consummation of the Business Combination, and to Fusemachines Inc. (the
publicly traded parent company) and its subsidiaries after the consummation of the Business Combination.
Recent
Developments
Business
Combination
Upon
consummation of the transaction on October 22, 2025, Legacy Fusemachines (the “Company”) was determined to be the
accounting acquirer, and the transaction was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Accordingly, the historical financial
statements of Legacy Fusemachines became the historical financial statements of the registrant.
33
Accordingly,
the following disclosure on “Reverse Recapitalization” is presented to summarize the common stock issued at Closing, the
application of the exchange ratio, and the resulting additional paid-in-capital recognized in connection with the recapitalization.
The
overall voting interest on closing date is summarized below:
Particulars
Shares
%Ownership
Shares held by Fusemachines Inc. Stockholders
14,864,110
52 %
Shares held by CSLM public stockholders, Sponsor, and related parties of Sponsor
12,654,921
45 %
Shares held by unrelated third parties
831,000
3 %
Total
28,350,031
100 %
On
October 22, 2025, all holders of 29,199,809 issued and outstanding Legacy Fusemachines common stock received shares of Fusemachines Inc
common stock at a par value $0.0001 per share after giving effect to the exchange ratio of 0.6580 (the “Conversion Ratio”)
resulting in 19,214,201 shares of Fusemachines Inc common stock issued and outstanding as of the Closing. The issuance reflects the following
events contemplated by the Business Combination Agreement:
(a) 9,043,234 shares of Legacy Fusemachines convertible preferred stock were converted into shares of Legacy Fusemachines common stock in
accordance with the applicable conversion terms. Subsequently, in connection with the Business Combination, all such shares of Legacy
Fusemachines common stock were exchanged for shares of common stock of Fusemachines Inc. (the “Company” or “PubCo”)
based on the exchange ratio specified in the Business Combination Agreement. After giving effect to the exchange ratio, an aggregate of
5,950,673 shares of the Company’s common stock were issued.
(b) The
surrender and exchange of all 29,199,809 issued and outstanding shares of Legacy Fusemachines common stock (including shares issued upon
conversion of preferred stock) into 19,214,201 shares of Fusemachines Inc. common stock as adjusted by the Exchange Ratio;
(c) The
other related events that occurred in connection with the Closing are summarized below:
● Upon the closing date, there is settlement of sponsor convertible note amounting to $ 3,978 thousand which was
effected through a combination of $2,343 thousand in cash and balance through issuance of 408,639 common stock of Fusemachines Inc.
● Public
shareholders of CSLM received an aggregate of 901,955 shares of Fusemachines Inc. common stock.
● All
public rights were converted into 1,897,486 shares of Fusemachines Inc. common stock.
● 1,184,000
shares of Fusemachines Inc. common stock issued in connection with the PIPE Financing
● Issuance
of 4,743,750 shares of Fusemachines Inc common stock upon conversion of non-redeemable CSLM Class A & Class B Ordinary Shares.
● Fusemachines
Inc. received funds from a convertible note with an affiliate of the Sponsor in the principal amount of $2,193 thousand. On the Closing
Date, the note was converted into a share of Fusemachines Inc. common stock pursuant to the conversion terms of the convertible note
agreement.
● Approximately
$11,005 thousand prepayment made by CSLM to the Meteora Parties pursuant to the Forward Purchase Agreement funded from the Trust Account.
● Repayment
of approximately $745 thousand (principal and accrued interest) on promissory notes issued to the Chief Executive Officer.
●
Each Convertible note of Legacy Fusemachines (including both related party and other convertible notes) outstanding immediately
prior to the Closing was converted into shares of Legacy Fusemachines common stock of 8,048,770 shares in accordance with the
applicable convertible note agreement and immediately thereafter exchanged into 5,296,271 shares of Fusemachines Inc. common stock
in accordance with the Conversion Ratio specified in the Business Combination Agreement, accordingly as a result of the conversions
and exchanges, no convertible notes or related-party notes payable remained outstanding as of December 31, 2025, other than related
party note payable related to Dolma Impact Fund I (“Dolma”) amounting $300 thousand.
●
Upon the closing of the business combination, the Company settled its obligation under the Second Agreement through the issuance of
29,610 shares of Fusemachines, Inc. common stock, reflecting the application of the 0.6580 conversion ratio to the 45,000 shares of
the Company’s common stock, and a partial cash payment of approximately $110 thousand. The remaining $98 thousand obligation
is still outstanding and is reflected in accounts payable as of December 31, 2025.
●
Upon the conversion of the April 2024, June 2024 and September 2024 Convertible Note to common stock, the Company shall issue the holder
a warrant to purchase 7,500 shares of common stock of CSLM with a per share exercise price of $11.50. The warrants issuable upon conversion
of the April 2024, June 2024 and September 2024 Convertible Notes are classified as equity instruments .
● The assumption of the public and private
warrants, as described in Note 24 Public and private warrants of Consolidated Financial Statements.
● The Company’s amended and restated
certificate of incorporation and amended and restated bylaws were adopted.
● The Company adopted the 2025 equity incentive plan.
34
(d)
The reverse recapitalization accounting treatment was primarily determined based on the fact that the stockholders of Legacy
Fusemachines held a relative majority of the voting power of Fusemachines Inc. and had the ability to nominate a majority of the
members of the Board of Directors. In addition, the senior management of Legacy Fusemachines becomes the senior management of
Fusemachines Inc., and the strategy and operations of Legacy Fusemachines prior to the merger represent the ongoing operations of
the combined Company.
Accordingly,
for accounting purposes, the financial statements of Fusemachines Inc. represent a continuation of the financial statements of Legacy
Fusemachines, with the Merger being treated as the equivalent of Legacy Fusemachines issuing shares for the net assets of CSLM, accompanied
by a recapitalization. The net assets of CSLM were recognized at their historical carrying amounts as of the Closing date, and no goodwill
or other intangible assets were recorded. Operations prior to the Merger are presented as those of Legacy Fusemachines Inc. and the accumulated
deficit of Legacy Fusemachines has been carried forward after Closing.
(e) Fusemachines Inc. incurred transaction cost of $1,873 thousands,
consisting of deferred transaction cost, banking fees, legal fees, and other professional fees, which has been recorded as a reduction
to additional paid-in capital as a direct and incremental cost of the reverse recapitalization.
(f) All
periods presented prior to the Merger have been retrospectively adjusted to reflect the Exchange Ratio for the equivalent number of shares
of Fusemachines Inc. common stock outstanding immediately after the Closing in order to effect the reverse recapitalization.
Covenant
Fees
Pursuant
to the Business Combination Agreement, the Company was covenanted to deliver to CSLM its audited financial statements for the year ended
December 31, 2023 and 2022 for inclusion in the registration statement on Form S-4 to be filed by CSLM in connection with the Merger,
and that such audited financial statements had been prepared in conformity with GAAP applied on a consistent basis and in accordance
with the requirements of the Public Company Accounting Oversight Board for public companies. The Company had covenanted to provide the
audited financial statements no later than February 29, 2024, or incur delay fees in the amount equal to $35.0 thousand for the first
one-month delay to March 31, 2024 (pro-rated for a partial month), $50.0 thousand for the second one-month delay to April 30, 2024, and
thereafter $70.0 thousand for each subsequent one-month delay (pro-rated for any partial month). The Company provided the audited financial
statements to CSLM in September 2024. As such, the Company has recorded $505 thousand of deferred transaction costs on the audited consolidated
balance sheets as of December 31, 2024. On February 4, 2025, the company entered into a second amendment of the original agreement wherein
the above-mentioned delay fee provision is deleted and provides the Company with relief from future penalties related to the delivery
of the 2023 financial statements. Accordingly, the company recorded waiver in the year ended December 31, 2025 which have no impact in
the consolidated Statements of Operations and Comprehensive Loss as the amount of provision was eliminated from the deferred transaction
cost and from the Accounts Payable, Accrued expense and other current liabilities in the consolidated balance sheets.
35
Amendment
of the maturity date and conversion option
Related
party convertible notes payable at fair value
On
January 31, 2025, the Company entered into an amendment agreement of the convertible note payable to Dolma. Pursuant to the amendment
agreement, the maturity date was revised to February 28, 2026. Further, it was agreed that if the Company enters into a SPAC Business
Combination Agreement at any time while the Notes are outstanding, any portion of the Aggregate Notes Amount that is not redeemed or
repaid in connection or prior to the closing of the SPAC Transaction will convert, without any required action by the Holder, into shares
of Common Stock immediately prior to the consummation of the SPAC Transaction contemplated by the SPAC Business Combination Agreement
at a conversion rate that is derived from a Company valuation of $85,000 thousand, on a fully-diluted basis (provided that the Notes will
be deemed have converted simultaneously with all other convertible notes being converted in connection the SPAC Transaction)
The
Company evaluated the above amendment agreement entered on January 31, 2025, under the guidance in ASC 470-50 Debt - Modifications and
Extinguishments, and it was determined terms of the amendment were not substantially different than the terms of the convertible notes
prior to the Amendment. Accordingly, the aforesaid amendment was accounted for as a debt modification.
2024
Convertible Notes at fair value
On
February 4, 2025, the maturity date of January 2024 convertible note was extended to July 12, 2025 pursuant to the second amendment.
The
Company evaluated the above amendment agreement entered on February 4, 2025, under the guidance in ASC 470-50 Debt - Modifications and
Extinguishments, and it was determined terms of the amendment were not substantially different than the terms of the convertible notes
prior to the Amendment. Accordingly, the aforesaid amendment was accounted for as a debt modification.
On
July 12, 2025, the maturity date of 2024 Convertible Notes were extended from July 12, 2025 to October 18, 2025, pursuant to the third
amendment. The Company applied the 10% cash flow test pursuant to ASC 470 to calculate the difference between the present value of the
amended note’s cash flows and the present value of the original remaining cash flow and concluded that the results didn’t
exceed the 10% factor, the debt modification is not considered substantially different and therefore did not apply extinguishment accounting,
rather it accounted for the modification on a prospective basis pursuant to ASC 470.
April
2024 Convertible Note
On
February 5, 2025, the conversion price of the April 2024 Convertible Promissory Notes with principal amount of $125,000 was
amended to $3.15 from the original conversion price of $4.94.
The
Company evaluated the conversion feature of April 2024 Convertible Note offering for embedded derivatives in accordance with ASC 815,
Derivatives and Hedging, and the substantial premium model in accordance with ASC 470, Debt. Based on our assessment, separate accounting
for the conversion feature of this note offering is not required and will be accounted for under the substantial premium model. Under
the substantial premium model, the excess above the fair value amounting to $113.0 thousand this note will be recorded as loss on extinguishment
of debt in additional paid-in-capital with a corresponding debit in the consolidated statement of profit and loss for the year ended
December 31, 2025.
The
April 2024 Convertible Notes were once again amended in April 2025 and basis the amendment the maturity date was revised from April 5,
2025, to April 5, 2026, pursuant to the second amendment. The Company applied the 10% cash flow test pursuant to ASC 470 to calculate
the difference between the present value of the amended note’s cash flows and the present value of the original remaining cash
flow and concluded that the results didn’t exceed the 10% factor, the debt modification is not considered substantially different
and therefore did not apply extinguishment accounting, rather it accounted for the modification on a prospective basis pursuant to ASC
470.
36
June
2024 Convertible Note
On
February 5, 2025, the conversion price of the June 2024 Convertible Promissory Note with principal amount of $130,000 was
amended to $3.15 from the original conversion price of $4.94.
The
Company evaluated the conversion feature of June 2024 Convertible Note offering for embedded derivatives in accordance with ASC 815,
Derivatives and Hedging, and the substantial premium model in accordance with ASC 470, Debt. Based on our assessment, separate accounting
for the conversion feature of this note offering is not required and will be accounted for under the substantial premium model. Under
the substantial premium model, the excess above the fair value amounting to $114.0 thousand this note was recorded as loss on extinguishment
of debt in additional paid-in-capital with a corresponding debit in the consolidated statement of profit and loss for the year ended
December 31, 2025.
On
July 23, 2025, the maturity date of June 2024 Convertible Note was extended from June 17, 2025, to June 17, 2026, pursuant to the amendment.
September
2024 Convertible Note
On
February 5, 2025, the conversion price of the two September 2024 Convertible Promissory Notes with principal amount of $100,000 each
was amended to $3.15 from the original conversion price of $4.94.
The
Company evaluated the conversion feature of September 2024 Convertible Notes offering for embedded derivatives in accordance with ASC
815, Derivatives and Hedging, and the substantial premium model in accordance with ASC 470, Debt. Based on our assessment, separate accounting
for the conversion feature of these notes offering is not required and will be accounted for under the substantial premium model. Under
the substantial premium model, the excess above the fair value amounting to $164.0 thousand these notes was recorded as loss on extinguishment
of debt in additional paid-in-capital with a corresponding debit in the consolidated statement of profit and loss for the year ended
December 31, 2025.
February
2025 Convertible Note
On
February 24, 2025, the company entered into a convertible promissory note amounting to $180,000 with an interest rate of 4.71% and maturity
date of February 19, 2028. Upon closing of the merger, the Note shall automatically convert into the number of shares of Common Stock
equal to the then outstanding Obligations under the note divided by the applicable Conversion Price i.e., $3.15.
The
February 2025 Convertible Note has customary events of default, are fully secured by the assets of the Company and because the conversion
feature does not meet the definition of a derivative are being accounted for at amortized cost. The proceeds of the February 2025 Convertible
Note will be used for working capital purposes.
Related
Party loan payable
On
February 12, 2025, an amendment to the seven promissory notes was entered into between the company and the CEO, Mr. Sameer Maskey. As
per the original agreement, the maturity date was earlier of (1) the occurrence of an Event of Default and (2) December 31, 2024. Pursuant
to the amendment agreement, the maturity date was extended to earlier of (1) the occurrence of an Event of Default and (2) December 31,
2025
The
Company evaluated the amendment in maturity date under the guidance in ASC 470-50 Debt - Modifications and Extinguishments, and it was
determined that there was no gain/loss to be recorded in the consolidated statements of operations and comprehensive loss, for the year
ended December 31, 2025.
37
The
Company incurred interest expense on promissory notes held at amortized cost and subsequently the promissory notes principal and accrued
and unpaid interest were repaid in cash upon the Closing of merger.
Others-
February 2025 Convertible Notes
In
connection with the second amendment to the Business Combination Agreement, an entity provided financing to Fusemachines in the amount
of $2,160,000, in exchange for a convertible note which note shall convert into shares of common stock of Fusemachines at a price of
$0.44 per share (a) automatically at the time of the Business Combination, or (b) on July 12, 2025 at the option of the holder, if not,
then payable in cash.
Pursuant
to the terms of the Note and related Escrow Agreement, the proceeds are required to be deposited into an escrow account and will be released
to the Company only upon the consummation of the Business Combination.
Further,
per Section 4.2 of the Escrow Agreement “Upon the Closing, the Company, Investor and Fusemachines shall jointly deliver a Joint
Release Notice to the Escrow Agent directing the Escrow Agent to disburse all Funds held in the Escrow Account to the Fusemachines Inc.”
Accordingly, the escrowed funds are not freely available to the Company prior to joint instruction by the Investor, Fusemachines and
the Company.
On
May 22, 2025, the proceeds from Consilium Frontier Equity Fund, LP have been received into an escrow account. Upon closing of the merger, these funds were subsequently released and received in the bank account of Fusemachines Inc.
Impact
of reverse capitalization on convertible note
In
connection with the consummation of the Business Combination on October 22, 2025, each Legacy Fusemachines convertible note, including
both related-party and non-related-party convertible notes, that was issued and outstanding immediately prior to the Closing was converted
into an aggregate of 8,048,770 shares of Legacy Fusemachines common stock in accordance with the convertible note agreements.
Convertible
notes that are exchanged for equity pursuant to their original contractual terms are accounted for in accordance with ASC 470-20, Debt
with Conversion and Other Options. Upon conversion, the carrying amount of the convertible debt is reclassified to equity, and no gain
or loss is recognized in earnings, as the conversion is executed in accordance with the original terms of the instruments
Immediately
following such conversions, all shares of Legacy Fusemachines common stock issued upon conversion were exchanged for shares of Fusemachines
Inc. common stock based on the exchange ratio specified in the Business Combination Agreement.
As
a result of the conversions and exchanges, no convertible notes or related-party notes payable remained outstanding as of December 31,
2025, other than related party note payable related to Dolma amounting $300 thousand.
Litigation
Fusemachines
Inc. received a legal notice dated March 27, 2025 requiring payment of $76.3 thousand to KCSA Strategic Communications under
a Work Labor & Services agreement due to non-fulfillment of payment obligations. Although there can be no assurance of the outcome
of such legal actions, in the opinion of management, the Company does not have a potential liability related to any current legal proceeding
or claim that would individually or in aggregate materially affect its results of operations, financial condition or cash flows. The
company has already recognized $41.3 thousand liability in its consolidated balance sheet as of December 31, 2025.
38
Forward
purchase agreement
On
July 31, 2025, CSLM and Legacy Fusemachines (CSLM prior to the Merger and the Company after the Merger, (the “Counterparty”),
entered into an over-the-counter (OTC) equity prepaid forward confirmation (the “Forward Purchase Agreement” or “FPA”)
with Meteora Capital Partners, LP, Meteora Select Trading Opportunities Master, LP and Meteora Strategic Capital, LLC (collectively,
the “Sellers”)
Upon
the consummation of the Merger on October 22, 2025, the Sellers (Meteora) delivered a Pricing Date Notice (as defined in the Forward
Purchase Agreement). Based on this notice, the applicable Prepayment Amount (as defined in the Forward Purchase Agreement) became determinable
and was subsequently funded by the Counterparty from the Trust Account (as defined in the Forward Purchase Agreement) in accordance with
the Forward Purchase Agreement.
Under
the material terms of the FPA:
●
The
Sellers committed (in one or more Pricing Date Notices) to provide up to a maximum of 3,000,000 shares of Class A common stock for
the Transaction.
●
The
Counterparty agreed to pay the Sellers a Prepayment Amount equal to the Number of Shares (as defined in the Forward Purchase Agreement)
specified in each Pricing Date Notice multiplied by the per-share redemption price (the “Initial Price” as defined in
the Counterparty’s organizational documents). The Prepayment Amount is payable from the Counterparty’s Trust Account
and subject to receipt of a Pricing Date Notice, will be wired no later than the earlier of (a) one Local Business Day after the
Closing Date and (b) the date any Trust Account assets are disbursed in connection with the Business Combination.
●
The
Sellers waived any rights to the Trust Account funds in respect of the FPA and agreed not to seek recourse against the Trust Account
except as expressly provided in the FPA.
●
Settlement
is by cash settlement at the end of the agreement: on the Valuation Date (generally three years after the Closing Date unless earlier
determined under specified events as set forth in the SPA) the Seller will pay the Counterparty a cash amount equal to the Number
of Shares as of the Valuation Date multiplied by the VWAP over the Valuation Period; the cash settlement payment date is the tenth
local business day following the end of the Valuation Period.
●
The
FPA includes an early termination mechanism: where Sellers sell (terminate) specified shares after closing, Sellers must pay an Early
Termination Obligation (as defined in the Forward Purchase Agreement) to Counterparty equal to the number of Terminated Shares (as
defined in the Forward Purchase Agreement) multiplied by the Termination Price of $12.00 per share (payable on the first local business
day following settlement of the sale).
●
The
Sellers may, at their election, request “Shortfall Warrants” (refer note 22) exercisable for a number of shares of common
stock equal to the difference between the Maximum Number of Shares (as defined in the Forward Purchase Agreement) and the number
of shares of common stock specified in a Pricing Date Notice; such warrants have exercise terms and an exercise price as set forth
in the FPA.
●
Payment
dates for periodic reporting / accounting purposes are the last day of each calendar quarter (or next local business day), until
the Valuation Date; the FPA also contains customary provisions addressing indemnities, representations, Calculation Agent rights,
and compliance with tender-offer and SEC rules.
The
Forward Purchase Agreement includes escrow arrangements pursuant to which the Prepayment Amount funded from the CSLM trust account is
held in escrow for the benefit of the Meteora Parties until settlement or release in accordance with the terms of the Forward Purchase
Agreement. The Company does not have unconditional access to the funds held in escrow, and such funds are not available to satisfy the
claims of the Company’s creditors.
Accordingly,
the Company recorded the prepayment amount $11,005 thousand as a contra-equity share subscription receivable, presented as a reduction
of stockholders’ equity (APIC), as the escrowed funds represent conditional consideration receivable from shareholders that is
subject to future settlement under the Forward Purchase Agreement. The Prepayment Amount was determined based on 891,930 shares of common
stock at a per share price equal to the SPAC per-share redemption price (the “Initial Price”), as defined in the Forward
Purchase Agreement
39
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
The
Forward Purchase Agreement contains features that meet the definition of a derivative under ASC 815, including an underlying based on
the Company’s Class A common stock, a notional amount, payment provisions, and provisions that require or permit net cash settlement.
Accordingly, at the Closing, the Company recognized a derivative liability measured at fair value, representing the portion of the escrowed
Prepayment Amount that may be payable to the Forward Counterparty based on conditions existing as of the Closing Date.
The
share subscription receivable and the derivative liability, when considered together, represent management’s estimate of the portion
of the escrowed funds that the Company expects to ultimately retain. Subsequent changes in the fair value of the derivative liability
associated with the Forward Purchase Agreement are recognized in earnings at each reporting date.
Upon receipt of consideration related to the sale
of any shares sold by Meteora, the Company will record the receipt of funds as an increase to cash and a decrease to the share subscription
receivable previously recorded as contra-equity.
The Company incurred no transaction costs that were directly related to issuance of the Forward Purchase Agreement.
Further
subsequent to year ended December 31, 2025, the Company entered into an amendment on February 3, 2026 to the Prepaid Forward Purchase
Agreement (the “Amendment”) originally entered into on July 31, 2025 with Meteora Capital Partners and affiliates, for detail
refer to Note 25 - Subsequent events.
As
of December 31, 2025, the value of the Forward purchase derivative liability is $9,692 thousand disclosed as Current Liability in the
Consolidated Balance Sheets. Further the derivative liability is measured at fair value on a recurring basis using Level 3 inputs, refer
to Note 3 – Fair Value Measurements for further information on the valuation techniques and significant unobservable inputs used
in determining the fair value of this instrument.
Further,
the derivative liability has been classified as current as the Company does not have an unconditional right to defer settlement beyond
twelve months. The Forward Purchase Agreement includes provisions for early termination upon sale of shares by the Sellers, which can
result in cash settlement within the next twelve months, as well as periodic settlement features, thereby requiring current classification
Subsequently
to year ended December 31, 2025, the Company entered into an amendment on February 3, 2026 to the Prepaid Forward Purchase Agreement
(the “Amendment”) originally entered into on July 31, 2025 with Meteora Capital Partners and affiliates. The Amendment replaces
the agreement’s previously fixed Termination Price of $12.00 per share with a weekly-reset Termination Price equal to the lower
of (a) $12.00 and (b) the volume-weighted average price (VWAP) of the Shares for the immediately preceding week (as reported by Bloomberg
L.P.), subject to Reset Price Floors applied on a tranche basis (50% of the Shares: $2.50 floor; 50% of the Shares: $5.00 floor). The
Company is currently evaluating the accounting and financial reporting implications of this Amendment, including its impact, if any,
on the valuation of the related derivative instrument.
Private
Investment in Public Equity (“PIPE”) Financing
On
December 23, 2025, Fusemachines Inc. (the “Company”) entered into and consummated a Securities Purchase Agreement with an
accredited investor pursuant to which the Company issued and sold shares of its common stock, par value $0.0001 per share, in a private
placement transaction (the “PIPE Financing”).
In connection with the PIPE Financing, the Company
issued 588,235 shares of its common stock at a purchase price of $1.70 per share, resulting in aggregate gross proceeds of $1,000 thousand.
The shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended,
and/or Regulation D promulgated thereunder.
The proceeds from the PIPE Financing were received
in cash at closing. For accounting purposes, the issuance of common stock was recorded within stockholders’ equity as permanent
equity.
Public
and private warrants
As
of December 31, 2025, there were 3,971,250 Private Warrants and 9,487,500 Public Warrants outstanding. There are no warrants exercised as at December 31, 2025.
Public
warrants
Each
Public Warrant entitles the holder to purchase one whole share of the Company’s common stock. Public Warrants are exercisable only
for whole warrants; no fractional warrants will be issued upon separation of the units, and only whole warrants will trade. The Public
Warrants became exercisable 30 days after the completion
of the Business Combination.
The
Company will not be obligated to deliver Class A common shares upon exercise of a Public Warrant (and will have no obligation to settle
a Public Warrant exercise) unless a registration statement under the Securities Act, covering the shares issuable upon exercise, is then
effective and a prospectus relating thereto is current, or a valid exemption from registration is available. If the conditions for registered
issuance are not satisfied, holders will not be able to exercise those Public Warrants for registered shares until such time as an effective
registration statement is available; in such circumstances the Company may permit (or require, as described below) cashless exercise
pursuant to Section 3(a)(9) or other available exemption.
Each
whole Public Warrant is exercisable for one share of the Company’s Class A common stock at an exercise price of $11.50 per share,
subject to the customary anti-dilution and other adjustment provisions set forth in the warrant agreement. The Public Warrants became
exercisable 30 days after the completion of an initial Business Combination and expire five years after the completion of an initial Business Combination or earlier
upon redemption or liquidation, in each case in accordance with the warrant agreement.
The
Public Warrants contain customary terms and features for contracts in the Company’s own equity, including (i) anti-dilution adjustments
to the exercise price and the number of shares issuable upon exercise for share capitalizations, sub-divisions, combinations, reclassifications,
certain rights offerings and Extraordinary Dividends, as described in Section 4 of the warrant agreement; (ii) the Alternative Issuance
provisions in Section 4.5 of the warrant agreement, pursuant to which, upon specified reclassifications, reorganizations, mergers, consolidations,
tender offers or similar change-of-control transactions, each Public Warrant becomes exercisable for the same form and amount of cash,
securities or other property that a holder would receive as a common shareholder on an as-if-exercised basis immediately prior to the
transaction; and (iii) an optional beneficial ownership limitation in Section 3.3.5 of the warrant agreement that permits a holder, at
its election, to limit the number of Class A common shares issuable upon exercise of its warrants such that, immediately after giving
effect to such exercise, the holder’s beneficial ownership of the Company’s outstanding Class A common shares does not exceed
a specified “Maximum Percentage” (initially 9.8% or such other percentage specified by the holder). Public Warrants are issued
in registered form, may be held in book-entry form through The Depository Trust Company and are transferable in accordance with the procedures
set forth in Section 5 of the warrant agreement, subject to applicable securities law restrictions. The warrant agreement also provides
that the Company is not required to net cash settle the Public Warrants and that, other than the fixed cash redemption price described
above, settlement of the Public Warrants occurs through the issuance of equity or the delivery of the Alternative Issuance consideration
specified in the contract.
40
The Company may call the Public Warrants for redemption
● in
whole and not in part;
● at
a price of $0.01 per warrant;
● upon
not less than 30 days’ prior written notice of redemption to each warrant holder; and
● if,
and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading
day period ending three trading days before the Company sends the notice of redemption to the warrant holders
If
and when the Public Warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to
register or qualify the underlying securities for sale under all applicable state securities laws.
In
addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection
with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A ordinary
shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and,
in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor
or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from
such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination
on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of
the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates
a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants
will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00
per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the
Newly Issued Price.
As
of December 31, 2025, if holders elect to exercise Public Warrants for cash, the Company would deliver one Class A common share for each
Public Warrant exercised and would receive cash equal to the fixed exercise price per share. The aggregate fair value of the shares issued
upon such cash exercise would vary directly with the then-current market price of the Company’s Class A common stock, whereas the
per-warrant exercise price and resulting cash proceeds to the Company remain fixed in accordance with the warrant agreement.
When
Public Warrants are exercised on a cashless basis in accordance with the warrant agreement, each warrant is settled through the issuance
of a reduced number of Class A common shares determined by reference to the then-current “Fair Market Value” of the Class
A common stock and the fixed exercise price. As the market price of the Company’s Class A common stock increases above the exercise
price, the number of shares issued per Public Warrant and the aggregate fair value of the shares delivered on cashless exercise increase;
conversely, as the market price approaches or falls below the exercise price, the number of shares issued per Public Warrant and the
aggregate fair value of the shares delivered decrease, and no shares would be delivered if the Public Warrants are out-of-the-money.
If
and when the Public Warrants become redeemable and the Company elects to redeem them for cash in accordance with the warrant agreement,
the Company would be obligated to pay the fixed contractual redemption price per Public Warrant and the Public Warrants would be cancelled
without the issuance of any Class A common shares. Although the fixed redemption price per warrant does not change with the market price
of the Company’s Class A common stock, the Company may only exercise this redemption alternative if the Reference Value of the
Class A common stock equals or exceeds the specified redemption trigger, which is based on the trading price of the Company’s shares.
In
the event of certain reclassifications, reorganizations, mergers, consolidations, tender offers or similar transactions that result in
a change of control, the Public Warrants provide for an “Alternative Issuance” under which each Public Warrant becomes exercisable
for the cash, securities or other property that the holder would have been entitled to receive if the holder had exercised the Public
Warrant and participated in the transaction as a common shareholder immediately prior to its consummation, as described in the warrant
agreement. Accordingly, the amount and form of consideration delivered upon settlement under this alternative will generally change in
direct proportion to the per-share consideration (whether in cash, stock or other property) payable to the Company’s common shareholders
in the underlying transaction, which reflects the then-current fair value of the Company’s equity shares.
41
Private
warrants
The Private Placement Warrants are substantially identical to the Public Warrants, except that (i) the Private Placement Warrants may
be exercised for cash or on a cashless basis, at the holder’s option; (ii) the Private Placement Warrants and the Class A common
shares issuable upon their exercise are subject to certain transfer restrictions pursuant to the letter agreement between the Company,
the Sponsor and other parties thereto, as amended from time to time, including that any permitted transferee must agree to be bound by
such transfer restrictions; (iii) the Private Placement Warrants are not redeemable by the Company; and (iv) the holders of the Private
Placement Warrants (including the Class A common shares issuable upon exercise thereof) may be entitled to certain registration rights.
The Private Placement Warrants will not become Public Warrants upon any transfer and shall remain non-redeemable.
As of December 31, 2025, if holders elect to exercise the Private Placement Warrants for cash, the Company would deliver one Class A common
share for each Private Placement Warrant exercised and would receive cash equal to the fixed exercise price per share. Consistent with
the Public Warrants, the aggregate fair value of the shares issued upon such cash exercise of the Private Placement Warrants would vary
directly with the then-current market price of the Company’s Class A common stock, while the per-warrant exercise price and resulting
cash proceeds to the Company remain fixed in accordance with the warrant agreement.
When
Private Placement Warrants are exercised on a cashless basis in accordance with the warrant agreement, each warrant is settled through
the issuance of a reduced number of Class A common shares determined by reference to the “Sponsor Exercise Fair Market Value”
of the Class A common stock and the fixed exercise price. As the market price of the Company’s Class A common stock increases above
the exercise price, the number of shares issued per Private Placement Warrant and the aggregate fair value of the shares delivered on
cashless exercise increase; conversely, as the market price approaches or falls below the exercise price, the number of shares issued
per Private Placement Warrant and the aggregate fair value of the shares delivered decrease, and no shares would be delivered if the
Private Placement Warrants are out-of-the-money.
The
Alternative Issuance provisions described above for the Public Warrants also apply to the Private Placement Warrants such that, upon
the specified reclassification, reorganization, merger, consolidation, tender offer or similar change-of-control transactions, each Private
Placement Warrant becomes exercisable for the same form and amount of cash, securities or other property that would be received by a
common shareholder on an as-if-exercised basis immediately prior to the transaction, and the settlement amount therefore varies directly
with the per-share consideration payable to the Company’s common shareholders.
Classification
and accounting: The Company evaluated the terms of the Public and Private Warrants under the relevant U.S. GAAP guidance for freestanding
financial instruments and derivative accounting and concluded that both the Public Warrants and the Private Warrants meet the criteria
for equity classification . In connection with the reverse recapitalization transaction, the Public Warrants and Private Warrants
that were outstanding immediately prior to the transaction were initially recorded through the reverse recapitalization and are presented
within stockholders’ equity on the consolidated balance sheet as part of additional paid-in capital (rather than as a separate
warrant liability line item). Because the Public Warrants and Private Warrants are classified in equity, there is no subsequent remeasurement
required after initial recognition and changes in the fair value of the Company’s common stock do not give rise to gains or losses
in the statement of operations related to these warrants.
Cashless
Exercise of Stock Options
In
August 2025, certain Fusemachines employees exercised an aggregate of 745,896 options to purchase shares of Fusemachines common stock
on a cashless basis via net share settlement resulting in the net share issuance of 666,662 shares of Fusemachines common stock. The
transaction has been accounted under the guidance of ASC 718 - Stock Compensation. The cashless exercise mechanism does not change the
substantive terms or fair-value-based measure of the awards and therefore does not constitute a modification under ASC 718.
42
2025
Omnibus Equity Incentive Plan (the “Plan”)
On
July 28, 2025, the Board of Directors and shareholders of the Company approved the Fusemachines Inc. 2025 Omnibus Equity Incentive Plan
(the “Plan”). The Plan authorizes the Company to issue up to 1,500,000 shares of the Company’s common stock, par value
$0.0001 per share, to eligible employees, directors, and consultants in the form of stock options, restricted stock, restricted stock
units, or other equity-based awards. Subsequent to December 31, 2025, the Company is in the process of granting awards under the Plan
to certain employees. As the awards were not granted and no shares were issued under the Plan as of December 31, 2025, no amounts have
been recognized in the accompanying consolidated financial statements.
Shortfall
Warrant
In
connection with the execution of the Forward Purchase Agreement the Company agreed to issue “Shortfall Warrants” to the Sellers
(Meteora) for shares not elected under the Forward Purchase Agreement, representing the difference between the maximum number of shares
subject to the FPA and the number of shares ultimately elected by the Forward Counterparty.
Seller
in its sole discretion may request (in one or more requests) warrants of the Counterparty exercisable for Shares in an amount equal to
(i) the Maximum Number of Shares less (ii) the Number of Shares specified in the Pricing Date Notice (the “Shortfall Warrants,”
and the Shares underlying the Shortfall Warrants, the “Shortfall Warrant Shares”). The Shortfall Warrants shall have an exercise
price equal to the termination price which is defined $12 in the forward purchase agreement and is subject to reset in accordance with
the pricing provisions of that agreement, and this termination price has subsequently been amended; for further details, refer to Note
25 – Subsequent Events.
The
warrants grant the holders the right to purchase a fixed number of shares (2,108,070) at a fixed exercise price/termination price. The
Shortfall Warrants are exercisable for shares of common stock and were issued concurrently with the consummation of the Business Combination
on October 22, 2025 (the “Initial Exercise Date”) and are exercisable at any time from the Initial Exercise Date until 5:00
p.m. (New York City time) on October 22, 2028 (the “Termination Date”). No shortfall warrants have been exercised as at
December 31, 2025.
The
Shortfall Warrants contain a beneficial ownership limitation that, subject to certain limited exceptions, restricts a holder from exercising
the Shortfall Warrants to the extent that, following such exercise, the holder, together with its affiliates and certain related parties,
would beneficially own more than 9.9% of the Company’s outstanding common stock. A holder may increase or decrease this beneficial
ownership limitation upon notice to the Company, provided that any increase will not be effective until the 61st day after such notice
and in no event may the beneficial ownership limitation exceed 9.9%.
The
exercise price and the number of Shortfall Warrant Shares are subject to customary anti-dilution adjustments for stock dividends and
other distributions on the Company’s common stock, stock splits, reverse stock splits, reclassifications and certain rights offerings.
In addition, subject to any required shareholder approvals and applicable stock exchange rules, the Company may, in its discretion, reduce
the exercise price of the Shortfall Warrants for any period of time.
The
Shortfall Warrants and the rights thereunder are transferable, in whole or in part, with the prior written consent of the Company and
subject to compliance with applicable securities laws and payment of any applicable transfer taxes. The warrants may be divided or combined
into new warrants, and, if properly assigned, may be exercised by a permitted transferee without the issuance of a new warrant certificate.
The
Company evaluated the Shortfall Warrants in accordance with ASC 480, Distinguishing Liabilities from Equity, and ASC 815, Derivatives
and Hedging, including the guidance in ASC 815-40 related to contracts indexed to, and potentially settled in, an entity’s own
equity.
43
In
making this assessment, the Company considered, among other factors:
● whether
the Shortfall Warrants are freestanding financial instruments,
● whether
the warrants are indexed to the Company’s own stock,
● whether
settlement is required to be in shares rather than cash, and
●
whether any provisions could require net cash settlement under circumstances outside the Company’s control
Accordingly,
in connection with the reverse recapitalization, the Company recognized the Shortfall Warrants at their initial fair value of $1,009
thousands, which is included within additional paid-in capital in the stockholders’ equity section of the consolidated balance
sheet.
Based
on this assessment, the Company concluded that the Shortfall Warrants meet all of the criteria for equity classification under ASC 815-40.
Accordingly, the Shortfall Warrants are classified as equity and are not subject to subsequent remeasurement.
Subsequent
to year ended December 31, 2025, the Company entered into an amendment on February 3, 2026, to the Common Stock Purchase Warrant (the
“Warrant Amendment”) originally issued on October 22, 2025 in connection with the Business Combination with Meteora Capital
Partners, LP, Meteora Select Trading Opportunities Master, LP and Meteora Strategic Capital, LLC (collectively, the “Holder”).
Pursuant to the Warrant Amendment, the exercise price of the warrant was amended such that the exercise price per share of the Company’s
common stock is $10.00, subject to customary adjustments as set forth in the warrant agreement. All other terms and conditions of the
warrant remain unchanged and continue in full force and effect. The Company is currently evaluating the accounting and financial reporting
implications of the Warrant Amendment, including its impact, if any, on the classification and valuation of the warrant.
Financial
Performance
For
the year ended December 31, 2025, and December 31, 2024, we generated revenues of $7.71 million and $8.81 million and reported a net
loss of $0.93 million and $15.38 million, respectively. Net cash used in operating activities was $5.53 million for the year ended December
31, 2025, and $2.20 million for the year ended December 31, 2024. As noted in our consolidated financial statements, we had an accumulated
deficit of $35.15 million as of December 31, 2025, and $34.21 million as of December 2024 .
Key
Factors and Trends Affecting Results of Operations
We
believe the following factors and trends may cause previously reported financial information not to be necessarily indicative of future
operating results or future financial conditions:
● Market
Competition : The AI industry is highly competitive and is changing rapidly with numerous players vying for market share. We attempt
to mitigate this risk by continuously innovating and differentiating our offerings, as we have been delivering AI solutions for well
over a decade and have deep institutional capabilities to stand apart in terms of our ability to provide value to our customers and scale.
Nevertheless, increasing competition could result in loss of business or pressure on margins for Fusemachines.
● Technological
Changes : Rapid technological advancements in AI can impact our offering, dilute our value proposition and require us to pivot in
different directions. However, given our broad spectrum of AI solutions, coupled with our ability to produce AI talent, our deep investment
in research and development, and a culture of continuous learning, we have been able to navigate these changes effectively.
● Adequate
Capital Raise : As of December 31, 2025, we have limited financial resources as our existing cash and cash equivalents provide limited
operating runway relative to our current cost structure and planned growth initiatives. Although we raised capital in connection with
the consummation of the Business Combination and related PIPE financing during 2025, we expect that additional capital will be required
to fund operations, support product development, expand sales and marketing activities, and meet our working capital requirements.
We
may seek to raise additional funds through equity offerings, debt financings, strategic investments, or other capital sources. However,
there can be no assurance that sufficient funding will be available to us to fund our operating expenses and to further develop our business.
Unless we achieve substantial profitability, we anticipate that we will likely need to raise additional capital to fund our operations
while we implement and execute our business plan.
● Ability
to manage costs and expenses while achieving revenue growth : Our results of operations may fluctuate, in part, because of the intensive
nature of our sales efforts and the length and unpredictability of our sales cycle. As part of our sales efforts, we invest considerable
time and expense evaluating the specific organizational needs of our potential customers and educating these potential customers about
the technical capabilities and value of our platforms and services. As part of our sales efforts, we also provide our platforms to potential
customers at no or low cost initially to them for evaluation purposes through short-term pilot deployments of our platforms, and there
is no guarantee that we will be able to convert customers from these short-term pilot deployments to full revenue generating contracts.
44
● Finance
costs : Historically, the Company issued certain convertible promissory notes to finance its operations, as further described in
Note 10 – Long-Term Debt to the consolidated financial statements. These instruments bore interest and were subject to
automatic conversion. In connection with the consummation of the Business Combination during 2025, the outstanding principal and
accrued interest under these convertible notes were converted into equity securities in accordance with their contractual terms. As
a result, no convertible promissory notes remained outstanding as of December 31, 2025 other than related party note payable related
to Dolma Impact Fund I (“Dolma”) amounting $300 thousand. Accordingly, finance costs for the year ended December 31,
2025 primarily reflect interest expense incurred prior to the conversion date. Following the conversion, the Company no longer
incurs interest expense related to these instruments, which has reduced ongoing finance costs compared to prior periods.
Emerging
Growth Company and Smaller Reporting Company Status
Section
102(b)(1) of the Jumpstart Our Business Startups Act (“JOBS Act”) exempts emerging growth companies from being required to
comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act
registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934,
as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a Company can elect
to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such
election to opt out is irrevocable. Until the Company is considered to be an emerging growth company, the Company has elected not to
opt out of such extended transition period which means that when an accounting standard is issued or revised and it has different application
dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time
private companies adopt the new or revised standard.
We
are also a “smaller reporting company” as defined in the Securities Exchange Act of 1934. We may continue to be a smaller
reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures
available to smaller reporting companies until the fiscal year following the determination that our voting and non-voting common stock
held by non-affiliates is $250 million or more measured on the last business day of our second fiscal quarter, or our annual revenues
are less than $100 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates
is $700 million or more measured on the last business day of our second fiscal quarter.
Segment
Reporting
We
operate as one operating segment with a focus on data engineering, artificial intelligence consulting, and technical services. Our Chief
Executive Officer (“CEO”), as our chief operating decision maker, manages and allocates resources to the operations of the
Company on a consolidated basis. This enables our CEO to assess the overall level of available resources and determine how best to deploy
these resources across service lines in line with our long-term company-wide strategic goals.
Results
of Operations
The
period-to-period comparisons of results of operations have been prepared using the historical periods included in our consolidated financial
statements. The following discussion should be read in conjunction with the consolidated financial statements and related notes included
elsewhere in this annual report. We have derived this data from our annual consolidated financial statements included elsewhere in this
annual report.
45
Year
ended December 31, 2025, Compared To Year Ended December 31, 2024
Year ended December 31,
(In thousands)
2025
2024
$ Variance
% Variance
Revenue
$ 7,714
$ 8,811
$ (1,097 )
(12 )%
Cost of revenue (1)
(3,407 )
(3,976 )
569
(14 )%
Gross profit
4,307
4,835
(528 )
(11 )%
Operating expenses:
Selling and marketing (1)
1,365
1,964
(599 )
(30 )%
General and administrative (1)
8,176
10,333
(2,157 )
(21 )%
Research and development (1)
720
732
(12 )
(2 )%
Total operating expenses
10,261
13,029
(2,768 )
(21 )%
Loss from operations
(5,954 )
(8,194 )
2,240
27 %
Other (expense) income:
Interest expense
(268 )
(234 )
(34 )
15 %
Loss on extinguishment of convertible notes payable / notes payable
(391 )
(601 )
210
(35 )%
Loss on extinguishment of payable
-
(70 )
70
100 %
Gain/(Loss) on change in fair value of convertible notes, and warrant liability
6,544
(6,104 )
12,648
(207 )%
Gain/(Loss) on change in fair value of forward purchase derivative liability
(1,076 )
-
(1,076 )
(100 )%
Other (expense) income
220
(148 )
368
(249 )%
Total other expense, net
5,029
(7,157 )
12,186
(170 )%
Loss before income taxes
(925 )
(15,351 )
14,426
(94 )%
Provision for income tax
(3 )
(31 )
28
90 %
Equity in earnings of investee, net of income tax position of $0 and $0, respectively
-
(1 )
1
(100 )%
Net loss
$ (928 )
$ (15,383 )
$ 14,455
94 %
Other comprehensive income (loss):
Change in foreign currency translation adjustment
$ 10
$ 57
$ (47 )
(82 )%
Total comprehensive loss
$ (918 )
$ (15,326 )
$ 14,408
(94 )%
Net loss per share - basic and diluted
$ (0.08 )
$ (2.21 )
$ 2.13
96 %
Weighted-average common shares outstanding - basic and diluted
11,525,384
6,958,570
(1) Includes
stock-based compensation expense as follows:
Year ended December 31,
2025
2024
$Variance
General and administrative
$ 154
$ 723
$ (569 )
Cost of revenue
$ 21
$ 44
$ (23 )
Selling and marketing
$ 38
$ 170
$ (132 )
Research and development
$ 18
$ 130
$ (112 )
Total stock-based compensation expense
$ 231
$ 1,067
$ (836 )
For Revenue recognition policy refer note details
under “Critical accounting policies and estimates” section
We
provide services to customers worldwide, with the majority of revenues being derived from contracts with customers located within the
United States. The table below presents the breakdown of our revenues, based on the customer’s location (in thousands).
Year Ended December 31,
2025
2024
Customer locations
United States
$ 7,342
$ 8,544
Rest of the world
$ 372
$ 267
Total revenue
$ 7,714
$ 8,811
46
The
table below presents the breakdown of our revenues, based on the type of services (in thousands).
Year Ended December 31,
2025
2024
Service type
AI Solutions (Product and Services) *
$ 7,581
$ 8,811
AI Education Services
$ 133
-
Total revenue
$ 7,714
$ 8,811
*AI Solutions (Products and
Services) includes both software product revenues and related services. Product revenue represents an insignificant portion of total revenue
for the periods presented and, accordingly, has not been separately disclosed.
Revenue
for the year ended December 31, 2025, reduced to $7.71 million as compared to $8.81 million for the year ended December 31,
2024, due to AI Solutions (Products and Services). Overall revenue decreased by $1.10 million mainly due to termination of 12 customers
and reduction in contract size of 16 customers which resulted in loss of revenue by $2.99 million. This decrease was partially offset
by 11 new customer contracts and increase in contract size of 9 customers adding $1.91 million of revenue.
Cost
of revenue – Cost of revenue primarily consists of consulting and payroll expenses that are assigned to building AI solutions.
Cost
of revenue decreased by $0.57 million to $3.40 million for the year ended December 31, 2025, compared to $3.97 million for the year ended
December 31, 2024. The decrease was primarily driven by lower consultancy expenses of $0.22 million and a reduction in payroll expenses
of $0.37 million. The decline in consultancy costs was mainly attributable to a decrease in the average cost per consultant which is
$50K in year 2024 and $48K in year 2025, in the United States (US) entity, while the average headcount of billable consultants also
decreases from 39 in year 2024 to 35 in year 2025. In the Nepal entity, the decrease was due to the offboarding of two consultants who
were engaged in client projects during 2024 but not in 2025. The reduction in payroll expenses was driven by a combination of factors.
In the US entity, the average cost per employee decreased slightly from $139k in year 2024 to $130k in year 2025, with the average headcount
remaining constant at 8. In contrast, in the Nepal entity, the decrease was mainly due to a decline in average headcount from 327 in
2024 to 270 in 2025 as there was reduction in billable resource and employee resignation, even though the average cost per consultant
increased in 2025. Additionally, there was a $0.02 million decrease in cost of revenue related to stock-based compensation, primarily
due to the completion of vesting for previously granted awards.
Gross
profit – Gross profit is calculated as revenue less total cost of revenue. Our gross profit in future periods will depend on
a variety of factors, including market conditions that may impact our pricing, sales mix changes among our service agreements, and product
mix changes between established services and new services.
Gross
profit decreased by $0.53 million to $4.31 million for the year ended December 31, 2025, compared to $4.84 million for the year ended
December 31, 2024, as a result of lower sales.
Selling
and marketing expenses – Selling and marketing expenses represent spending associated with promoting and selling of our services.
These expenses comprise of personnel costs, travel and accommodation expenses, as well as advertising and consulting costs related to
such activities.
Selling
and marketing expenses decreased by $0.59 million, from $1.96 million for the year ended December 31, 2024, to $1.37 million for the
year ended December 31, 2025. The decrease was primarily attributable to lower commission expenses, consulting fees, payroll costs, and
stock-based compensation.
Commission
expenses decreased by $0.06 million, as only few business deal brought on by sales team in current year 2025, unlike in the prior year.
Consulting fees for the selling and marketing team decreased by $0.06 million, mainly because consultants worked fewer hours in 2025
compared to 2024, and one consultant was transitioned to payroll.
47
Payroll
expenses decreased by $0.11 million, primarily due to a reduction in headcount as three employees resigned and one shifted to consultant
in, in the United States (US) entity, additionally the average costs has slightly decreased $142 thousand in year 2024 to $131 thousand
in year 2025.
In
addition, stock-based compensation expenses decreased by $0.13 million, due to the completion of vesting for previously granted awards.
General
and administrative expenses – General and administrative expenses consist of expenses associated with general and administrative
functions of the business such as the costs of salaries, IT infrastructure, bad debt, travel, legal and accounting services, insurance,
rent, software and tools, meals, other professional services activities, and certain non-income taxes.
General
and administrative expenses decreased by $2.15 million, from $10.33 million for the year ended December 31, 2024, to $8.18 million for
the year ended December 31, 2025. The decrease was primarily driven by lower professional charges, stock-based compensation, and bad
debt expenses, partially offset by higher payroll and consultancy expenses.
Professional charges decreased by approximately $2.5 million compared to the prior year, primarily driven by management’s
conscious efforts to optimize and reduce operational costs, resulting in lower professional expenses during the period. Further Stock-based compensation expense declined by $0.57 million,
primarily due to the completion of vesting for previously granted awards. Additionally, bad debt expense has been decreased by $0.48
million during the period as allowances were provided for the long outstanding Accounts receivables in previous year. Further, there
has been decrease in consultancy expense for approximately $0.30 million as in US entity there has been decrease in headcount from 16
in year 2024 to 10 in year 2025 and there has also been decrease in IT infrastructure expense due to significant decrease of utilization
for Amazon Web, Google Suite and termination of Meta Workspace.
These
reductions were partially offset by an increase in payroll expenses of $0.49 million and payout of incentive linked to business
combination amounting to $1.0 million. The payroll expense has been increasing as in US entity the average head count has increased
from 9 in year 2024 to 11 in year 2025 and there is an increment of insurance cost due to increase in premium amount of Director
and officer.
Research
and development expenses – Research and development expenses include costs associated with software product development, testing,
quality assurance, documentation, enhancements and upgrades for existing customers under maintenance.
Research
and development expenses for the year ended December 31, 2025, decreased by $0.01 million to $0.72 million as compared to $0.73 million
for the year ended December 31, 2024. The decrease was primarily due to stock-based compensation of $0.11 million due to the completion
of vesting for previously granted awards. This was partially offset by increases in payroll expenses of $0.08 million as the headcount
increased from 36 in year 2024 to 44 in year 2025.
Interest
expense – Interest expense represents interest payable on our borrowings including the debt discount that is being amortized,
as well as debt financing and equity issuance costs that are amortized to interest expense.
Interest
expense increased by $0.03 million to $0.27 million for the year ended December 31, 2025, from $0.23 million for the year ended December
31, 2024. The increase was primarily due to a higher outstanding balance of promissory notes reflecting the issuance of a new promissory
notes between the periods. Further Pursuant consummation of the Business Combination on October 22, 2025, substantially all Fusemachines
convertible notes that were issued and outstanding immediately prior to the Closing were converted into shares of Legacy Fusemachines
common stock in accordance with the respective convertible note agreements. As a result of the conversions and exchanges, no convertible
notes or related-party notes payable remained outstanding as of December 31, 2025 other than related party note payable related
to Dolma amounting $300 thousand.
48
Loss
on extinguishment of debt – Loss on extinguishment of debt for the year ended December 31, 2025 represents $0.1 million
related to April 2024 Convertible Note, $0.1 million related to June 2024 Convertible Note and $0.2 million related to September
2024 Convertible Notes. Loss on extinguishment of debt are related to modification of the aforementioned loans on account of change
in conversion price from $4.94 to $3.15 was accounted for under the substantial premium model in accordance with ASC 470, Debt where
the excess above the fair value of these notes was recorded as loss on extinguishment of debt.
Loss
on extinguishment of debt for year ended December 31, 2024 represents the repayment of the 2023 Notes Agreement. In August 2023, we entered
into a loan and security agreement with a lender (the “2023 Notes Agreement”) that will make available to us the loans in
an aggregate principal amount of up to $4.0 million in three separate tranches. In January 2024, we repaid the entire aggregate outstanding
principal on the 2023 Notes Payable along with an additional payment for interest, prepayment fees, and lender fees. These payments resulted
in a loss, recorded in loss on extinguishment of debt.
Loss
on extinguishment of debt for the year ended December 31, 2025, was $0.39 million as compared to $0.60 million for the year ended December
31, 2024.
Loss
on change in fair value – Loss on change in value represents the changes in fair value related to our convertible notes, warrant
liability and forward purchase derivative liability.
Gain/(Loss)
on change in fair value for the year ended December 31, 2025 was a gain of $5.47 million as compared to ($6.10 million) for the year
ended December 31, 2024. We qualified for and elected to account for the convertible notes under the fair value option and, in doing
so, bypassed the analysis of potential embedded derivative features. As a result, the convertible notes were recorded at fair value
upon issuance and recorded as gain and loss on change in fair value in the consolidated statements of operations and comprehensive
loss, for the year ended December 31, 2025 and December 31, 2024, respectively.
In
connection with the consummation of the Business Combination on October 22, 2025, substantially all outstanding convertible notes were
either converted into equity or repaid, and therefore fair value changes were recognized only up to the closing date of the Business
Combination. During this period, the Company recorded a net increase of approximately $5.72 million in gains related to changes in the
fair value of the convertible notes. The increase in fair value promissory note was primarily driven by a decline in the estimated
market price of the Company’s underlying equity, which decreased from approximately $7.48 per share as of December 31, 2024 to
approximately $3.40 per share immediately prior to the Business Combination, resulting in a corresponding reduction in the fair value
of the convertible instruments.
In
addition, the Company recorded an increase of approximately $1.08 million in the fair value of forward purchase derivative
liability. This increase was primarily driven by changes in key valuation inputs, including the Company’s relatively low share
price of $1.65, elevated equity volatility of 65.0%, and the remaining contractual term of approximately 2.81 years. These factors
increased the probability-weighted value of the potential share settlement under the arrangement. Further, the fair value was
further impacted by adjustments for counterparty credit risk of 6.3%. The remaining changes in fair value during the period
primarily relate to the re-measurement of the warrant liability.
Upon
conversion, the carrying amount of the convertible debt is reclassified to equity, and no gain or loss is recognized in earnings, as
the conversion is executed in accordance with the original terms of the instruments The Company’s management performed a quantitative
assessment of Gain/(Loss) on change in fair value for prior period, and in doing so, considered an independent fair valuation report
obtained by management.
49
Other
(expense) income – Other (expense) income consists of our proportional share of earnings and losses related to our equity method
investment as well as impairment loss, penalties and settlements, and other miscellaneous expenses.
Other
income for the year ended December 31, 2025, was $0.22 million, compared to other expenses of $(0.15) million for the year ended December
31, 2024, representing an improvement of $0.37 million. The improvement was primarily attributable one time impairment loss booked last
year amounting $0.12 million and balance pertains to forex exchange gain and other income as compared to last year
Provision
for income tax – Provision for income tax is accounted for using the asset and liability method, which requires the recognition
of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in our consolidated
financial statements or tax returns. In addition, deferred tax assets are recorded for all future benefits including, but not limited
to, net operating losses, research and development credit carryforwards, and basis differences with certain assets and liabilities.
Provision
for income tax is $0.003 million for the for the year ended December 31, 2025 and $0.03 million for year ended December 31,2024.
Net
loss – Net loss for the year ended December 31, 2025, was $0.93 million, compared to a net loss of $15.38 million for
December 31, 2024. The change was the result of increase in profit on change in fair value of convertible notes, warrant
liability and forward purchase derivative liability, decrease in General and administrative and Selling and Marketing expense
and due to decrease in stock-based compensation due to the completion of vesting for previously granted awards, payroll expenses and
decrease in Loss on extinguishment of debt.
Non-GAAP
Financial Measures
Our
consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”).
We report certain key financial measures that are not required by, or presented in accordance with GAAP, and these non-GAAP financial
measures should not be considered as an alternative to the information prepared in accordance with GAAP. In addition, the Company’s
management reviews performance by focusing on several key performance indicators not prepared in conformity with GAAP. We believe these
non-GAAP financial measures provide a useful measure of our operating results, a meaningful comparison with historical results and with
the results of other companies, and insight into our ongoing operating performance. Further, we utilize these measures, in addition to
GAAP measures, when evaluating and comparing our operating performance against internal financial forecasts and budgets.
However,
there are several limitations related to the use of non-GAAP financial measures because it excludes significant expenses or credits that
are required by GAAP to be included in our financial statements. In addition, other companies may calculate non-GAAP measures differently
or may use other measures to calculate their financial performance. Therefore, non-GAAP measures may not be directly comparable to similarly
titled measures of other companies.
The
Company defines adjusted earnings before interest, tax, depreciation and amortization (“EBITDA”) as net loss before interest
expense, income tax expense (benefit), depreciation and amortization, as adjusted to exclude stock-based compensation, fair value changes,
loss on extinguishment of debt and payable, and aborted IPO costs that consisted of direct and incremental costs, such as accounting,
consulting, and legal fees, incurred in connection with the aborted IPO.
Non-GAAP
Reconciliations
We
use the non-GAAP measures EBITDA and adjusted EBITDA to help us evaluate our business, identify trends affecting our business, formulate
business plans and financial projections, and make strategic decisions. Also, we exclude depreciation and amortization, stock-based compensation
and fair value changes, which are non-cash expenses, from these non-GAAP financial measures because we believe that excluding these items
provides meaningful supplemental information regarding operational performance and provides useful information to investors and others
in understanding and evaluating our operating results in the same manner as our management team.
50
Our
definitions may differ from the definitions used by other companies and therefore comparability may be limited. In addition, other companies
may not publish these or similar metrics. Further, these metrics have certain limitations, as they do not include the impact of certain
expenses that are reflected in our consolidated statements of operations and comprehensive loss. Thus, our non-GAAP EBITDA and adjusted
EBITDA should be considered in addition to, not as a substitute for, or in isolation from, measures prepared in accordance with GAAP.
We
compensate for these limitations by providing reconciliations of these non-GAAP measures to the most comparable GAAP measures. We encourage
investors and others to review our business, results of operations, and financial information in its entirety, not to rely on any single
financial measure, and to view these non-GAAP measures in conjunction with the most directly comparable GAAP financial measures.
The
reconciliation of our net loss to EBITDA and Adjusted EBITDA for the year ended December 31, 2025, and December 31, 2024, is as follows:
Year Ended December 31,
(In thousands)
2025
2024
Net loss
$ (928 )
$ (15,383 )
Interest expense
268
234
Provision for tax
3
31
Depreciation and amortization
189
179
EBITDA
$ (468 )
$ (14,939 )
Stock-based compensation
231
1,067
Fair value adjustments (1)
(5,468 )
6,104
Extinguishment of payable
-
70
Extinguishment of debt
391
601
Adjusted EBITDA
$ (5,314 )
$ (7,097 )
(1)
Represents change in fair value of convertible notes, warrant liability and forward purchase derivative liability.
Liquidity
and Capital Resources as of December 31, 2025
Liquidity
is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate
on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable
and accounts payable and capital expenditure.
We
formally evaluated our liquidity and cash position most recently in 2025 when preparing our 2025 consolidated financial statements. As
of December 31, 2025, we had cash of approximately $4.22 million and a net working capital deficit of approximately $13.30 million. As
of that date, we also had an accumulated deficit of approximately $35.15 million and a net loss of $0.93 million for the year then ended.
As
of December 31, 2024, we had cash of approximately $0.50 million and a net working capital deficit of approximately $16.18 million. As
of December 31, 2024, we had an accumulated deficit of $34.22 million and a net loss of $15.38 million for the year ended December 31,
2024.
51
These
factors raise substantial doubt regarding the Company’s ability to continue as a going concern within one year of the date these
consolidated financial statements were issued. The continuation of the Company as a going concern is dependent upon the continued financial
support from its stockholders and debt holders. Specifically, the Company’s ability to continue operations depends on obtaining
additional equity or debt financing and, ultimately, on generating profits from operations and achieving positive operating cash flows
— neither of which is assured.
On
October 22, 2025, Merger Sub merged with and into Legacy Fusemachines with Legacy Fusemachines continuing as the surviving company and
becoming a wholly owned subsidiary of Fusemachines Inc. In connection with the closing, approximately $14.0 million in cash was received
for the issuance of shares of Fusemachines Inc. common stock. Substantially all convertible notes were settled through the issuance of
Fusemachines Inc. Common Stock, other than related party note payable related to Dolma Impact Fund I (“Dolma”) amounting $300 thousand, and certain
promissory notes were repaid in cash upon closing. Following the business combination, the net balance of cash and cash equivalents was
approximately $9.4 million. The Company’s trade payables, accrued expenses, and other current liabilities exceed the net cash and
cash equivalents balance. Management is evaluating initiatives to streamline operations through reductions in headcount and consultant
costs, and continued negotiations with vendors to achieve more favorable terms. In addition, the Company’s business plan anticipates
a measured growth trajectory supported by new client acquisitions and expansion of existing customer relationships. While these actions
are expected to enhance the Company’s financial position and extend its operational runway once implemented, they remain in the
planning and negotiation stages.
As
of the date on which these consolidated financial statements were available to be issued, we believe that the cash on hand, and additional
investments available through issuance of new Common Stock, will be inadequate to satisfy the Company’s working capital and capital
expenditure requirements for at least the next twelve months. The ability of the Company to continue as a going concern is dependent
upon management’s plan to raise additional capital from issuance of equity or receive additional borrowings to fund the Company’s
operating and investing activities over the next year. These consolidated financial statements do not include any adjustments to the
recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company
be unable to continue as a going concern.
Cash
flows
Year
End Cash Flows
The
following table summarizes our cash flows for the periods presented
Year Ended Dec 31,
(In thousands)
2025
2024
Variance
Net cash provided by (used in):
Operating activities
$ (5,529 )
$ (2,201 )
$ (3,328 )
Investing activities
$ (165 )
$ (176 )
$ 11
Financing activities
$ 9,418
$ 2,612
$ 6,806
Effect of exchange rate changes on cash
$ (3 )
$ (1 )
$ (2 )
Net increase (decrease) in cash
$ 3,721
$ 234
$ 3,487
52
Operating
Activities
Net cash used in operating activities for the year ended December 31, 2025 increased by $3.32 million to $5.53
million, compared to $2.2 million in the same period in 2024. This increase was primarily driven by a reduction in non-cash gains, as
net loss decreased to $0.93 million for the year ended December 31, 2025 from $(15.38) million in 2024, largely due to changes in the
fair value of convertible notes, warrant liability and forward purchase derivative liabilities. Additionally, selling and marketing expenses
decreased due to lower stock-based compensation following the completion of vesting for previously granted awards. Further, changes in
working capital decreased to $0.21 million from $4.39 million in the prior year. The $5.53 million net cash used in operating activities
in 2025 was primarily related to (i) a net loss of $(0.93) million, offset by; (ii) depreciation and amortization of $0.19 million; (iii)
provision for credit losses of $0.06 million; (iv) stock-based compensation of $0.23 million; (v) amortization of right-of-use assets
of $0.09 million; (vi) Loss on extinguishment of debt of $0.39 million; (vii) Changes in fair value of Convertible Notes at Fair Value
and Forward Purchase derivative liability of $ (6.54) million; (viii) Change in fair value of common stock warrant liability of $1.08
million (ix) Accretion of cumulative mandatorily redeemable common and preferred stock liability of $0.10 million; (x) Working capital
changes of $(0.21) million.
Net
cash used in operating activities during the year ended December 31, 2024 was $2.2 million. The $2.2 million net cash used in operating
activities in 2024 was primarily related to (i) a net loss of $15.4 million, offset by; (ii) depreciation and amortization of $0.18
million; (iii) provision for credit losses of $0.5 million; (iv) stock-based compensation of $1.1 million; (v) amortization
of right-of-use assets of $0.1 million; (vi) changes in fair value of convertible notes and common stock warrant liability totalling
$6.1 million ($5.6 million and $0.5 million, respectively); (vii) Accretion of cumulative mandatorily redeemable common and preferred
stock liability of $0.1 million; (viii) Loss on extinguishment of debt and payable of $0.7 million ($0.6 million and $0.1 million,
respectively) and (ix) Working capital changes of $4.4 million.
Investing
Activities
Net
cash used in investing activities during the year ended December 31, 2025, was $0.17 million compared to $0.18 million during the year
ended December 31, 2024. The $0.17 million net cash used in investing activities in 2025 consisted of $0.11 million in costs capitalized
for internally developed software and $0.05 million in purchases of property and equipment.
Net
cash used in investing activities for the year ended December 31, 2024 was $0.18 million and consisted of purchases of property and equipment
of $0.02 million, costs capitalized for internally developed software of $0.14 million.
Financing
Activities
Net
cash provided by financing activities was $9.42 million in the year ended December 31, 2025, compared to $2.61 million in December 2024,
representing an increase of $6.81 million over the respective periods. The increase in cash flow from financing activities was primarily
due to i) proceeds from reverse capitalization of $9.43 million; (ii) proceeds from Issuance of issuance of shares pursuant to PIPE transaction
of $1.00 million; (iii) proceeds from convertible notes payable of $0.18 million (iv) payments of related party notes payable of $(0.70)
million. Balance $0.84 million pertains to payment of deferred transaction cost and $0.34 million relates to proceeds received and payments made in connection with directors’ and officers’ insurance during
the current period.
Net
cash provided by financing activities was $2.6 million in the year ended December 31, 2024 . The $2.6 million net cash
provided by financing activities in 2024 consisted of (i) proceeds from convertible notes at fair value of $6.5 million; (ii) proceeds
from convertible notes payable of $0.5 million; (iii) proceeds from related party loan payable of $0.7 million, offset by (iv) payments
on notes payable of $3.0 million; (v) common stock repurchase of $2.0 million; and partially offset by (vi) exercise of stock
options and payment of deferred transaction costs
53
Contractual
Obligations and Commitments
Our
contractual cash obligations as of December 31, 2025, are summarized in the table below:
(in thousands)
2026
2027
2028
2029
Thereafter
Total
Debt (1)
300
-
-
-
-
300
Interest
83
5
-
-
-
88
Mandatorily redeemable preferred and ordinary stock
-
1,433
-
-
-
1,433
Common Stock Contingent Obligation (2)
-
-
-
-
-
-
Operating lease
167
175
185
193
452
1,172
Legal counsel arrangement
650
-
-
-
-
650
Consulting arrangement
238
159
-
-
-
397
Total
1,438
1,772
185
193
452
4,040
(1)
As discussed in Note 10, Long-Term Debt, pursuant to business combination substantially all convertible debt and related party debt has
been settled either in cash or equity as per the terms of respective debt agreements. Accordingly, no convertible notes or related-party
notes payable remained outstanding as of December 31, 2025, other than related party note payable related to Dolma amounting $300 thousand.
(2)
Upon the closing of the business combination, the Company settled its obligation under the Second Agreement through the issuance
of 29,610 shares of Fusemachines, Inc. common stock, reflecting the application of the 0.6580 conversion ratio to the 45,000 shares of
the Company’s common stock, and a partial cash payment of approximately $110 thousand. The remaining $98 thousand obligation is
still outstanding and is reflected in accounts payable as of December 31, 2025.
Debt
Financing Arrangements
On
October 15, 2019, we entered into a convertible promissory note agreement with a lender and issued a convertible promissory note for
a principal amount of $2.0 million (the “2019 Convertible Note Agreement”). On September 7, 2021 a second convertible promissory
note was issued to the same lender for a principal amount of $0.5 million (the “2021 Convertible Note Agreement”), collectively
with the 2019 Convertible Note Agreement referred to as the “Convertible Notes Agreements”. On December 22, 2022, the Convertible
Notes Agreements were amended (the “2022 Amended Convertible Notes Agreements”) to extend the maturity date to December 23,
2023, increase the interest rate to 15% for the period from December 22, 2022, to December 22, 2023, adding a prepayment option, amending
one of the conversion scenarios, and amending the definition of a next equity financing to require a sale of equity securities to result
in gross proceeds of $7.5 million (the “Next Equity Financing”). The 2022 Amended Convertible Notes Agreements also added
a partial payment of the interest accrued and outstanding on the note of $0.4 million due no later than March 22, 2023. Failure to pay
by the payment deadline obligated the Company to pay interest at a rate of twenty percent (20%) per annum, compounded quarterly, on the
outstanding $0.4 million. On December 20, 2023, the 2022 Amended Convertible Notes Agreements were amended again (the “2023 Amended
Convertible Notes Agreements”), extending the maturity date of both notes to January 22, 2024. In January 2024, these convertible
notes were amended again (the “2024 Amended Convertible Notes Agreements”), extending the maturity date to January 2025.
The amendment also added a provision surrounding conversion in the case we complete the business combination mentioned above. On January
31, 2025, the company entered into an amendment agreement of the convertible note payable pursuant to which the maturity date was revised
to February 28, 2026. The 2021, 2022, 2023 and 2025 amendments were accounted for as debt modifications, prospectively, with any change
in fair value from the new terms incorporated into future valuations. The 2024 amendment is accounted for as an extinguishment of debt.
On
August 24, 2023, we entered into a loan and security agreement with a lender (the “2023 Notes Agreement”) that will make
available to us loans in an aggregate principal amount of up to $4.0 million in three separate tranches. On that day, we withdrew $3.0
million (the “First Tranche”). We additionally had the opportunity to request, subject to the terms of the 2023 Notes Agreement,
an additional tranche of $0.5 million on or before March 31, 2024 (the “Second Tranche”) and a third tranche of $0.5 million
on or before September 30, 2024 (the “Third Tranche”) (the First Tranche, Second Tranche and Third Tranche are collectively
referred to as the “2023 Notes”). The 2023 Notes bear interest at a rate of 13.25% per annum, compounded annually, payable
at maturity. The 2023 Notes are secured by substantially all of our assets. The 2023 notes mature on August 24, 2027. In January 2024,
we repaid the entire aggregate outstanding principal on the 2023 Notes Payable in the amount of $3.0 million along with an additional
payment of $0.1 million for interest, prepayment fees, and lender fees. These payments resulted in a 0.6 million loss, recorded in loss
on extinguishment of debt, in the consolidated statements of operations and comprehensive loss.
54
In
connection with the 2023 Notes Agreement, we issued to the lender common stock warrants (the “Common Stock Warrants”) to
purchase up to 92,211 shares of the Company’s common stock, exercisable immediately, with an exercise price of $0.46 per share
with a contractual term of 10 years. As of December 31, 2025, the fair value and carrying amount of the Common Stock Warrant Liability
was $0.02 million.
In
January 2024, we entered into two convertible promissory note agreements (the “January 2024 Convertible Notes Agreements”)
with a lender for the principal amounts of $2.0 million (“January 2024 Convertible Note A”) and $4.5 million (“January
2024 Convertible Note B”), respectively, payable at maturity (the “January 2024 Convertible Notes”). The January 2024
Convertible Notes mature in January 2025.
On
February 4, 2025, the maturity date of January 2024 convertible note was extended to July 12, 2025 pursuant to the second amendment.
In
April 2024, we entered into a convertible note agreement (the “April 2024 Convertible Note Agreement”) with a lender for
the aggregate principal amount of $0.1 million and is convertible to common stock (the “April 2024 Convertible Note”). The
April 2024 Convertible Promissory Note matures in April 2025.
Upon
the conversion of the April 2024 Convertible Note to common stock, we shall issue the holder a warrant to purchase 7,500 shares of common
stock of CSLM with a per share exercise price of $11.50.
On
February 5, 2025, the conversion price of the April 2024 Convertible Promissory Notes with principal amount of $125,000 was amended to
$3.15 from the original conversion price of $4.94. Further these were once again amended in April 2025 and basis the amendment the maturity
date was revised from April 5, 2025 to April 5, 2026 pursuant to the second amendment.
In
June 2024, we entered into a convertible note agreement (the “June 2024 Convertible Note Agreement”) with a lender for the
principal amount of $0.1 million and is convertible to common stock (the “June 2024 Convertible Note”). The June 2024 Convertible
Promissory Note matures in June 2025. Upon the conversion of June 2024 Convertible Note to common stock of CSLM, we shall issue the holder
a warrant to purchase 7,500 shares of common stock with a per share exercise price of $11.50.
On
February 5, 2025, the conversion price of the June 2024 Convertible Promissory Note with principal amount of $130,000 was amended to
$3.15 from the original conversion price of $4.94. Further, these were once again amended in July 2025 and basis the amendment, the maturity
date was revised from June 17, 2025, to June 17, 2026, pursuant to the amendment.
In
September 2024, we entered into two convertible note agreements (the “September 2024 Convertible Notes Agreements”) with
two lenders, each for the principal amount of $0.1 thousand (the “September 2024 Convertible Notes”). The 2024 September
Convertible Notes mature in September 2026. Upon the conversion of the September 2024 Convertible Notes to common stock, we shall issue
the holders each a warrant to purchase 7,500 shares of common stock with a per share exercise price of $11.50.
On
February 5, 2025, the conversion price of the two September 2024 Convertible Promissory Notes with principal amount of $100,000 each
was amended to $3.15 from the original conversion price of $4.94.
During
2024, we have entered into seven separate promissory notes with the Sameer Maskey, the Company CEO for aggregate principal amount of
$0.7 million. On February 12, 2025, an amendment to the seven promissory notes was entered into between the company and the
CEO, Mr. Sameer Maskey. As per the original agreement, the maturity date was earlier of (1) the occurrence of an Event of Default and
(2) December 31, 2024. Pursuant to the amendment agreement, the maturity date was extended to earlier of (1) the occurrence of an Event
of Default and (2) December 31, 2025.
On
February 24, 2025, the Company entered into a convertible promissory note (“February 2025 Convertible Notes) amounting to $180,000
with an interest rate of 4.71% and maturity date of February 19, 2028. Upon closing of the merger, the Note shall automatically convert
into the number of shares of common stock equal to the then outstanding Obligations under the note divided by the applicable Conversion
Price i.e., $3.15.
55
In
connection with the consummation of the Business Combination on October 22, 2025, each Legacy Fusemachines convertible note, including
both related-party and non-related-party convertible notes, that was issued and outstanding immediately prior to the Closing was converted
into an aggregate of 8,048,770 shares of Legacy Fusemachines common stock in accordance with the respective convertible note agreements.
Immediately following such conversions, all shares of Legacy Fusemachines common stock issued upon conversion were exchanged for shares
of Fusemachines common stock based on the exchange ratio specified in the Business Combination Agreement, As a result of the conversions
and exchanges, no convertible notes or related-party notes payable remained outstanding as of December 31, 2025, other than related party
note payable related to Dolma amounting $300 thousand. Refer to the section entitled ‘Recent Developments’ for details.
Equity
financing, if obtained, could result in dilution to our then-existing stockholders and/or require such stockholders to waive certain
rights and preferences. If such financing is not available on satisfactory terms, or is not available at all, we may be required to delay,
scale back, or eliminate the development of business opportunities and our operations and financial condition may be materially adversely
affected.
Off-Balance
Sheet Arrangements
We
do not have any off-balance sheet arrangements (as that term is defined in Item 303 of Regulation S-K) that are reasonably likely to
have a current or future material effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditures
or capital resources.
Related
Party Transactions
Refer
to Note 18, “Related Parties” of the consolidated financial statements contained elsewhere in this annual report, for disclosure
of our related party transactions.
Critical
Accounting Policies and Estimates
Our
consolidated financial statements have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements
requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related
disclosures. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the
circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results could differ materially from those estimates
due to risks and uncertainties, including uncertainty in the current economic environment. To the extent that there are material differences
between these estimates and our actual results, our future consolidated financial statements will be affected.
The
critical accounting estimates, assumptions, and judgments that have the most significant impact on our consolidated financial statements
are described below. For further information on significant accounting policies, see “Note 2, Summary of Significant Accounting
Policies” of our audited consolidated financial statements included herein.
Revenue
Recognition
The
Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). Under ASC
606, the Company recognizes revenue when (or as) customers obtain control of promised goods or services, in an amount that reflects the
consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenue following the
five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the
contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract;
and (v) recognize revenues when (or as) the Company satisfies a performance obligation. The Company applies the provisions of ASC 606
to an arrangement when a substantive contract exists and collectability is probable.
The
Company derives the majority of its revenue from AI Solutions (Products and Services) that largely represents the professional services
Fusemachines provides to its customers to help them achieve any AI-related goals within their organization. Standard contractual arrangements
are governed by Master Services Agreements (“MSAs”), which set out general terms including payment, termination rights, and
intellectual property ownership. Detailed scope, pricing, and performance obligations are defined in Statements of Work (“SOWs”),
which are executed for each engagement or project phase. The Company’s contracts for AI Services have different terms based on
the scope and complexity of engagements; pricing for the majority of contracts are invoiced monthly on a time-and-materials basis. The
Company notes that its contracts meet the requirements for over-time revenue recognition, as the customer is simultaneously receiving
the benefits and able to consume the benefits of the services being provided. For professional services that are distinct and billed
on a time-and-materials basis, revenue is generally recognized as the services are provided, which is reflective of the transfer of the
services to the customer. The Company elected the “right to invoice” practical expedient based on the Company’s right
to invoice a customer at an amount that approximates the value to the customer and the performance completed to date.
56
The
Company also provides AI Education Services which represents a customized curriculum of educational services provided to train the customer’s
C-suite on AI for Business. The Company provides AI Education Services over time as the course proceeds and the students retain knowledge
over time. Thus, the customer receives and consumes benefits as the Company performs the AI Education Services, and revenue is recognized
over time.
Company’s
AI Solutions includes product revenues primarily comprising software license fees from sales of term-based license contracts, under which
we grant customers the license right to use the software for a specified period (i.e. when the customer can access, use, and benefit
from the software license). Term software licenses are satisfied at a point in time and associated revenue is recognized upon the later
of 1) delivery of the software, or 2) the beginning of the period in which the customer has received the license right to use the software.
For customer contracts that include software license fees, implementation and/or other consulting services, the portion of the transaction
price allocated to software licenses is generally recognized when delivered. Implementation, customization, or model tuning services
if applicable, when included, are evaluated as separate performance obligations when they are distinct from the software and not highly
interdependent. These services are generally satisfied over time as the work progresses. During the year ended December 31, 2025, and
December 31, 2024, the product revenues were insignificant.
For
most contracts, the Company uses a Master Services Agreements (“MSA”) to govern the overall relevant terms and conditions
of the business agreement, and a Statement of Work (“SOW”) to specify the services delivered and the associated prices. Performance
obligations specific to each individual contract are defined within the terms of each SOW. Each performance obligation is identified
based on the services that will be transferred to our customer that are both capable of being distinct and are distinct within the context
of the contract. The transaction price is determined based on the consideration to which the Company will be entitled and expect to receive
in exchange for transferring services to the customer.
Consideration
for some contracts may include variable consideration including volume discounts and rebates. If the consideration promised includes
a variable amount, the Company only includes estimated amounts of consideration in the transaction price to the extent it is probable
that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration
is resolved. These estimates require management judgments and estimates. The determination of whether to constrain consideration in the
transaction is based on historical, current, and forecasted information that is reasonably available to the Company, taking into consideration
the type of customer, the transaction, and specific facts and circumstances of each arrangement. The Company uses judgement to determine
if collectability of consideration is uncertain, and accordingly, revenue recognition is deferred until the uncertainty is resolved and
cash is collected.
Payment
terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days of the invoice
date. In certain arrangements, the Company will receive payment from a customer either before or after the performance obligation to
which the invoice relates has been satisfied. As a practical expedient, the Company does not account for significant financing components
if the period between when it transfers the promised good or service to the customer and when the customer pays for the product or service
will be one year or less.
For
contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation
based on its relative standalone selling price. The stand-alone selling prices are determined based on the prices at which the Company
separately sells these products. For items that are not sold separately, the Company estimates the stand-alone selling prices using other
observable inputs. As Fusemachines Inc. is the sole reportable segment, all revenues are attributed to the sole segment.
57
Income
Taxes
The
provision for income taxes includes federal, state, local and foreign taxes. Deferred tax assets and liabilities are recognized for the
estimated future tax consequences of temporary differences between the consolidated financial statements carrying amounts and their respective
tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in
which the temporary differences are expected to be reversed. Changes to enacted tax rates would result in either increases or decreases
in the provision for income taxes in the period of changes.
The
realizability of deferred tax assets is primarily dependent on future earnings. The Company evaluates the realizability of deferred tax
assets and recognizes a valuation allowance when it is more likely than not that all, or a portion of, deferred tax assets will not be
realized. A reduction in estimated forecasted results may require that we record valuation allowances against deferred tax assets. Once
a valuation allowance has been established, it will be maintained until there is sufficient positive evidence to conclude that it is
more likely than not that the deferred tax assets will be realized. A pattern of sustained profitability will generally be considered
as sufficient positive evidence to reverse a valuation allowance. If the allowance is reversed in a future period, the income tax provision
will be correspondingly reduced. Accordingly, the increase and decrease of valuation allowances could have a significant negative or
positive impact on future earnings.
The
United States subjects corporations to taxes on Global Intangible Low-Taxed Income (“GILTI”) earned by certain foreign subsidiaries.
The Company elected to provide for the tax expense related to GILTI in the year the tax is incurred.
Stock-Based
Compensation
Stock-based
compensation expense attributable to equity awards granted to employees and non-employees is measured at the grant date based on the
fair value of the award. For employee awards, the expense is recognized on a straight-line basis over the requisite service period for
awards that actually vest, which is generally the period from the grant date to the end of the vesting period. For non-employee awards,
the expense for awards that actually vest is recognized based on when the goods or services are provided.
The
Company records stock-based compensation in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”).
This standard requires all equity-based payments to employees and non-employees, including grants of employee stock options and restricted
stock awards, to be recognized in the consolidated statements of operations and comprehensive loss based on the grant date fair value
of the award. The stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the award,
which is generally the period from the accounting grant date to the end of the vesting period. The Company elected to account for forfeitures
of awards as they occur.
Since
the adoption of ASU 2018-07, Improvements to Nonemployee Stock-Based Payment Accounting, the measurement date for non-employee awards
is the date of grant, and stock-based compensation costs are recognized in the same period and in the same manner as if the entity had
paid cash for the goods or services. Stock-based compensation expense is classified as general and administrative, cost of revenue, selling
and marketing and research and development expenses in the consolidated statements of operations and comprehensive loss.
The
Company estimates the fair value of stock option awards granted using the Black Scholes Merton option pricing formula (the “Black-Scholes
Model”). This model requires various significant judgmental assumptions in order to derive a final fair value determination for
each type of award, including the expected term, expected volatility, expected dividend yield, risk-free interest rate and fair value
of the Company’s stock on the date of grant. The expected option term for options granted is calculated using the “simplified
method”. This election was made based on the lack of sufficient historical exercise data to provide a reasonable basis upon which
to estimate the expected term. The simplified method defines the expected term as the average of the contractual term and the vesting
period. Estimated volatility is based on similar entities whose stock prices are publicly traded. The Company uses the historical volatilities
of similar entities due to the lack of sufficient historical data for the Company’s common stock price. The Company estimates volatility
based upon the observed historical volatilities of comparable companies over a lookback period commensurate with the estimated holding
period, adjusted for relative leverage using the Black-Scholes-Merton formula. Dividend yields are based on the Company’s history
and expected future actions. The Company has not declared or paid dividends to date and does not anticipate declaring dividends. As such,
the dividend yield has been estimated to be zero. The risk-free interest rate is based on the yield curve of a zero-coupon U.S. Treasury
bond on the date the stock option award was granted with a maturity equal to the expected term of the stock option award. All grants
of stock options generally have an exercise price equal to or greater than the fair market value of the Company’s common stock
on the date of grant.
The
fair value of the shares of common stock underlying the stock options has historically been determined by the Company’s Board of
directors as there was no public market for the underlying common stock prior to October 22, 2025. In estimating the fair value of its
stock, the Company uses a third-party valuation specialist and considers factors it believes are material to the valuation process, including
but not limited to, the price at which recent equity was issued by the Company to independent third parties or transacted between third
parties, any indications of value from offers to acquire the Company, actual and projected financial results, risks, prospects, economic
and market conditions, and estimates of weighted average cost of capital. The Company believes the combination of these factors provides
an appropriate estimate of the expected fair value of the Company and reflects the best estimate of the fair value of the Company’s
common stock at each grant date.
Recent
Accounting Pronouncements
For
further information on recent accounting pronouncements, see “Note 2, Summary of Significant Accounting Policies” of our
audited consolidated financial statements included herein
Quantitative
and Qualitative Disclosures About Market Risk
We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise
required under this item.
Item
7A. Quantitative and Qualitative Disclosures about Market Risk.
Not
Applicable.
Item
8. Financial Statements and Supplementary Data.
The
consolidated financial statements required pursuant to this item are included in Part IV, Item 15 of this Annual Report, and are presented
beginning on page F-1.
Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
None.
58
Item
9A. Controls and Procedures.
Evaluation
of Disclosure Controls and Procedures
Our
management, with the participation of our Chief Executive Officer and Chief Financial Officer has evaluated the effectiveness of our
disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e)
under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be
disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported,
within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation,
controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits
under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive and principal
financial officers, as appropriate to allow timely decisions regarding required disclosure.
Management
recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving
their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and
procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s
disclosure controls and procedures were not effective as of the end of the fiscal year covered by this Annual Report as a result of the material
weaknesses in Internal Control over Financial Reporting described below.
Management’s
Report on Internal Control over Financial Reporting
Management,
including our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal
control over financial reporting as defined in Rules 13a- 15(f) and 15d-15(f) under the Exchange Act and based upon the criteria established
in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “COSO
framework”). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of our financial reporting and the preparation of our financial statements for external purposes in accordance with U.S.
GAAP.
An
effective internal control system, no matter how well designed, has inherent limitations, including the possibility of human error or
overriding of controls, and therefore can provide only reasonable assurance with respect to reliable financial reporting. Because of
its inherent limitations, our internal control over financial reporting may not prevent or detect all misstatements, including the possibility
of human error, the circumvention or overriding of controls, or fraud. Effective internal controls can provide only reasonable assurance
with respect to the preparation and fair presentation of financial statements.
Under
the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we
have conducted an evaluation of the effectiveness of our internal control over financial reporting based on the COSO framework.
Based on evaluation under these criteria, management determined that our internal controls over financial reporting were not
effective as of December 31, 2025.
Remediation
of Material Weakness in Internal Controls
In
connection with the preparation and audit of our consolidated financial statements as of and for the years ended December 31, 2025 and
2024, material weaknesses were identified in its internal control over financial reporting. A material weakness is a deficiency, or combination
of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement
of the financial statements will not be prevented or detected on a timely basis. The following material weaknesses were identified:
● Incomplete implementation of internal
control framework (e.g., COSO 13) to establish an effective control environment, risk assessment,
control activities, communication, and monitoring processes.
● Lack of formal process for Board review or approval of significant CEO-initiated transactions.
● Lack of formal process for independent review of significant accounting estimates by qualified personnel
at each reporting date.
● Lack of sufficient trained accounting staff with US GAAP expertise.
● Inadequate segregation of duties and lack of review of accounting entries.
● Absence of a robust monthly and annual close process.
● Lack of centralized contract repository or checklist for key contract terms and accounting implications.
● Lack of adequate IT controls.
Management expects to
address these deficiencies by implementing remediation measures, including those that have already been taken to date, which include the
following:
●
the Company’s hiring of the current CFO and additional consulting resources with extensive technical accounting and internal control advisory background;
●
the already introduced reconciliation processes including balance sheet account reconciliations, and a review of chart of accounts and mapping of expense accounts as of December 31, 2023;
●
establishing a central repository of signed contracts with periodic management review for completeness and assessment of accounting implications; and
●
establishing a quarterly management oversight and review mechanism for identifying significant unusual/non-recurring transactions, critical accounting and complex financial instruments and evaluating related accounting implications.
Management expects to take the following additional remedial measures
to address the internal control deficiencies:
● Strengthen its monthly payroll reconciliation process to ensure accuracy with the general ledger and trial balance, especially for
North American entities.
● Maintaining a vendor master list and strengthening documentation, with proper segregation by vendor type to ensure accurate classification
of expenses (Cost of Services, G&A, R&D, Sales & Marketing) including software, hardware, and IT consultants.
● Strengthen the monthly accrual process for services received by maintaining a schedule of accrued expenses to ensure proper expense
cut-off and accurate financial statement presentation.
● Perform monthly reconciliations and adjustments for loan balances, fixed assets, accounts payable, and related party transactions
to ensure accurate financial statements for management decisions, tax planning, and statutory compliance.
● Strengthen fixed asset tagging and serial numbering to maintain an accurate fixed asset schedule and enable timely reconciliation
with the trial balance.
● Strengthen documentation of inter-company transactions and perform transfer pricing studies for Nepal and Canadian subsidiaries.
● Adopt and implement the COSO 13 Framework (or equivalent) to establish an effective control environment, perform risk assessments,
implement controls, and monitor internal control over financial reporting.
59
Changes
in Internal Control Over Financial Reporting
Other
than the changes associated with the material weaknesses and remediation actions noted above, there have been no changes to our internal
control over financial reporting that occurred during the year ended December 31, 2025.
Inherent
Limitations on Effectiveness of Disclosure Controls and Procedures, and Internal Controls Over Financial Reporting
Our
management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and
procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well
designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further,
the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered
relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance
that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments
in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented
by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any
system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance
that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate
because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Due to inherent limitations
in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Item
9B. Other Information.
Rule
10b5-1 Trading Plans
For
the year and quarter ended December 31, 2025, none of our directors or officers adopted , modified , or terminated a “Rule 10b5-1
trading arrangement” (as defined in Item 408 of Regulation S-K of the Exchange Act) intended to satisfy the affirmative defense
conditions of Rule 10b5-1(c) under the Exchange Act.
Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not
applicable.
60
PART
III
Item
10. Directors, Executive Officers and Corporate Governance.
Information
required by this item will be contained in our Definitive Proxy Statement for our 2026 Annual Meeting of Stockholders, to be filed pursuant
to Regulation 14A with the Securities and Exchange Commission within 120 days of December 31, 2025. Such information is incorporated
herein by reference.
Our
board of directors has adopted a Code of Business Conduct applicable to all officers, directors, and employees, which is available on
our website (ir.fusemachines.com) under “Governance Documents.” We intend to satisfy the disclosure requirement under Item
5.05 of Form 8-K regarding amendment to, or waiver from, a provision of our Code of Business Conduct by posting such information on the
website address and location specified above.
We
have adopted an insider trading policy applicable to our directors, officers, employees, and other covered persons, and have implemented
processes for the company, that we believe are reasonably designed to promote compliance with insider trading laws, rules and regulations,
and the Nasdaq Stock Market LLC listing standards. Our insider trading policy is filed as Exhibit 19.1 to this Annual Report on Form
10-K.
Item
11. Executive Compensation.
Information
required by this item will be contained in our Definitive Proxy Statement for our 2026 Annual Meeting of Stockholders, to be filed pursuant
to Regulation 14A with the Securities and Exchange Commission within 120 days of December 31, 2025. Such information is incorporated
herein by reference.
Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Information
required by this item will be contained in our Definitive Proxy Statement for our 2026 Annual Meeting of Stockholders, to be filed pursuant
to Regulation 14A with the Securities and Exchange Commission within 120 days of December 31, 2025. Such information is incorporated
herein by reference.
Item
13. Certain Relationships and Related Transactions, and Director Independence.
Information
required by this item will be contained in our Definitive Proxy Statement for our 2026 Annual Meeting of Stockholders, to be filed pursuant
to Regulation 14A with the Securities and Exchange Commission within 120 days of December 31, 2025. Such information is incorporated
herein by reference.
Item
14. Principal Accounting Fees and Services.
Information
required by this item will be contained in our Definitive Proxy Statement for our 2026 Annual Meeting of Stockholders, to be filed pursuant
to Regulation 14A with the Securities and Exchange Commission within 120 days of December 31, 2025. Such information is incorporated
herein by reference.
PART
IV
Item
15. Exhibits, Financial Statement Schedules.
(1) For
a list of the financial statements included herein, see Index to the Consolidated Financial
Statements on page F-1 of this Annual Report, incorporated into this Item by reference.
(2) Financial
statement schedules have been omitted because they are either not required or not applicable
or the information is included in the consolidated financial statements or the notes thereto.
Item
16. Form 10-K Summary
None.
61
Exhibit
Index
Exhibit
Number
Description
Schedule/
Form
File
No.
Exhibit
Filing
Date
2.1+
Merger Agreement, dated January 2024, by and among CSLM Acquisition Corp., CSLM Merger Sub, Inc. and Fusemachines Inc.
8-K
001-42909
2.1+
October
29, 2025
2.1+
Amendment No. 1 to the Merger Agreement by and among CSLM Acquisition Corp., CSLM Merger Sub, Inc. and Fusemachines Inc., dated August 27, 2024.
8-K
001-42909
2.2+
October
29, 2025
2.3+
Amendment No. 2 to the Merger Agreement dated February 4, 2025, by and among CSLM Acquisition Corp., CSLM Merger Sub, Inc. and Fusemachines Inc.
8-K
001-42909
2.3+
October
29, 2025
3.1*
Amended
and Restated Certificate of Incorporation (as amended and restated)
3.2
Amended and Restated Bylaws.
8-K
001-42909
3.2
October
29, 2025
4.1*
Description of Registrant’s Securities
4.2
Warrant Agreement, dated January 12, 2022, by and between the Registrant and Continental Stock Transfer & Trust Company, as warrant agent
S-4
333-283520
4.2
June
24, 2025
4.3
Form of Warrant Certificate (included as Exhibit A-1 to the Warrant Agreement dated January 12, 2022, by and between the Registrant and Continental Stock Transfer & Trust Company, as warrant agent
S-4
333-283520
4.2
June
24, 2025
4.4
Form of Private Placement Warrant
S-1
333-292318
4.3
January 30, 2026
4.5
Amendment No. 1 to Warrant
8-K
001-42909
4.1
February 4, 2026
10.1
Amended and Restated Registration Rights Agreement
8-K
001-42909
10.1
October
29, 2025
10.2¥
2025 Omnibus Equity Incentive Plan
8-K
001-42909
10.2
October
29, 2025
10.3¥
Employment Agreement between Fusemachines, Inc. and Sameer Maskey, dated October 22, 2025
8-K
001-42909
10.3
October
29, 2025
10.4¥
Offer Letter between Fusemachines, Inc. and Christine Chambers, dated July 21, 2025
8-K
001-42909
10.4
October
29, 2025
10.5¥
Form of Indemnity Agreement
8-K
001-42909
10.5
October
29, 2025
10.6
Securities Purchase Agreement by and between Fusemachines Inc. and Consilium Frontier Equity Fund LP, dated December 23, 2025.
8-K
001-42909
10.1
January 2, 2026
10.7
Forward Purchase Agreement dated July 31, 2025 between CSLM Acquisition Corp., CSLM Holdings, Inc., and Fusemachines Inc., with Meteora Capital Partners, LP, Meteora Select Trading Opportunities Master, LP, and Meteora Strategic Capital, LLC.
8-K
001-42909
10.1
February 4, 2026
10.8
Amendment No. 1 to Forward Purchase Agreement dated February 3, 2026 between Fusemachines Inc. and Meteora Capital Partners, LP, Meteora Select Trading Opportunities Master, LP, and Meteora Strategic Capital, LLC.
8-K
001-42909
10.2
February 4, 2026
19.1*
Insider Trading Policy
21.1*
List of Subsidiaries
23.1*
Consent of KNAV CPA
24.1*
Power of Attorney (included on a signature page of the initial filing of this Annual Report)
31.1*
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*
Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
97.1*
Fusemachines Inc. Clawback Policy
101.INS
Inline
XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded
within the Inline XBRL document.
101.SCH
Inline
XBRL Taxonomy Extension Schema With Embedded Linkbase Documents
104
Cover
Page Interactive Data File (embedded within the Inline XBRL document)
* Filed herewith
**
The certifications attached as Exhibits 32.1 and 32.2 that accompany this Annual Report are not deemed filed with the SEC and are not
to be incorporated by reference into any filing of Fusemachines Inc. under the Securities Act of 1933 or the Securities Exchange Act
of 1934, whether made before or after the date of this Annual Report, irrespective of any general incorporation language contained in
such filing.
+
Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally a
copy of any omitted schedule or exhibit to the SEC upon request.
¥
Denotes management contract or any compensatory plan, contract or arrangement.
62
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report
to be signed on its behalf by the undersigned, thereunto duly authorized .
FUSEMACHINES
INC.
Date:
March 27, 2026
By:
/s/
Sameer Maskey
Sameer
Maskey
Chief
Executive Officer
The
undersigned officers and directors of Fusemachines Inc., hereby severally constitute and appoint Sameer Maskey and Christine Chambers,
and each of them individually, with full power of substitution and resubstitution, as their true and lawful attorneys and agents, to
do any and all acts and things in their name and behalf in their capacities as directors and officers and to execute any and all instruments
for them and in their names in the capacities indicated below, which said attorneys and agents, may deem necessary or advisable to enable
said corporation to comply with the Securities Exchange Act of 1934, as amended, and any rules, regulations and requirements of the Securities
and Exchange Commission, in connection with this Annual Report, including specifically but without limitation, power and authority to
sign for them or any of them in their names in the capacities indicated below, any and all amendments hereto, and they do hereby ratify
and confirm all that said attorneys and agents, or either of them, may lawfully do or cause to be done by virtue hereof.
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on
behalf of the Registrant in the capacities and on the dates indicated.
Name
Title
Date
/s/
Sameer Maskey
Chief
Executive Officer, Director
March
27, 2026
Sameer
Maskey
(Principal
Executive Officer)
/s/
Christine Chambers
Chief
Financial Officer
March
27, 2026
Christine
Chambers
(Principal
Financial Officer and Principal Accounting Officer)
/s/
Bharat Krish
Director
March
27, 2026
Bharat
Krish
/s/
Tim Gocher
Director
March
27, 2026
Tim
Gocher
/s/
Sanjay Shrestha
Director
March
27, 2026
Sanjay
Shrestha
/s/
Salman Alam
Director
March
27, 2026
Salman
Alam
63
INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS
Report of Independent Registered Public Accounting Firm (PCAOB ID 2983 )
F-2
Consolidated Balance Sheets as of December 31, 2025 and 2024
F-3
Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2025 and 2024
F-4
Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2025 and 2024
F-5
Consolidated Statements of Cash Flows for the years ended December 31, 2025 and 2024
F-7
Notes to Consolidated Financial Statements
F-8
F- 1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the Board of Directors and Stockholders of
Fusemachines
Inc. and its subsidiaries
Opinion
on the consolidated financial statements
We
have audited the accompanying consolidated balance sheets of Fusemachines Inc. and its subsidiaries (the Company) as of December 31,
2025 and December 31, 2024 and the related consolidated statements of operations and comprehensive loss, stockholders’ deficit
and cash flows for each of the years in the two-year period ended December 31, 2025 and the related notes (collectively referred to as
the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects,
the financial position of the Company as of December 31, 2025 and December 31, 2024, and the results of its operations and its cash flows
for each of the years in the two-year period ended December 31, 2025, in conformity with accounting principles generally accepted in
the United States of America.
Substantial
doubt about the Company’s ability to continue as a going concern
The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As
discussed in Note 2 to the consolidated financial statements, the Company has suffered recurring losses, has an accumulated deficit
and stockholders’ deficit. The continuation of the Company as a going concern is dependent upon the continued financial
support from its stockholders and debt holders including management’s plan to raise additional capital from issuance of equity
or receive additional borrowings to fund the Company’s operating and investing activities over the next year. These conditions raise substantial doubt about the
Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to
the recoverability and classification of recorded asset amounts and classification of liabilities that might be
necessary should the Company be unable to continue as a going concern.
Basis
for opinion
These
consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion
on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.
We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing
an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audit provides a reasonable basis for our opinion.
/s/
KNAV CPA LLP
KNAV
CPA LLP
We
have served as the Company’s auditor since 2023.
Atlanta,
Georgia
March
27, 2026
PCAOB
ID – 2983
F- 2
Fusemachines
Inc. and Subsidiaries
Consolidated
Balance Sheets
(all
amounts in USD, in thousands, except number of shares and per share data)
December
31, 2025
December
31, 2024
Assets
Current assets:
Cash and cash equivalents
4,221
500
Accounts receivable, current, net
1,264
1,427
Unbilled revenue
16
113
Deferred transaction costs
-
1,865
Prepaid expenses and other current assets
753
219
Total current assets
6,254
4,124
Property and equipment, net
305
348
Intangible assets, net
206
187
Accounts receivable, net
-
4
Deferred tax asset
11
10
Operating lease right-of-use assets
744
870
Other assets
16
5
Total assets
7,536
5,548
Liabilities and stockholders’
deficit
Current liabilities:
Accounts payable
5,012
6,537
Accrued expenses and other current liabilities
4,618
3,700
Deferred revenue
-
54
Convertible notes payable, at fair value, current
-
8,986
Convertible notes payable, current
-
255
Related party loan payable, current
300
700
Operating lease liability, current
85
74
Forward purchase derivative liability
9,692
-
Short term debt
342
Total current liabilities
20,049
20,306
Accounts payable non-current
143
Related party convertible notes payable, at
fair value
-
6,524
Convertible notes payable
-
200
Warrant liability
121
945
Cumulative mandatorily redeemable common and
preferred stock liability
1,048
1,000
Operating lease liability
751
878
Total liabilities
22,112
29,853
Commitments and Contingencies (Note 17)
-
-
Stockholder’s deficit:
Convertible preferred stock ($ 0.0001 par
value, 5,000,000 and 5,972,716 shares authorized as of December 31,2025 and December 31, 2024, respectively; Nil and 5,950,673 shares issued
as of December 31, 2025 and December 31, 2024, respectively; Nil and 5,950,673 shares outstanding as of December 31, 2025 and December
31, 2024)
-
7,865
Common stock ($ 0.0001 par value, 500,000,000
shares and 15,924,202 shares authorized as of December 31,2025 and December 31, 2024; 29,377,169 and 7,709,867 shares issued as of
December 31,2025 and December 31,2024 respectively; 28,938,266 shares and 7,264,192 shares outstanding as of December 31,2025 and
December 31, 2024, respectively)
3
1
Additional paid in capital
31,311
4,699
Treasury stock, at cost ( Nil and 438,903 as
of December 31,2025 and December 31, 2024, respectively)
-
( 2,903 )
Share subscription receivable
( 11,005 )
-
Accumulated deficit
( 35,145 )
( 34,217 )
Accumulated other comprehensive income
260
250
Total stockholders’
deficit
( 14,576 )
( 24,305 )
Total liabilities and stockholders’
deficit
7,536
5,548
The
accompanying notes are an integral part of these consolidated financial statements.
F- 3
Fusemachines
Inc. and Subsidiaries
Consolidated
Statements of Operations and Comprehensive Loss
(all
amounts in USD, in thousands, except number of shares and per share data)
Year
ended
December 31, 2025
Year
ended
December
31, 2024
Revenue
7,714
8,811
Cost of revenue
( 3,407 )
( 3,976 )
Gross Profit
4,307
4,835
Operating expenses:
Selling and marketing
1,365
1,964
General and administrative
8,176
10,333
Research and development
720
732
Total operating expenses
10,261
13,029
Loss from operations
( 5,954 )
( 8,194 )
Other (expense) income:
Interest expense
( 268 )
( 234 )
Loss on extinguishment of convertible notes payable
( 391 )
-
Loss on extinguishment of notes payable
( 601 )
Loss on extinguishment of payable
-
( 70 )
Gain/(Loss) on change in fair value of convertible
notes and warranty liability
6,544
( 6,104 )
Gain/(Loss) on change in fair value of forward purchase derivative liability
( 1,076 )
-
Other (expense) income
220
( 148 )
Total other expense/(income),
net
5,029
( 7,157 )
Loss before income taxes
and equity in earnings of investee
( 925 )
( 15,351 )
Provision for income tax
( 3 )
( 31 )
Equity in earnings of investee,
net of income tax provision of $ 0 and $ 0 , respectively
-
( 1 )
Net loss
( 928 )
( 15,383 )
Other comprehensive income
(loss)
Change in foreign currency translation adjustment
10
57
Total comprehensive loss
( 918 )
( 15,326 )
Net loss per share - basic
and diluted
( 0.08 )
( 2.21 )
Weighted-average common
shares outstanding - basic and diluted
11,525,384
6,958,570
The
accompanying notes are an integral part of these consolidated financial statements.
F- 4
Fusemachines
Inc. and Subsidiaries
Consolidated
Statements of Stockholders Deficit
(all
amounts in USD, in thousands, except number of shares and per share data)
Shares
Amount
Shares
Amount
Amount
Shares
Amount
Amount
Amount
Amount
Amount
Convertible
Preferred Stock*
Common
stock*
Additional
paid-in
capital
Treasury
stock*
Share
Subscription
Receivable
Accumulated
deficit
Accumulated
other
comprehensive
Income
Total
stockholders’
deficit
Shares
Amount
Shares
Amount
Amount
Shares
Amount
Amount
Amount
Amount
Amount
Balance at December
31, 2024
5,950,673
$ 7,865
7,264,192
$ 1
$ 4,699
438,903
$ ( 2,903 )
-
$ ( 34,217 )
$ 250
$ ( 24,305 )
Stock-based compensation
-
-
-
-
231
-
-
-
-
231
Net loss
-
-
-
-
-
-
-
( 928 )
-
( 928 )
Issuance of shares upon repayment
and forgiveness of 2023 Promissory Notes
-
-
6,772
-
3
-
-
-
-
3
Issuance of common stock upon
cashless exercise of stock option
-
-
745,896
-
707
707
Shares withheld related to
cashless exercise of stock option
-
-
( 79,234 )
-
( 707 )
( 707 )
Issuance of common stock upon
the reverse recapitalization, net of issuance costs (refer note 20)
-
12,456,071
1
8,507
-
8,508
Issuance of shares as a result of Conversion of convertible
notes
-
1,976,050
-
10,157
10,157
Shares issued to a vendor of
Legacy Fusemachines to settle outstanding invoices.
-
29,611
-
198
198
Transfer of Fusemachines Inc. common stock to a third party vendor
-
-
151
151
Conversion of convertible preferred
stock into common stock in connection with the reverse recapitalization
( 5,950,673 )
( 7,865 )
5,950,673
1
7,864
-
Treasury stock cancellation
upon reverse recapitalization
-
( 2,903 )
( 438,903 )
2,903
-
Prepaid forward purchase
agreement
-
( 11,005 )
( 11,005 )
Issuance of shares pursuant
to PIPE transaction (refer note 23)
-
588,235
-
1,000
1,000
Issuance of warrants related
to forward purchase agreement and convertible note agreement (refer note 10 &22 )
-
1,013
1,013
Loss for extinguishment of
convertible notes payable
-
-
-
-
391
-
-
-
-
391
Foreign
currency translation
-
-
-
-
-
-
-
-
10
10
Balance
at December 31, 2025
-
$ -
28,938,266
$ 3
$ 31,311
-
$ -
$ ( 11,005 )
$ ( 35,145 )
$ 260
$ ( 14,576 )
F- 5
Fusemachines
Inc. and Subsidiaries
Consolidated
Statements of Stockholders Deficit
(all
amounts in USD, in thousands, except number of shares and per share data)
Convertible
preferred stock*
Common
stock*
Additional
paid-in
capital
Treasury
stock*
Share
Subscription
Receivable
Accumulated
deficit
Accumulated
other
comprehensive
income
Total
stockholders’
deficit
Shares
Amount
Shares
Amount
Amount
Shares
Amount
Amount
Amount
Amount
Amount
Balance at
December 31, 2023
9,043,234
$ 7,865
9,220,534
$ 2
$ 2,307
-
$ -
-
$ ( 18,834 )
$ 193
$ ( 8,467 )
Retroactive application of
recapitalization (a)(b)
( 3,092,561 )
-
( 3,153,193 )
( 1 )
( 1 )
-
-
-
-
-
Balance at December 31,
2023
5,950,673
$ 7,865
6,067,341
$ 1
$ 2,308
-
-
-
$ ( 18,834 )
$ 193
$ ( 8,467 )
Balance
5,950,673
$ 7,865
6,067,341
$ 1
$ 2,308
-
-
-
$ ( 18,834 )
$ 193
$ ( 8,467 )
Stock-based compensation
-
-
-
-
1,067
-
-
-
-
-
1,067
Net loss
-
-
-
-
-
-
-
-
( 15,383 )
-
( 15,383 )
Common stock repurchase
-
-
( 438,903 )
-
-
438,903
( 2,903 )
-
-
-
( 2,903 )
Exercise of stock options
-
-
17,205
-
12
-
-
-
-
-
12
Gain on extinguishment recorded
as a capital transaction
-
-
-
-
343
-
-
-
-
-
343
Issuance of shares upon repayment
of 2023 Promissory Notes
-
-
1,618,549
-
899
-
-
-
-
-
899
Premium from extinguishment
of payable
-
-
-
-
70
-
-
-
-
-
70
Foreign
currency translation
-
-
-
-
-
-
-
-
-
57
57
Balance
at December 31, 2024
5,950,673
$ 7,865
7,264,192
$ 1
$ 4,699
438,903
$ ( 2,903 )
-
$ ( 34,217 )
$ 250
$ ( 24,305 )
Balance
5,950,673
$ 7,865
7,264,192
$ 1
$ 4,699
438,903
$ ( 2,903 )
-
$ ( 34,217 )
$ 250
$ ( 24,305 )
* The
number of shares of convertible preferred stock and common stock issued and outstanding prior to the Merger have been retroactively adjusted
by the Exchange Ratio to give effect to the reverse recapitalization treatment of the Merger.
* In
connection with the consummation of the business combination, the Company adopted a new capital structure and amended the par value
of its common stock from $ 0.00001
per share to $ 0.0001
per share. Accordingly, the historical equity presentation has been adjusted to reflect the revised par value of the Company’s
common stock. The change resulted in a reclassification of amounts within stockholders’ equity from additional paid-in capital
to common stock to reflect the increased par value per share. This reclassification had no impact on total stockholders’
equity.
The
accompanying notes are an integral part of these consolidated financial statements.
F- 6
Fusemachines
Inc. and Subsidiaries
Consolidated
Statements of Cash Flows
(all
amounts in USD, in thousands)
2025
2024
Year ended December 31,
2025
2024
Cash flows from operating activities
Net Loss
( 928 )
( 15,383 )
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment
96
109
Amortization of intangible asset
93
70
Provision for credit losses
55
540
Stock-based compensation
231
1,067
Amortization of right-of-use assets
88
110
Changes in fair value of convertible notes at fair value, warranty liability and forward purchase agreement liability
( 6,544 )
6,104
Change in fair value of forward purchase derivative liability
1,076
Accretion of cumulative mandatorily redeemable common and preferred stock liability
99
80
Equity method investment obtained in exchange for services
-
( 122 )
Impairment of Equity investments
-
120
Equity in earnings of investee
-
2
Loss on extinguishment of convertible notes payable
391
601
Loss on extinguishment of payable
-
70
Unrealized foreign exchange gain/(loss)
27
49
Deferred income taxes
( 2 )
( 11 )
Changes in operating assets and liabilities:
Accounts receivable, current, net
47
( 904 )
Unbilled revenue
82
( 39 )
Prepaid expenses and other current assets
( 74 )
( 85 )
Accounts receivable, net
4
18
Other assets
22
( 2 )
Accounts payable
( 200
)
3,715
Operating lease liabilities
( 73 )
( 87 )
Accrued expenses and other current liabilities
34
1,744
Deferred revenue
( 54 )
33
Net cash used in operating activities
( 5,529 )
( 2,201 )
Cash flows from investing activities
Costs capitalized for internally developed software
( 112 )
( 144 )
Purchases of property and equipment
( 53 )
( 15 )
Payment made to Capital Creditors
-
( 20 )
Disposal of property and equipment
-
3
Net cash used in investing activities
( 165 )
( 176 )
Cash flows from financing activities
Proceeds from convertible notes payable
180
455
(Repayment)/ Proceeds from related party loan payable
( 700 )
700
Proceeds from convertible note payable, at fair value
-
6,500
Payments on notes payable, net of penalty and lender fees
-
( 3,000 )
Payment of deferred transaction costs
( 836 )
( 2 )
Common stock repurchase
-
( 2,000 )
Proceeds from reverse recapitalization
9,432
Proceeds from issuance of shares pursuant to PIPE transaction
1,000
Debt Extinguishment cost paid
-
( 53 )
Exercise of stock options
-
12
Proceeds from director and officer insurance funding (short term debt)
382
Payment of director and officer insurance funding ( short
term debt)
( 40
)
Net cash provided by financing activities
9,418
2,612
Effect of exchange rate changes on cash and cash equivalents
( 3 )
( 1 )
Net change in cash and cash equivalents
3,721
234
Cash and cash equivalents at beginning of the period
500
266
Cash and cash equivalents at end of the period
4,221
500
Supplemental disclosures of cash flow information
Cash paid for interest
-
26
Cash paid for income taxes
31
10
Non-cash investing and financing activities:
Purchase of property and equipment through capital advances
-
38
Common Stock issued upon cashless exercise of stock options
707
-
Unpaid deferred transaction costs as of the end of the period
242
1,684
Waiver of deferred transaction costs as of the end of the period
1,177
-
Issuance of shares vested upon repayment and forgiveness of 2023 Promissory Notes
3
899
Issuance of subscription receivable
( 11,005 )
Settlement of non-recourse 2023 promissory note in exchange for common stock repurchase consideration
-
903
Issuance of shares as a result of conversion of related party convertible notes at fair value
4,168
Issuance of shares as a result of conversion of convertible notes at fair value
5,321
Issuance of shares as a result of conversion of convertible notes
668
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization
7,864
Treasury stock repurchase cancellation upon reverse recapitalization
( 2,903 )
Shares issued to a vendor of Legacy Fusemachines to settle outstanding invoices.
198
(Loss)/Gain on extinguishment of debt (Refer Note no. 10 - Long Term Debt)
( 391 )
Extinguishment of debt (Refer Note no. 10 - Long Term Debt and Note no.17 - Commitments and Contingencies)
4,091
Settlement of vendor payable by SPAC sponsor accounted as a capital contribution
137
Issuance of warrants related to forward purchase agreement and convertible note agreemen t (refer
note 10 &22)
1,013
Recognition of debt at fair value (Refer Note no. 10 - Long Term Debt and Note no.17 - Commitments and
Contingencies)
-
3,818
Investment in Equity securities
122
Transfer of Fusemachines Inc. common stock to third party purchaser
151
The
accompanying notes are an integral part of these consolidated financial statements.
F- 7
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
Note
1. Organization
Fusemachines
Inc. (“Company” or “Pubco”) provide enterprise artificial intelligence solutions and services across North America,
Latin America and Asia. The Company was originally incorporated on April 13, 2021 under the name CSLM Acquisition, Corp. (“CSLM” ) ,
as a Cayman Islands exempted Company, a special purpose acquisition company (“SPAC”) formed for the purpose of effecting
a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses
or entities. Upon consummation of the Business Combination, Fusemachines USA, Inc. (“Legacy Fusemachines”) became the surviving
corporation and a wholly-owned subsidiary of the Company. The Company operated through the following legal entities and branch:
●
Fusemachines
USA, Inc (Wholly Owned Subsidiary)
●
Fusemachines
Nepal Inc. (Wholly Owned Holding Company)
●
Fusemachines
Nepal Private Ltd. (Majority Owned Subsidiary)
●
Fusemachines
Canada Inc (Wholly Owned Subsidiary)
●
Fusemachines
India Inc. (Dormant Holding Company)
●
Fusemachine
Inc. Dominican Republic (Wholly Owned Branch)
Business
Oxygen Private Limited (“BO2”), a company domiciled in Nepal, holds certain redeemable common and preferred stock of Fusemachines
Nepal Private Ltd. (see Note 8 — Cumulative Mandatorily Redeemable Financial Instruments).
Merger
Agreement and Business Combination
On
January 2024, the Company entered into an Agreement and Plan of Merger (as amended in August 2024 and February 2025, the
“Business Combination Agreement”) with CSLM Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of CSLM
(“Merger Sub”), and Fusemachines USA, Inc. (formerly Fusemachines Inc.) (“Legacy Fusemachines”). On October 22, 2025, the Company consummated the business combination whereby
(a) CSLM merged with and into CSLM Holdings, Inc., a Delaware corporation and wholly owned subsidiary of CSLM at which time the separate
existence of CSLM ceased and CSLM Holdings became the surviving corporation (“Pubco”) in accordance with the Delaware
General Corporation Law (“DGCL”), the Cayman Islands Companies Act (As Revised) (the “Companies Act”), the
Certificate of Merger, (the “Certificate of Merger”), and the amended and restated memorandum and articles of
association of CSLM (the “Domestication”); (b) the merger (the “Merger”) of Merger Sub with and into Legacy
Fusemachines, pursuant to which, at the closing of the transactions contemplated by the Business Combination Agreement (the
“Closing”), the separate corporate existence of Merger Sub ceased and Legacy Fusemachines became the surviving
corporation and a wholly-owned subsidiary of Pubco, pursuant to the terms of the Business Combination Agreement and in accordance
with the laws of the State of Delaware, as more fully described elsewhere in the Proxy Statement/Prospectus; and (c) the other
transactions contemplated by the Business Combination Agreement and documents related thereto (such transactions, together with the
Domestication and the Merger, the “Business Combination”). In connection with the Business Combination, Pubco was
renamed “Fusemachines Inc.” (the “Company”) and Fusemachines Inc. was renamed “Fusemachines USA,
Inc.” (“Legacy Fusemachines”).
The
common stock of the Company began trading on The Nasdaq Stock Market (Nasdaq Global Market) under the symbol “FUSE”, and
the warrants trade under the symbol “FUSEW”, beginning on October 23, 2025. The Merger between CSLM and Legacy Fusemachines
was accounted for as a reverse recapitalization. See Note 20 - Reverse Recapitalization for more information.
Throughout
the notes to the consolidated financial statements, unless otherwise noted or the context otherwise requires, the term “Company”
refers to Legacy Fusemachines and its subsidiaries prior to the consummation of the Business Combination, and to Fusemachines Inc. (the
publicly traded parent company) and its subsidiaries after the consummation of the Business Combination.
F- 8
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
Covenant
Fees
Pursuant
to the Business Combination Agreement, the Company was covenanted to deliver to CSLM its audited financial statements for the year ended December 31,
2023 and 2022 for inclusion in the registration statement on Form S-4 to be filed by CSLM in connection with the Merger, and that such
audited financial statements had been prepared in conformity with GAAP applied on a consistent basis and in accordance with the requirements
of the Public Company Accounting Oversight Board for public companies. The Company had covenanted to provide the audited financial statements
no later than February 29, 2024, or incur delay fees in the amount equal to $ 35.0 thousand for the first one-month delay to March 31,
2024 (pro-rated for a partial month), $ 50.0 thousand for the second one-month delay to April 30, 2024, and thereafter $ 70.0 thousand
for each subsequent one-month delay (pro-rated for any partial month). The Company provided the audited financial statements to CSLM
in September 2024. As such, the Company has recorded $ 505 thousand of deferred transaction costs on the audited consolidated balance
sheets as of December 31, 2024. On February 4, 2025, the company entered into a second amendment of the original agreement wherein the
above-mentioned delay fee provision is deleted and provides the Company with relief from future penalties related to the delivery of
the 2023 financial statements. Accordingly, the company recorded waiver in the year ended December 31, 2025 which have no impact in the
consolidated Statements of Operations and Comprehensive Loss as the amount of provision was eliminated from the deferred transaction
cost and from the Accounts Payable, Accrued expense and other current liabilities in the consolidated balance sheets.
Note
2. Summary of Significant Accounting Policies
Basis
of Presentation and Principles of Consolidation
The
Company prepares its consolidated financial statements in accordance with U.S. Generally Accepted Accounting Principles (“U.S.
GAAP” or “GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the
“SEC”) regarding financial reporting. The consolidated financial statements include the financial statements of
Fusemachines Inc. and its subsidiaries. Investments in entities where we hold at least a 20% ownership interest and have the ability
to exercise significant influence, but not control, over the investee are accounted for using the equity method of accounting. All
intercompany balances and transactions have been eliminated. These consolidated financial statements are presented in United States
Dollars (“USD” or $), which is the functional currency of the Parent Company. The consolidated financial statements as
of and for the year ended December 31, 2024, included herein was derived from the audited consolidated financial statements of
Legacy Fusemachines (now known as Fusemachines USA, Inc.).
Prior
Period Reclassifications
Certain
amounts in prior periods have been reclassified to conform with current period presentation.
Use
of Estimates
The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions. These
estimates and assumptions affect reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at
the date of the consolidated financial statements, as well as revenues and expenses during the reporting period. On an ongoing basis,
the Company evaluates its estimates and assumptions, including those related to the valuation of operating lease right-of-use assets,
convertible notes, cumulative mandatorily redeemable common and preferred stock liability, common stock warrants, common and convertible
preferred stock, current expected credit losses (“CECL”), stock-based compensation, useful lives of property and equipment
and intangible assets, impairment of long-lived assets, capitalization of software development costs, forward purchase derivative liability,
equity method investments and income taxes.
The
Company bases its estimates and judgments on historical experience, knowledge of current conditions and its beliefs of what could occur
in the future, given available information. Actual results could differ from those estimates, and such differences may be material to
the consolidated financial statements. Changes in facts and circumstances may cause the Company to revise its estimates.
Cash
& cash equivalents
The
Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. These
investments are carried at cost, which approximates fair value.
F- 9
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
Accounts
Receivable and Related Allowance for Expected Credit Losses
The
Company classifies its right to consideration in exchange for deliverables as an accounts receivable. A receivable is a right to consideration
that is unconditional (i.e., only the passage of time is required before payment is due) regardless of whether the amounts have been
billed. Accounts receivable represents amounts due from the Company’s customers for AI solutions (products and services). The Company
receives payments from customers based upon agreed-upon contractual terms. The timing of revenue recognition may differ from the timing
of invoicing to customers.
Account
receivables are stated net of allowance for expected credit losses. Outstanding receivables are reviewed periodically, and allowances
are provided for the estimated amount of receivables that may not be collected. The allowance for expected credit loss is based on the
probability of future collection determined by applying a loss-rate method using the Company’s historical loss experience. The
Company also considers reasonable and supportable current and future conditions in determining its estimated loss rates, such as external
forecasts, macroeconomic trends or other factors including customer specific credit risk characteristics. The adequacy of the allowance
is evaluated on a regular basis. Account balances are written off after all means of collection are exhausted and the balance is deemed
uncollectible, which occurs when balances reach 365 days past due. Subsequent recoveries are credited to the allowance. Changes in the
allowance are recorded as adjustments to bad debt expense in the period incurred.
Bad
debt expense is included in general and administrative expenses in the consolidated statements of operations and comprehensive loss.
Property
and Equipment, net
Property
and equipment acquired in the ordinary course of the Company’s operations are stated at cost, net of accumulated depreciation.
Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets. Leasehold improvements are amortized
on a straight-line basis over the shorter of the term of the lease or the estimated useful life of the improvement. Maintenance and repairs
are expensed as incurred
Depreciation
expense is included in general and administrative expenses in the consolidated statements of operations and comprehensive loss.
Depreciable
lives by major classification generally are as follows:
Schedule
of Property and Equipment, Net
Useful
life
Computers and other hardware
5 - 8 years
Vehicles and other fixed assets (excluding
computers)
2 - 10 years
Office, furniture, and equipment
2 - 10 years
Leasehold improvements - shorter of lease term
of estimated useful life
2 - 10 years
Intangible
assets, net
Intangible
assets consists of internally developed capitalized software, which will help in the management of the AI solutions business and will
be sold on a license basis.
Internal
use software
The
Company capitalizes certain costs related to internal use software acquired, modified, or developed related to the Company’s services
in accordance with ASC 350, Internal use software. These capitalized costs are primarily related to salaries and other personnel costs.
Costs incurred in the preliminary stages of development and the post implementation phase are expensed as incurred. The company adopts
agile method of software development which is generally characterized as an iterative and more dynamic process where the planning, design
and coding are less distinct and performed in short sprints. The Company analyses the nature of the development and implementation activities
- i.e. whether Subtopic 350-40 characterizes them as capitalizable application development stage activities - when deciding whether the
costs of those activities should be capitalized or expensed as incurred. Maintenance and training costs are expensed as incurred. The
amortization expense is recorded in “General and administration” on the consolidated statements of operations and comprehensive
loss.
Software
costs that are expensed are recorded in “Research and Development” on the consolidated statements of operations and comprehensive
loss.
F- 10
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
Software
developed for sale
The
costs incurred for the development of computer software to be sold, leased or otherwise marketed are capitalized in accordance with ASC
985, Costs of Software to be sold, leased or marketed, when technological feasibility has been established. Technological feasibility
generally occurs when all planning, designing, coding and testing activities are completed that are necessary to establish that the product
can be produced to meet its design specifications, including functions, features, and technical performance requirements. These capitalized
costs are primarily related to salaries and other personnel costs.
Schedule
of Intangible Assets, Net Useful Lives
Useful
life
Internally developed software
3 years
Segment
reporting
Under
Topic 280, an operating segment is defined as a component of a public entity that engages in business activities from which it may recognize
revenues and incur expenses, has operating results that are regularly reviewed by the CODM to make decisions about resources to be allocated
to the segment and assess its performance, and has discrete financial information available.
The
Company operates as one operating segment with a focus on data engineering, AI consulting, and technical services. The Company’s
Chief Executive Officer (“CEO”), as the Company’s chief operating decision maker, manages and allocates resources to
the operations of the Company on a consolidated basis. This enables the Company’s CEO to assess the overall level of available
resources and determine how best to deploy these resources across service lines in line with the Company’s long-term company-wide
strategic goals.
The
CODM considers the Company’s net income/(loss), expenses and the components of total assets to assess the segment’s performance
and make resource allocation decisions for the Company’s single segment which is consistent with that presented within these financial
statements.
As
the Company’s operations are comprised of a single reporting segment, the Company’s segment assets are reflected on the accompanying
consolidated balance sheet as “total assets” and its significant segment expenses and net loss are listed on the accompanying
Consolidated Statements of Operations and Comprehensive loss.
Impairment
of Long-Lived Assets
Long-lived
assets, such as property and equipment and finite-lived intangible assets, are reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses the straight-line method of depreciation
and amortization. When the carrying value of an asset is more than the sum of the undiscounted expected future cash flows, an impairment
is recognized. An impairment loss is measured as the excess of the asset’s carrying amount over its fair value. Intangible assets
that have finite useful lives are amortized over their estimated useful lives on a straight-line basis. Factors that would necessitate
an impairment assessment include a significant adverse change in the extent or manner in which an asset is used, a significant adverse
change in legal factors or the business climate that could affect the value of the asset, or a significant decline in the observable
market value of an asset, among others.
The
Company holds long-lived assets in two countries worldwide. The table below presents the breakdown of the Company’s long-lived
assets, based on geographic region (in thousands).
Schedule of Long-lived Assets, Based on Geographic Region
2025
2024
Long
lived assets as of
December 31,
December 31,
2025
2024
Nepal
$ 247
$ 286
United States
264
249
Total long-lived assets
$ 511
$ 535
F- 11
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
Fair
Value Option (“FVO”) Election
The
Company entered into related party convertible notes payable, at fair value in October 2019, September 2021, and Convertible Notes
payable at fair value in January 2024, (the “Convertible Notes at Fair Value”). (Refer to “Note 10 –
Long-Term Debt”). As permitted under ASC 825, Financial Instruments (“ASC 825”), the Company elected the FVO to
account for the Convertible Notes at Fair Value and Related Party Convertible notes at Fair Value. In accordance with ASC 825, the
Company recorded them at fair value. The FVO may be applied instrument by instrument, but it is irrevocable. Subsequent changes in
fair value would be recorded as a separate line in the consolidated statements of operations and comprehensive loss. As a result of
applying the FVO, direct costs and fees related to the Convertible Notes at Fair Value and Related Party Convertible notes at Fair
Value were expensed as incurred. The Company concluded it was appropriate to apply the FVO to Convertible Notes at Fair Value and
Related Party Convertible notes at Fair Value because they are liabilities that are not, in whole or in part, classified as a
component of stockholders’ equity. In addition, the Convertible Notes at Fair Value and Related Party Convertible notes at
Fair Value met other applicable criteria for electing the FVO under ASC 825.
Accumulated
Other Comprehensive Income
Accumulated
other comprehensive income consists of changes in the cumulative foreign currency translation adjustments.
Revenue
Recognition
The
Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). Under ASC
606, the Company recognizes revenue when (or as) customers obtain control of promised goods or services, in an amount that reflects the
consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenue following the
five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the
contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract;
and (v) recognize revenues when (or as) the Company satisfies a performance obligation. The Company applies the provisions of ASC 606
to an arrangement when a substantive contract exists and collectability is probable.
The
Company derives the majority of its revenue from AI Solutions (Products and Services) that largely represents professional services the
Company provides to its customers to help them achieve any AI-related goals within their organization. Standard contractual arrangements
are governed by Master Services Agreements (“MSAs”), which set out general terms including payment, termination rights, and
intellectual property ownership. Detailed scope, pricing, and performance obligations are defined in Statements of Work (“SOWs”),
which are executed for each engagement or project phase. The Company’s contracts for AI Services have different terms based on
the scope and complexity of engagements; pricing for the majority of contracts are invoiced monthly on a time-and-materials basis. The
Company notes that its contracts meet the requirements for over-time revenue recognition, as the customer is simultaneously receiving
the benefits and able to consume the benefits of the services being provided. For professional services that are distinct and billed
on a time-and-materials basis, revenue is generally recognized as the services are provided, which is reflective of the transfer of the
services to the customer. The Company elected the “right to invoice” practical expedient based on the Company’s right
to invoice a customer at an amount that approximates the value to the customer and the performance completed to date.
The
Company also provides AI Education Services which represents a customized curriculum of educational services provided to train the customer’s
C-suite on AI for Business. The Company provides AI Education Services over time as the course proceeds and the students retain knowledge
over time. Thus, the customer receives and consumes benefits as the Company performs the AI Education Services, and revenue is recognized
overtime.
Company’s
AI Solutions includes product revenues primarily comprising of software license fees from sales of term-based license contracts, under
which we grant customers the license right to use the software for a specified period (i.e. when the customer can access, use, and benefit
from the software license). Term software licenses are satisfied at a point in time and associated revenue is recognized upon the later
of 1) delivery of the software, or 2) the beginning of the period in which the customer has received the license right to use the software.
For customer contracts that include software license fees, implementation and/or other consulting services, the portion of the transaction
price allocated to software licenses is generally recognized when delivered. Implementation, customization, or model tuning services
if applicable, when included, are evaluated as separate performance obligations when they are distinct from the software and not highly
interdependent. These services are generally satisfied over time as the work progresses. During the year ended December 31, 2025 and
December 31, 2024, the product revenues were insignificant.
F- 12
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
For
most contracts, the Company uses a Master Service Agreements (“MSA”) to govern the overall relevant terms and conditions
of the business agreement, and a Statement of Work (“SOW”) to specify the services delivered and the associated prices. Performance
obligations specific to each individual contract are defined within the terms of each SOW. Each performance obligation is identified
based on the services that will be transferred to our customer that are both capable of being distinct and are distinct within the context
of the contract. The transaction price is determined based on the consideration to which the Company will be entitled and expect to receive
in exchange for transferring services to the customer.
Consideration
for some contracts may include variable consideration including volume discounts and rebates. If the consideration promised includes
a variable amount, the Company only includes estimated amounts of consideration in the transaction price to the extent it is probable
that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration
is resolved. These estimates require management judgments and estimates. The determination of whether to constrain consideration in the
transaction is based on historical, current, and forecasted information that is reasonably available to the Company, taking into consideration
the type of customer, the transaction, and specific facts and circumstances of each arrangement. The Company uses judgement to determine
if collectability of consideration is uncertain, and accordingly, revenue recognition is deferred until the uncertainty is resolved and
cash is collected.
Payment
terms and conditions vary by contract type, although terms generally include a requirement of payment within 30 to 60 days of the invoice
date. In certain arrangements, the Company will receive payment from a customer either before or after the performance obligation to
which the invoice relates has been satisfied. As a practical expedient, the Company does not account for significant financing components
if the period between when it transfers the promised good or service to the customer and when the customer pays for the product or service
will be one year or less.
For
contracts with multiple performance obligations, the Company allocates the contract’s transaction price to each performance obligation
based on its relative standalone selling price. The stand-alone selling prices are determined based on the prices at which the Company
separately sells these products. For items that are not sold separately, the Company estimates the stand-alone selling prices using other
observable inputs. As Fusemachines Inc. is the sole reportable segment, all revenues are attributed to the sole segment.
Contract
Balances
Differences
in timing between revenue recognition and cash collection result in contract assets and contract liabilities. The Company classifies
these assets as unbilled revenue; the liabilities are classified as deferred revenue.
Deferred
revenue represents the amounts billed or cash payments received in advance of revenue recognition at the end of the reporting period.
These amounts are recorded in deferred revenue until revenue is recognized through delivery of service or upon meeting the performance
obligation. The Company’s deferred revenue represents contract liabilities. Generally, when billing occurs subsequent to revenue
recognition, the Company reports unbilled revenue on the consolidated balance sheets.
Cost
of Revenue
Consists
principally of consulting and payroll expenses as well as stock-based compensation expense that are assigned to customer projects.
Selling
and Marketing Expenses
Selling
and marketing expenses represent costs incurred to promote the Company’s services offered, including salaries, benefits and related
costs of our sales and marketing personnel, and represent costs of advertising and other selling and marketing expenses. All sales and
marketing costs are expensed as incurred.
General
and Administrative Expenses
Consists
of expenses associated with general and administrative functions of the business such as the costs of salaries, stock-based compensation
expense, Information Technology (“IT”) infrastructure, allowance for expected credit losses, travel, legal and accounting
services, insurance, rent, software and tools, meals, other professional services activities, and certain non-income taxes.
Defined
Contribution Plan
Contributions
to defined contribution plans are expensed in the period in which services are rendered by the covered employees. The Company recognizes
its liabilities for compensated absences dependent on whether the obligation is attributable to employee services already rendered, relates
to rights that vest or accumulate and payment is probable and estimable.
F- 13
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
Stock-Based
Compensation
Stock-based
compensation expense attributable to equity awards granted to employees and non-employees is measured at the grant date based on the
fair value of the award. For employee awards, the expense is recognized on a straight-line basis over the requisite service period for
awards that actually vest, which is generally the period from the grant date to the end of the vesting period. For non-employee awards,
the expense for awards that actually vest is recognized based on when the goods or services are provided.
The
Company records stock-based compensation in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”).
This standard requires all equity-based payments to employees and non-employees, including grants of employee stock options and restricted
stock awards, to be recognized in the consolidated statements of operations and comprehensive loss based on the grant date fair value
of the award. The stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the award,
which is generally the period from the accounting grant date to the end of the vesting period. The Company elected to account for forfeitures
of awards as they occur.
Since
the adoption of ASU 2018-07, Improvements to Nonemployee Stock-Based Payment Accounting, the measurement date for non-employee awards
is the date of grant, and stock-based compensation costs are recognized in the same period and in the same manner as if the entity had
paid cash for the goods or services. Stock-based compensation expense is classified as general and administrative, cost of revenue, selling
and marketing and research and development expenses in the consolidated statements of operations and comprehensive loss.
The
Company estimates the fair value of stock option awards granted using the Black Scholes Merton option pricing formula (the “Black-Scholes
Model”). This model requires various significant judgmental assumptions in order to derive a final fair value determination for
each type of award, including the expected term, expected volatility, expected dividend yield, risk-free interest rate and fair value
of the Company’s stock on the date of grant. The expected option term for options granted is calculated using the “simplified
method”. This election was made based on the lack of sufficient historical exercise data to provide a reasonable basis upon which
to estimate the expected term. The simplified method defines the expected term as the average of the contractual term and the vesting
period. Estimated volatility is based on similar entities whose stock prices are publicly traded. The Company uses the historical volatilities
of similar entities due to the lack of sufficient historical data for the Company’s common stock price. The Company estimates volatility
based upon the observed historical volatilities of comparable companies over a lookback period commensurate with the estimated holding
period, adjusted for relative leverage using the Black-Scholes-Merton formula. Dividend yields are based on the Company’s history
and expected future actions. The Company has not declared or paid dividends to date and does not anticipate declaring dividends. As such,
the dividend yield has been estimated to be zero. The risk-free interest rate is based on the yield curve of a zero-coupon U.S. Treasury
bond on the date the stock option award was granted with a maturity equal to the expected term of the stock option award. All grants
of stock options generally have an exercise price equal to or greater than the fair market value of the Company’s common stock
on the date of grant.
The
fair value of the shares of common stock underlying the stock options has historically been determined by the Company’s Board of
directors as there was no public market for the underlying common stock prior to October 22, 2025. In estimating the fair value of its
stock, the Company uses a third-party valuation specialist and considers factors it believes are material to the valuation process, including
but not limited to, the price at which recent equity was issued by the Company to independent third parties or transacted between third
parties, any indications of value from offers to acquire the Company, actual and projected financial results, risks, prospects, economic
and market conditions, and estimates of weighted average cost of capital. The Company believes the combination of these factors provides
an appropriate estimate of the expected fair value of the Company and reflects the best estimate of the fair value of the Company’s
common stock at each grant date.
Notes
Receivable from Stockholders
From
time to time the Company has entered into promissory note agreements with certain employees for the purpose of financing the early exercise
of the Company’s stock options. Although the shares of common stock purchased by the employees in exchange for the promissory notes
are considered legally issued, the Company does not consider them outstanding for accounting purposes. Instead, the Company treats them
as restricted until the options are fully vested and the outstanding principal and accrued interest on the notes are repaid in full.
Unvested shares for which the promissory notes are fully satisfied are recorded as a share repurchase liability and as shares vest are
recognized to additional paid-in capital in the Consolidated Balance Sheets.
Advertising
Cost
Advertising
costs are expensed as incurred. Advertising costs were $ 61.8
thousand and $ 126.2
thousand for the years ended December 31, 2025, and 2024, respectively, which are included in selling and marketing costs on the
consolidated statements of operations and comprehensive loss.
F- 14
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
Income
Taxes
The
provision for income taxes includes federal, state, local and foreign taxes. Deferred tax assets and liabilities are recognized for the
estimated future tax consequences of temporary differences between the consolidated financial statements carrying amounts and their respective
tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in
which the temporary differences are expected to be reversed. Changes to enacted tax rates would result in either increases or decreases
in the provision for income taxes in the period of changes
The
realizability of deferred tax assets is primarily dependent on future earnings. The Company evaluates the realizability of deferred tax
assets and recognizes a valuation allowance when it is more likely than not that all, or a portion of, deferred tax assets will not be
realized. A reduction in estimated forecasted results may require that we record valuation allowances against deferred tax assets. Once
a valuation allowance has been established, it will be maintained until there is sufficient positive evidence to conclude that it is
more likely than not that the deferred tax assets will be realized. A pattern of sustained profitability will generally be considered
as sufficient positive evidence to reverse a valuation allowance. If the allowance is reversed in a future period, the income tax provision
will be correspondingly reduced.
Accordingly,
the increase and decrease of valuation allowances could have a significant negative or positive impact on future earnings
The
United States subjects corporations to taxes on Global Intangible Low-Taxed Income (“GILTI”) earned by certain foreign subsidiaries.
The Company elected to provide for the tax expense related to GILTI in the year the tax is incurred.
Deferred
Transaction Costs
The
Company records deferred transaction costs, which consist of legal, accounting, and other fees related to the preparation of the Merger.
(Refer to “Note 1 – Organization”). The deferred transaction costs will be offset against proceeds from the transaction
upon the effectiveness of the Business Combination. Fusemachines Inc. incurred transaction cost of $ 1,873
thousands, consisting of deferred transaction cost, banking
fees, legal fees, and other professional fees as at October 22, 2025, which has been recorded as a reduction to Additional paid-in capital
as a direct and incremental cost of the reverse recapitalization.
Convertible Preferred Stock
The Company applies the guidance
enumerated in ASC Subtopic 480-10,
Distinguishing Liabilities from Equity-Overall ( “ ASC
480-10 ” ),
when determining the classification and measurement of convertible preferred stock. Convertible preferred stock subject to mandatory
redemption are classified as liability instruments and are initially measured at fair value in accordance with ASC 480-10 and accreted
to their redemption value under the effective interest method. All other issuances of convertible preferred stock are subject to the
classification and measurement principles of ASC 480-10. Accordingly, the Company classifies conditionally redeemable preferred stock
(if any), which includes preferred stock that feature redemption rights that are either within the control of the holder or subject to
redemption upon the occurrence of uncertain events not solely within the Company ’ s
control, as temporary equity. At all other times, the Company classifies its convertible preferred stock in stockholder’s deficit.
Research
and Development Costs
The
Company accounts for research and development costs in accordance with the ASC 730, Research and Development. Under ASC 730, all research
and development costs are expensed as incurred, with the exception of certain software development costs discussed above. Our research
and development costs consist primarily of payroll costs associated with software product development, testing, quality assurance, documentation,
enhancements and upgrades for existing customers under maintenance.
Research and Development costs were $ 720
thousand and $ 732
thousand for the years ended December 31, 2025 and 2024 respectively, which are included in the consolidated statements of
operations and comprehensive loss.
Net
Loss per Share
The
Company applies the two-class method to compute basic and diluted net loss per share attributable to common shareholders, when shares
meet the definition of participating securities. The two-class method determines net loss per share for each class of common and participating
securities according to dividends declared or accumulated and participation rights in undistributed earnings. The two-class method requires
income (loss) available to common shareholders for the period to be allocated between common and participating securities based upon
their respective rights to share in the earnings as if all income (loss) for the period had been distributed. The Company reported a
net loss attributable to common shareholders for the year ended December 31, 2025 and 2024.
Basic
net loss per share is computed by dividing the net loss attributable to common shareholders by the weighted-average number of shares
of common stock outstanding during the year. Diluted net loss per share is computed by dividing the net loss attributable to common shareholders
by the weighted average number of shares outstanding, plus the impact of potential common shares, if dilutive, resulting from the potential
exercise of warrants or options, and the potential conversion of preferred stock or convertible notes, into common stock, under the if-converted
method. Due to the net losses for the year ended December 31, 2025 and 2024, basic and dilutive net loss per share were the same, as
the effect of potentially dilutive securities would have been anti-dilutive
F- 15
Fusemachines
Inc. and Subsidiaries Notes to the Consolidated Financial Statements
Warrants
The Company accounts for warrants as either equity-classified
or liability-classified instruments based on an assessment of the specific terms of the instruments in accordance with FASB ASC Topic
480, Distinguishing Liabilities from Equity (“ASC 480”) and FASB ASC Topic 815, Derivatives and Hedging (“ASC
815”).
Shortfall warrants, public and private warrants, and
warrants issued in connection with convertible notes were evaluated under ASC 480 and ASC 815-40 and determined not to meet the criteria
for liability classification. These warrants are indexed to the Company’s own stock and meet the requirements for equity classification.
Accordingly, such warrants are recorded within stockholders’ equity and are not subsequently remeasured.
All other warrants that do not meet the criteria for
equity classification are accounted for as liabilities and measured at fair value, with changes in fair value recognized in the consolidated statement of operations and comprehensive loss in each reporting period.
Commitments
and Contingencies
The
Company may at times be involved in litigation in the ordinary course of business. The Company will, from time to time, when
appropriate in management’s estimation, record adequate reserves in the Company’s consolidated financial statements for
pending litigation. Currently there are no material
pending or threatened litigation matters that management believes require accrual or disclosure in addition to those presented in
the Note on Litigation (refer Note 17 – Commitments and Contingencies).
Foreign
Currency Translation and Remeasurement
Assets
and liabilities of consolidated foreign subsidiaries whose functional currency is not the U.S. dollar are translated into U.S. dollars
at period-end exchange rates and revenues and expenses are translated into U.S. dollars using average exchange rates during the year.
Equity transactions are translated using historical exchange rates. The adjustment resulting from translating the consolidated financial
statements of such foreign subsidiaries into U.S. dollars is reflected as a cumulative translation adjustment and reported as a component
of Accumulated other comprehensive loss.
Risks
and Uncertainties
As
a result of its global operations, the Company may be subject to certain inherent risks.
Concentration
of Credit - Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of cash
and cash equivalents, and accounts receivable. The Company maintains cash and cash equivalents with financial institutions. The Company
believes its credit policies reflect normal industry terms and business risk and there is no expectation of non-performance by the counterparties.
Accounts receivables are generally dispersed across many customers operating in different industries; therefore, concentration of
credit risk is limited. If any of the Company’s customers enter bankruptcy protection or otherwise take steps to alleviate their
financial distress, the Company’s credit losses and write-offs of receivables could increase, which would negatively impact its
results of operations.
Significant
Customers and Suppliers — The concentration of credit risk with respect to accounts receivable is primarily limited to certain
customers to which the Company makes substantial sales. To minimize credit risk related to accounts receivable, the Company maintains
allowances for potential credit losses based on historical loss patterns as well as future expectations. As of December 31, 2025 and
December 31, 2024, the Company had three and four customers whose accounts receivable balance accounted for at least 10% of the Company’s
/stocks — the workspaceLOADING